fluorodeoxyglucose f18 has been researched along with Breast Cancer in 1463 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.07) | 18.7374 |
| 1990's | 88 (6.02) | 18.2507 |
| 2000's | 394 (26.93) | 29.6817 |
| 2010's | 724 (49.49) | 24.3611 |
| 2020's | 256 (17.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abrar, DB; Antoch, G; Bittner, AK; Breuckmann, K; Bruckmann, NM; Buchbender, C; Dietzel, F; Fendler, WP; Häberle, L; Herrmann, K; Hoffmann, O; Ingenwerth, M; Kirchner, J; Mohrmann, S; Morawitz, J; Ruckhäberle, E; Sawicki, LM; Ullrich, T; Umutlu, L | 1 |
| Cholewiński, W; Kunikowska, J; Marszałek, A; Medak, A; Pietrasz, K; Pietrzak, A; Piotrowski, T; Wojtowicz, J | 1 |
| Fujimoto, A; Hasebe, T; Kosaka, Y; Saeki, T | 1 |
| Kim, S; Kwon, HW; Lee, JH; Pahk, K; Park, KH | 1 |
| Emi, A; Kadoya, T; Kawamata, A; Masumoto, N; Sasada, S | 1 |
| Chen, G; Chen, X; Fu, Z; Li, Q | 1 |
| Mankoff, DA; Sellmyer, MA | 1 |
| Okazawa, H | 1 |
| Cai, L; Chen, Y; Tang, W; Wang, Q | 1 |
| Huang, Y; Lai, B; Zheng, S | 1 |
| Gantumur, D; Kamioka, H; Li, Y; Mizoi, K; Ogihara, T; Tsushima, Y; Zhang, X; Zhu, M | 1 |
| Choi, YJ; Kang, T; Kim, H; Kim, IJ; Kim, K; Pak, K; Seol, YM | 1 |
| Lane, DL; Neelapu, SS; Weaver, O; Xu, G | 1 |
| Boudy, AS; Dabi, Y; Darai, E; Despierres, M; Gligorov, J; Khaldoun, K; Montravers, F; Richard, S; Selleret, L; Thomassin, I; Touboul, C; Zilberman, S | 1 |
| Alavi, A; Baun, C; Duvnjak, S; Falch, K; Gerke, O; Hansen, JA; Hildebrandt, MG; Høilund-Carlsen, PF; Naghavi-Behzad, M | 1 |
| Le-Petross, HT; Patel, MM | 1 |
| Bartel, T; Decker, T; Herrmann, K; Kersting, D; Pabst, KM; Seifert, R; Sraieb, M | 1 |
| Antoch, G; Bittner, AK; Bruckmann, NM; Buchbender, C; Herrmann, K; Hoffmann, O; Ingenwerth, M; Kirchner, J; Li, Y; Mohrmann, S; Morawitz, J; Sawicki, LM; Schaarschmidt, BM; Stang, A; Umutlu, L | 1 |
| Chen, H; Hao, B; Meng, T; Pang, Y; Shang, Q; Sun, L; Xu, W | 1 |
| Adam, JA; Booij, J; Bronner, IM; van Eerde, MS | 1 |
| Kadoya, T; Kai, A; Kimura, Y; Masumoto, N; Sasada, S | 1 |
| Karanth, SS; Khanna, G; Malik, D; Manda, D; Raina, V; Sen, IB | 1 |
| Asmussen, JT; Braad, PE; Gerke, O; Hildebrandt, MG; Kidholm, K; Kodahl, AR; Naghavi-Behzad, M; Olsen, MMB; Oltmann, H; Vach, W; Vester, RM; Vogsen, M; Weber, W | 1 |
| Chen, M; Dong, A; Hu, Y; Li, H; Ran, P | 1 |
| Emi, A; Kadoya, T; Masumoto, N; Okada, M; Sasada, S | 1 |
| Cai, L; Chen, Y; Wang, W; Xu, T; Yang, C | 1 |
| Çağlar, HB; Canoğlu, MD; Küçük, N; Küçükmorkoç, E; Rzazade, R; Turna, M | 1 |
| Fujioka, T; Imokawa, T; Kawase, T; Kubota, K; Mori, M; Onishi, H; Satoh, Y; Takahashi, K; Tateishi, U; Yamaga, E | 1 |
| Ishiwata, K; Kubota, K; Munechika, H; Nakasato, T; Saginoya, T | 1 |
| Aker, F; Atag, E; Coban, E; Gungor, S; Sari, M; Simsek, ET | 1 |
| Borm, KJ; Buschner, G; Combs, SE; Duma, MN; Düsberg, M; Ernst, L; Oechsner, M; Voppichler, J; Weber, W | 1 |
| Albatineh, AN; Sarikaya, A; Sarikaya, I; Sezer, YA; Tastekin, E | 1 |
| Albano, D; Bellini, P; Bertagna, F; Dondi, F; Giubbini, R | 1 |
| Inoue, T; Noritake, M; Utsunomiya, D; Yamada, A; Yamanaka, S | 1 |
| Cheng, S; Qiu, S; Song, S; Zhu, X; Zou, S | 1 |
| Choi, B | 1 |
| Arac, E; Cakabay, B; Can, C; Guzel, Y | 1 |
| Caracciolo, M; Catalano, O; Cistaro, A; Evangelista, L; Panareo, S; Stracuzzi, F; Urso, L | 1 |
| Chen, H; Meng, T; Pang, Y; Shang, Q; Xu, W | 1 |
| Chotipanich, C; Kiatkittikul, P; Kunawudhi, A; Promteangtrong, C; Siripongsatian, D | 1 |
| Allen, SD; Bhaludin, BN; Downey, K; Gagliardi, T; Johnston, SRD; Koh, DM; McGrath, SE; Messiou, C; Okines, AF; Parton, MM; Pope, R; Ring, AE; Sharma, B; Tunariu, N | 1 |
| Alhoubani, Y; Catalano, OA; Davidson, T; Domachevsky, L; Eifer, M; Eshet, Y; Kanana, N; Klang, E; Konen, E; Pinian, H; Tau, N | 1 |
| Abraham, P; Bodapati, S; Chen, A; Guilbault, D; Matro, J; McDonald, M; Obrzut, S; Shatsky, R | 1 |
| Jochelson, MS; Lobbes, MBI; van Nijnatten, TJA | 1 |
| Jacene, HA; Sakellis, CG | 1 |
| Hildebrandt, MG; Naghavi-Behzad, M; Vogsen, M | 1 |
| Baek, JH; Chang, YW; Chun, SY; Hwang, J; Kang, KW; Kim, C; Kim, SJ; Shin, JH; Yang, KH; Yoo, JW | 1 |
| Buffa, FM; Carter, RD; Cheng, WC; Fenwick, JD; Gleeson, F; Harris, AL; Liu, D; Lord, SR; McGowan, DR; Patel, N; Ralli, GP; Teoh, EJ | 1 |
| Daimaru, Y; Kajitani, K; Kawamura, S; Koi, Y; Kondo, T; Ohara, M; Oride, Y; Sasada, T | 1 |
| Ishigaki, S; Ishiguchi, T; Kato, K; Naganawa, S; Satake, H; Sato, T; Shimamoto, K; Shimizu, Y; Tadokoro, M; Uota, F | 1 |
| Allen, TJ; Bradshaw, TJ; Fowler, AM; Henze Bancroft, LC; Kumar, M; McMillan, AB; Strigel, RM | 1 |
| Alimoglu, O; Baysal, B; Baysal, H; Ekinci, O; Erol, CI; Gungor, S; Ozemir, IA; Ozsoy, MS; Serdaroglu, AY | 1 |
| Groheux, D | 6 |
| An, C; Li, X; Zhang, W | 1 |
| Babiker, A; Bhaludin, BN; Downey, K; Hujairi, N; Koh, DM; McGrath, SE; Messiou, C; Okines, AF; Ring, AE; Senthivel, N; Sharma, B; Soneji, ND; Tunariu, N | 1 |
| Kiyono, Y; Makino, A; Mori, T; Okazawa, H; Tsujikawa, T; Tsuyoshi, H; Yoshida, Y | 1 |
| Agrawal, A; Choudhury, S; Purandare, N; Puranik, A; Rangarajan, V; Shah, S; Shet, T | 1 |
| Alavi, A; Basu, S; Kumar, R; Phulia, A; Yadav, D | 1 |
| Donswijk, ML; Haarsma, R; Scholten, AN; van Duijnhoven, FH; van Loevezijn, AA; Vrancken Peeters, MTFD | 1 |
| Edmonds, CE; Mankoff, DA; O'Brien, SR; Pantel, AR | 1 |
| Bal, A; Bhatia, A; Chadha, V; Chhabra, A; Kaur, K; Kumar, R; Laroiya, I; Mittal, BR; Sharma, U; Shukla, J; Singh, G; Upadhyay, D; Vatsa, R | 1 |
| Albader, FL; Elhaggracy, RS; Marafi, F; Usmani, S | 1 |
| Akashi-Tanaka, S; Hashimoto, R; Ide, Y; Kobayashi, Y; Kuwayama, T; Masuda, H; Nakamura, S; Takamaru, T; Takimoto, M; Taruno, K; Watanabe, C | 1 |
| Bhoriwal, S; Ephraim, R; Kar, M; Muduly, DK; Pathak, M; Ray, S; Sultania, M | 1 |
| Beets-Tan, RGH; de Mooij, CM; Heuts, EM; Kooreman, LFS; Lobbes, MBI; Mitea, C; Samiei, S; Smidt, ML; van Nijnatten, TJA | 1 |
| Emi, A; Ikejiri, H; Kadoya, T; Masumoto, N; Okada, M; Sasada, S | 1 |
| Erdil, TY; Filizoglu, N; Ozguven, S | 1 |
| Nangia, S; Patil, S; Sirohi, B; Sundaraiya, S; T, R | 1 |
| Besli, LU; Kayadibi, Y; Kocael, P; Kurt, SA; Nazari, A; Ozturk, T; Samanci, C; Sayman, H | 1 |
| de Andrés Gómez, A; Ferrer Rebolleda, J; Fuster Diana, CA; García García, JÁ; García-Vilanova Comas, A; Sánchez Jurado, R; Villalba Ferrer, F | 1 |
| Campone, M; Colombie, M; Ferrer, L; Fourcade, C; Guillerminet, C; Jezequel, P; Lacombe, M; Moreau, N; Normand, N; Rousseau, C; Rubeaux, M; Santini, G | 1 |
| Airò Farulla, LS; Ceci, F; Gilardi, L | 1 |
| Helbich, TH; Pinker, K; Romeo, V | 1 |
| Bun, A; Fujimoto, Y; Fukui, R; Higuchi, T; Kanaoka, H; Kitajima, K; Miyoshi, Y; Nagahashi, M; Ozawa, H; Yamakado, K | 1 |
| Abo, N; Hirata, K; Ikegawa, C; Imai, M; Kusuzaki, M; Onishi, H; Oyama-Manabe, N; Satoh, Y | 1 |
| Arikan, AE; Dulgeroglu, O; Kara, H; Uras, C | 1 |
| Brunotte, F; Cochet, A; Courcet, E; Coutant, C; Desmoulins, I; Payan, N; Presles, B; Truntzer, C; Vrigneaud, JM | 1 |
| Choi, EK; Chung, YA; Oh, JH; Oh, JK; Park, SY; Yoo, IR | 1 |
| Li, W; Shi, W | 1 |
| Comito, T; Di Cristina, L; Di Gallo, A; Dominici, L; Franceschini, D; Franzese, C; Lo Faro, L; Marini, B; Marzo, MA; Scorsetti, M; Spoto, R; Stefanini, S; Vernier, V | 1 |
| Borrego, MR; Braga, S; Colleoni, M; Cortés, J; Dalenc, F; Gebhart, G; Kerrou, K; Llombart-Cussac, A; Malfettone, A; Marmé, F; Pérez-García, JM; Prat, A; Sampayo-Cordero, M; Schmid, P | 1 |
| Baron-Hay, S; Batty, K; Bernard, EJ; Boyle, F; Chan, DL; Clarke, SJ; Diakos, CI; Guminski, A; Pavlakis, N; Taylor, AM | 1 |
| Abikhzer, G; Bénard, F; Black, P; Burrell, S; Cossette, M; Eigl, BJ; Harsini, S; Krauze, A; Mar, C; Martin, M; Metser, U; Nichol, A; Romsa, J; Saad, F; Soucy, JP; Tardif, JC; Turcotte, E; Wilson, D; Zukotynski, K | 1 |
| Albano, D; Bellini, P; Bertagna, F; Camoni, L; Dondi, F; Treglia, G | 1 |
| Capanu, M; Chou, JF; Janjigian, YY; Lewis, JS; Lumish, MA; Lyashchenko, SK; Maron, SB; O'Donoghue, JA; Pandit-Taskar, N; Paroder, V; Philemond, S; Schöder, H | 1 |
| Fujimoto, K; Ishimori, T; Kataoka, M; Matsumoto, Y; Miyake, KK; Nakamoto, Y; Sugie, T; Toi, M; Yuge, S | 1 |
| Glaudemans, AWJM; Keijsers, RGM; Lam, MGEH; Lavalaye, J; van den Hoven, AF; Verburg, FA; Vogel, WV | 1 |
| Choudhury, S; Dwivedi, P; Jha, AK; Rangarajan, V; Sawant, V; Vajarkar, V; Vatsa, R | 1 |
| Bourke, A; Menon, P | 1 |
| Albrecht-Beste, E; Aleksyniene, R; Andersen, FL; Fischer, BM; Korsholm, K; Vadstrup, ES | 1 |
| Lai, AYT; Lo, SSW; Mo, CKM; Wong, TS; Wong, WWC | 1 |
| Fujimoto, Y; Higuchi, T; Inao, Y; Ishikawa, E; Kitajima, K; Komoto, H; Miyoshi, Y; Yamakado, K; Yokoyama, H | 1 |
| Ruan, D; Sun, L | 1 |
| Hong, JH; Kwon, SJ; Lee, A; Lee, J; Lee, SW; Park, HL; Park, SY; Yoo, IR | 1 |
| Hod, N; Lantsberg, S; Nalbandyan, K; Porges, T | 1 |
| Antunovic, L; Benvenuti, C; Chiti, A; De Sanctis, R; Farina, E; Gaudio, M; Jacobs, F; Miggiano, C; Pastore, M; Santoro, A; Tiberio, P; Viganò, A | 1 |
| Arikan, AE; Capkinoglu, E; Dulgeroglu, O; Kara, H; Uras, C | 1 |
| Cao, G; Fan, H; Liu, Y; Shao, W; Shi, X; Wang, W; Zhang, J | 1 |
| Liang, Z; Liu, W; Mo, Y; Zeng, X; Zhang, C | 1 |
| Chae, SY; Gong, G; Han, S; Lee, J; Lee, SB; Moon, DH; Oh, JS | 1 |
| Apter, S; Bernstein-Molho, R; Davidson, T; Domachevsky, L; Eifer, M; Eshet, Y; Gal-Yam, E; Globus, O; Gorfine, M; Itay, A; Levanon, K; Nissan, N; Oedegaard, C; Shapira, T; Tau, N | 1 |
| Heyman, SN; Khamaisi, M; Khateeb, J; Shlon, D | 1 |
| Chen, X; Chen, Y; Lin, J; Miao, W; Zhang, J; Zheng, S; Zhu, Y | 1 |
| Alçin, G; Arslan, E; Çermik, TF; Ergül, N; Menengiç Koç, MS; Tatar, G | 1 |
| Aftimos, P; Beelen, AP; Bektas, HO; Boellaard, R; de Vries, EGE; Gebhart, G; Glaudemans, AWJM; Iqbal, R; Menke-van der Houven van Oordt, CW; Oprea-Lager, DE; Schuit, RC; Windhorst, AD; Yaqub, M | 1 |
| Agrawal, K; Bishnoi, K; Kumar, P; Parida, GK; Singh, P; Singhal, T | 1 |
| Ulaner, GA | 1 |
| Hassan, A; Muzaffar, M | 1 |
| Cardoso, F; Marques, HP; Oliveira, C; Oliveira, F; Vaz, SC | 1 |
| Linden, HM; Mankoff, DA | 2 |
| Alpoim, T; Cristo Santos, J; Duarte, H; Henriques Abreu, M; Henriques Abreu, P; Próspero, I; Seoane Santos, M; Sousa, S | 1 |
| Fujimori, S; Ishihara, M; Kawabata, H; Kawaguchi, S; Kinowaki, K; Kobayashi, Y; Nishikawa, A; Ogura, T; Sato, J; Shibata, A; Shiiba, M; Suzuki, S; Tamura, N; Tanaka, K | 1 |
| Coskun, G; Hasbek, Z; Karabacak, U; Karadayi, K; Mollaoglu, MC; Turkan, H | 1 |
| Civan, C; Has Simsek, D; Isik, EG; Kuyumcu, S; Sanli, Y | 1 |
| Balber, T; Baltzer, PAT; Berroterán-Infante, N; Clauser, P; Fueger, BJ; Hacker, M; Helbich, TH; Kapetas, P; Milos, RI; Rasul, S | 1 |
| Arnaout, A; Blanchette, P; Chan, A; Cil, TD; Dayes, IS; Eisen, AF; George, R; Hodgson, N; Levine, MN; Metser, U; Parpia, S | 1 |
| Dendl, K; Giesel, FL; Haberkorn, U; Koerber, SA; Watabe, T | 1 |
| Abe, K; Cardinale, J; Doki, Y; Eguchi, H; Giesel, FL; Inohara, H; Kamiya, T; Kato, H; Kimura, T; Kobayashi, S; Kurokawa, Y; Miyake, T; Mori, Y; Naka, S; Shimazu, K; Shintani, Y; Tatsumi, M; Watabe, T | 1 |
| Muzahir, S; Schuster, DM; Ulaner, GA | 1 |
| Evangelista, L; Filippi, L; Schillaci, O | 1 |
| Aksoy, T; Alçın, G; Arslan, E; Beyhan, E; Çermik, TF; Cin, M; Ergül, N; Erol Fenercioğlu, Ö | 1 |
| Cecil, K; Dibble, EH; Huppert, L; Lawhn-Heath, C; Mukhtar, R; O'Brien, SR; Ulaner, GA | 1 |
| Nemzow, G; Zuckier, LS | 1 |
| Beavers, K; Fardanesh, R; Jochelson, MS; Ulaner, GA | 1 |
| Ae, K; Ariga, A; Hayakawa, K; Kurosawa, N; Matsumoto, S; Minami, Y; Saito, M; Tanizawa, T; Terauchi, T; Yamashita, K | 1 |
| Deng, S; Jia, T; Lv, Q; Sang, S; Yu, C; Zhang, B | 1 |
| Hanazaki, K; Kitagawa, H; Kobayashi, M; Maeda, H; Namikawa, T; Satake, H; Seo, S; Sugimoto, T; Tamura, M; Yokota, K | 1 |
| Castro, PHR; Coelho, FARFB; Kurkowski, FD; Lopes, RW; Matushita, CS; Pianta, DB; Rodrigues, DF; Silva, MMD; Souza, SAL; Stasiak, CES | 1 |
| Aksoy, T; Alçın, G; Arslan, E; Baykara Ulusan, M; Çermik, TF; Ergül, N | 1 |
| Bian, H; Chen, W; Dai, D; Li, X; Liu, J; Ma, W; Wang, Z; Xu, W; Yin, G; Zhang, H; Zhang, Y; Zhang, Z; Zhu, L | 1 |
| Cesmecioglu, E; Dede, F; Karaman, D; Kesim, S; Turoglu, HT | 1 |
| Agrawal, K; Parida, GK; Patro, SS; Singh, P; Singhal, T | 1 |
| Atilgan, HI; Bulut, G; Çınarer, G; Kılıç, K; Parlar, T; Yıkar, D | 1 |
| Seban, RD | 1 |
| Af Burén, S; Altena, R; Axelsson, R; Tran, T | 1 |
| Gu, B; Hu, X; Liu, C; Ma, G; Song, S; Wang, B; Xie, Y; Yang, Z; You, S | 1 |
| Biernaski, H; Butler, J; Chau, OW; deKemp, R; El-Sherif, O; Gaede, S; Mouawad, M; Prato, FS; Renaud, J; Sykes, JM; Wisenberg, G | 1 |
| Cheng, J; Liu, C; Ma, G; Song, S; Yang, Z; Zhang, J | 1 |
| Han, B; Liu, S; Lu, L; Yuan, M; Zhang, N | 1 |
| Rasheed, N; Razi, M | 1 |
| Avsar, G; Bayar, S; Cetindag, Ö; Deryol, R; Eroglu, A; Ertekin, SÇ; Hakseven, M; Karasoy, D | 1 |
| Gebhart, G | 1 |
| Erdogan, M; Eroglu, HE; Gurdal, O; Ozkan, EE; Sengul, SS | 1 |
| Çermik, TF; Dağ, S; Ergul, N; Yilmaz, B | 1 |
| Dağ, A; Koc, ZP; Özcan Kara, P; Tuncel Daloğlu, F | 1 |
| Bernhardt, G; Keller, M; Kuwert, T; Maschauer, S; Ott, JJ; Prante, O | 1 |
| Cho, YS; Jung, KH; Lee, EJ; Lee, JH; Lee, KH; Moon, SH; Park, JW | 1 |
| Borm, KJ; Buschner, G; Combs, SE; Duma, MN; Düsberg, M; Oechsner, M; Weber, W | 1 |
| Bryce, R; Dujka, M; Hyman, DM; Jhaveri, K; Mann, G; Mayer, I; Meric-Bernstam, F; Piha-Paul, SA; Quinn, D; Saura, C; Shahin, S; Solit, DB; Stone, B; Ulaner, GA | 1 |
| Dai, Y; Duan, X; Guo, Y; Li, Y; Wang, J | 1 |
| Andreassen, MMS; Bathen, TF; Deng, C; Eikesdal, HP; Goa, PE; Hedayati, R; Jerome, NP; Lundgren, S; Sjøbakk, TE; Østlie, A | 1 |
| Lam, WW; Leong, LCH; Peh, WM; Tan, PH; Tan, VK; Tang, CYL; Xie, W | 1 |
| Apala, JV; Caleiras, E; Cortés, J; Cortés-Salgado, A; Gasol Cudos, A; Gion, M; Guerra, J; Lopez-Alonso, A; Malón, D; Manso, L; Morales, S; Mouron, S; Mulero, F; Muñoz, M; Quintela-Fandino, M; Salla Fortuny, J | 1 |
| Gluskin, JS; Montane, G; Nanni, G; Perez, R | 1 |
| Kirchner, J; Riedl, CC; Ulaner, GA | 1 |
| Ma, X; Ou, X; Pang, F; Wang, J; Wang, Y; Wei, X; Zhang, J | 1 |
| Liu, Y | 1 |
| Bang, JI; Kim, BS; Kim, HL; Kim, HN; Lim, W; Moon, BI; Paik, NS; Yoon, HJ | 1 |
| Hu, Y; Li, X; Liu, L; Wen, W; Xu, D; Xuan, D | 1 |
| Azevedo, ÍM; Macedo, R; Medeiros, AC; Oliveira, CN; Rocha, KBF | 1 |
| Hoshina, H; Takei, H | 1 |
| De Leiris, N; Djaileb, L; Nika, E; Phan Sy, O; Rouchy, RC | 1 |
| Bian, Y; Hu, Y; Tian, C; Wei, Q; Zhang, X | 1 |
| Boers, J; de Vries, EFJ; Elias, SG; Glaudemans, AWJM; Hospers, GAP; Kwee, TC; Martens, JWM; Schröder, CP; Schuuring, E; Venema, CM | 1 |
| Aksoy, T; Arslan, E; Can Trabulus, FD; Çermik, TF; Kelten Talu, C; Yeni, B | 1 |
| Amersi, F; Srour, MK | 1 |
| Hida, AI; Kubota, K; Murakami, W; Ohi, Y; Sagara, Y; Sasaki, M; Tozaki, M | 1 |
| Laffon, E; Marthan, R | 1 |
| Groheux, D; Hindié, E | 3 |
| Arici, S; Atci, MM; Cekin, R; Cihan, Ş; Geredeli, C; Karyagar, S; Karyagar, SS; Sakin, A; Seçmeler, Ş | 1 |
| Antunovic, L; Cavinato, L; Chiti, A; Cozzi, L; Kirienko, M; Ninatti, G; Sollini, M | 1 |
| Feng, D; Fulham, MJ; Huang, G; Li, P; Liu, C; Song, S; Wang, L; Wang, X; Xu, C; Zheng, C | 1 |
| Gajjala, SR; Hulikal, N; Kadiyala, S; Kalawat, T; Kottu, R | 1 |
| Barres, B; Chanchou, M; Coudert, B; Durando, X; Gadéa, E; Ginzac, A; Merlin, C; Molnar, I; Thivat, E | 1 |
| Gu, B; Lian, W; Liu, C; Lu, L; Pan, H; Song, S; Wang, M; Yang, Z; Yao, Z; Zhang, J; Zhang, Y | 1 |
| Basso, L; Garbino, N; Nicolai, E; Pace, L; Salvatore, M; Soricelli, A | 1 |
| Bangiyev, L; Bernstein, C; Cattell, R; Cohen, J; Duanmu, H; Duong, TQ; Ha, R; Huang, P; Jambawalikar, S; Li, H; Liu, MZ; Ren, T; Vanguri, R; Wang, F | 1 |
| Dalci, K; Guney, IB; Kucuker, KA; Teke, ZT | 1 |
| Fujii, T; Hirakata, T; Honda, C; Kaira, K; Katayama, A; Kurozumi, S; Nakazawa, Y; Obayashi, S; Oyama, T; Shirabe, K; Tokuda, S; Yajima, R; Yanai, K | 1 |
| Di, G; He, M; Liu, C; Liu, G; Liu, Y; Shao, Z; Shi, Q; Sun, Y; Wang, Z; Xu, X; Yang, Z; Yuan, H; Zhang, Y | 1 |
| Autore, F; Fresa, A; Innocenti, I; Laurenti, L; Paolini, A; Sica, S; Sora, F; Zini, G | 1 |
| Giladi, MR; Hod, N; Kazap, DE; Lantsberg, S; Levin, D | 1 |
| Castanheira, J; Costa, DC; Mairos Teixeira, S; Mascarenhas Gaivão, A; Pereira, PJ | 1 |
| Cochet, A; Desmoulins, I; Drouet, C; Vrigneaud, JM | 1 |
| Chua, HW; Mipuri, TM; Ngaserin, S | 1 |
| Arihiro, K; Emi, A; Kadoya, T; Kimura, Y; Masumoto, N; Okada, M; Sasada, S | 2 |
| Emi, A; Kadoya, T; Kimura, Y; Masumoto, N; Okada, M; Sasada, S | 1 |
| Bagnardi, V; Corso, G; De Scalzi, AM; Gilardi, L; Girardi, A; Grana, CM; Montagna, G; Pagan, E; Pagani, G; Rossi, EMC; Veronesi, P | 1 |
| Ejilemele, AA; Nava, VE | 1 |
| Li, L; Ma, W; Qian, Z; Qiu, L; Song, Z; Wang, X; Xu, W; Zhang, H; Zhao, P; Zhou, S; Zhu, L; Zhu, X | 1 |
| Abramson, RG; Abramson, VG; Arlinghaus, LR; Chakravarthy, AB; Fakhoury, K; Kang, H; Whisenant, JG; Williams, JM; Yankeelov, TE | 1 |
| Liu, Y; Luo, H; Zhang, J; Zhang, X | 1 |
| Boers, J; de Vries, EFJ; Glaudemans, AWJM; Hospers, GAP; Schröder, CP | 1 |
| Afşar, ÇU; Aksoy, T; Aral, H; Arslan, E; Çermik, TF; Gürsu, RU; Karabulut, S; Trabulus, FDC | 1 |
| Adachi, T; Fukuma, E; Machida, Y; Tateishi, U | 1 |
| Iagaru, A; Ikeda, D; Kozlov, A; Pantel, A | 1 |
| Bensch, F; Brouwers, AH; de Vries, EGE; Elias, SG; Glaudemans, AWJM; Iersel, MW; Kwee, TC; Maduro, JH; Oosting, SF; Schröder, CP; van Es, SC; Velleman, T | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Baghdadi, Y; Ko, H; Love, C; Sparano, JA | 1 |
| Chen, H; Pang, Y; Zhao, L | 1 |
| Bille, C; Braad, PE; Christensen, IY; Ewertz, M; Gerke, O; Hildebrandt, MG; Jensen, JD; Jylling, AMB; Larsen, LB; Søe, KL; Vogsen, M | 1 |
| An, J; Bang, JI; Kang, SY; Kim, BS; Kim, HO; Kim, JH; Yoon, HJ | 1 |
| Mester, A; Piciu, A; Piciu, D | 1 |
| Andersen, JD; Petersen, LJ; Zacho, HD | 1 |
| Arslan, E; Can Trabulus, D; Çermik, TF; Mermut, Ö; Şavlı, TC | 1 |
| Findikcioglu, A; Guler, OC; Onal, C; Reyhan, M | 1 |
| Choi, JY; Han, S | 2 |
| Accurso, A; Basso, L; Campanino, MR; Canta, L; Cavaliere, C; Garbino, N; Imbriaco, M; Nicolai, E; Romeo, V; Verde, F; Vigliar, E | 1 |
| Beckwith, H; Chien, AJ; Esserman, LJ; Flavell, RR; Forero-Torres, A; Hirst, GL; Hyland, CJ; Isaacs, CJ; Khoury, K; Melisko, ME; Varghese, F; Varnado, W; Yau, C; Yee, D | 1 |
| Bassett, RL; Le, VT; Whitman, GJ; Wong, FC | 1 |
| Chae, YS; Jeong, SY; Jung, JH; Lee, IH; Lee, J; Lee, SJ; Lee, SW; Park, HY | 1 |
| Maw, AM; Schembri, GP; Sood, S | 1 |
| Dubruc, E; Fernandes Vieira, V; Meyer, M; Prior, JO; Raffoul, W | 1 |
| Akdeniz, N; Işikdoğan, A; Kaplan, MA; Kömek, H; Küçüköner, M; Oruç, Z; Urakçi, Z | 1 |
| Esserman, LJ; Flavell, RR; Franc, BL; Hathi, DK; Hylton, NM; Joe, BN; Jones, EF; Kornak, J; Li, W; Seo, Y | 1 |
| Debarbieux, S; Dietz, M; Harou, O; Righetti, M; Tordo, J | 1 |
| El Khoury, M; Lalonde, L; Maietta, A; Mesurolle, B; Tran, A; Trop, I | 1 |
| Antoch, G; Bittner, AK; Bruckmann, NM; Buchbender, C; Dietzel, F; Esposito, I; Häberle, L; Herrmann, K; Ingenwerth, M; Kirchner, J; Li, Y; Martin, O; Mohrmann, S; Morawitz, J; Rischpler, C; Sawicki, LM; Umutlu, L | 1 |
| Wang, H; Xu, H; Xue, Y | 1 |
| Song, BI | 1 |
| Goto, Y; Iwase, T; Tanaka, H | 1 |
| Ahmad, U; Ahmad, W; Hassan, A | 1 |
| Emi, A; Kadoya, T; Masumoto, N; Okada, M; Sasada, S; Sueoka, S | 1 |
| Mohamadien, NRA; Sayed, MHM | 1 |
| Bove, S; Collarino, A; Fragomeni, S; Garganese, G; Gentileschi, S; Moro, F; Rufini, V; Scambia, G; Sperduti, I; Testa, AC; Triumbari, EKA; Verri, D | 1 |
| Erdil, TY; Filizoglu, N; Kesim, S; Ones, T; Ozguven, S | 1 |
| Ozer, N; Sahin, A | 1 |
| Bartelink, H; Bosma, SCJ; Elkhuizen, PHM; Loo, CE; van de Vijver, MJ; van der Leij, F; Vogel, WV; Vreeswijk, S | 1 |
| Chitalia, R; Cohen, EA; Gastounioti, A; Karp, J; Kontos, D; Mankoff, DA; Muzi, M; Pantel, AR; Peterson, LM; Viswanath, V | 1 |
| De Ridder, M; Everaert, H; Farid, K; Fontaine, C; Gorobets, O; Lamote, J; Nguyen, NP; Perrin, J; Storme, G; Van Parijs, H; Vanhoeij, M; Verfaillie, G; Verschraegen, C; Vinh-Hung, V | 1 |
| Garg, R; Jain, TK; Krishnaraju, VS; Kumar, R; Kumar, S; Mittal, BR; Sood, A | 1 |
| Fujita, Y; Hamada, S; Honma, K; Kim, SJ; Miyake, T; Naoi, Y; Shimazu, K; Shimoda, M; Tanei, T; Tokuda, Y; Tomiyama, N; Yanagawa, M | 1 |
| Asakawa, Y; Hirata, K; Ikegawa, C; Imai, M; Onishi, H; Satoh, Y | 1 |
| Bidard, FC; Buvat, I; Champion, L; Deleval, N; Guinebretiere, JM; Latouche, A; Rouzier, R; Seban, RD | 1 |
| Brown, RKJ; Neal, CH; Nees, AV; Rahman, WT | 1 |
| Bozkurt, MF; Soydas Turan, B | 1 |
| Brown, AH; Groves, AM; Malhotra, A; Shah, S; Wan, S | 1 |
| Girgin, RB; Gungor, S | 1 |
| Barshack, I; Ben-Haim, S; Chikman, B; Davidson, T; Halevy, A; Nissan, E; Shehade, N; Sklair-Levy, M; Zippel, D | 1 |
| Dufour, J; Richter, S; Wagner, M; West, FG; Wuest, F; Wuest, M; Yuen, R | 1 |
| Feng, W; Gao, Y; Lei, JQ; Lu, XR; Qu, MM; Zhai, YN | 1 |
| Chen, R; He, H; Huang, Y; Li, Q; Li, Y; Long, X; Wei, W; Yi, X | 1 |
| Abramson, V; Camp, M; Carey, LA; Carpenter, A; Cimino-Mathews, A; Connolly, RM; Gaffney, K; Huang, CY; Krop, IE; Leal, JP; Liu, MC; Miller, RS; Park, BH; Rimawi, M; Solnes, L; Specht, J; Stearns, V; Storniolo, AM; Vaklavas, C; Valero, V; Wahl, RL; Winer, EP; Wolff, AC | 2 |
| Chae, YS; Jeong, SY; Jung, JH; Kim, HJ; Kim, WH; Kim, WW; Lee, J; Lee, RK; Lee, SJ; Lee, SW; Park, CS; Park, HY; Park, JY | 1 |
| Deveci, EK; Irkorucu, O; Kulahci, O; Tas, ZA | 1 |
| Groheux, D; Jacene, HA; Parihar, AS; Ulaner, GA | 1 |
| Avril, N; Avril, S; Jones, RS; Kikano, EG; Marshall, H; Montero, AJ | 1 |
| Decker, T; Fendler, WP; Herrmann, K; Heuschmid, M; Küper, A; Seifert, R; Tewes, M; Welt, A | 1 |
| Ahn, SG; Bae, SJ; Cha, C; Cha, YJ; Jeong, J; Kim, D; Lee, J; Min, EK; Park, S | 1 |
| Agrawal, S; Deshmukh, M; Dongre, A; Dongre, T; Kanchankar, N | 1 |
| Chen, Y; Miao, W; Yao, S; Zheng, S; Zhu, Y | 1 |
| Alsa'di, HS; Donald, JS | 1 |
| Alberini, JL; Bottoni, G; Brain, E; DeCensi, A; Degenhardt, T; Dib, B; Fiz, F; Gennari, A; Harbeck, N; Matteucci, F; Monti, M; Nanni, O; Piccardo, A; Rocca, A; Rollandi, GA; Rossi, V; Sacchetti, GM; Saggia, C; Siri, G; Wuerstlein, R | 1 |
| Atag, E; Coban, E; Gungor, S; Gurleyik, G; Sari, M; Simsek, ET | 1 |
| Dong, A; Yu, Z; Zhang, J; Zhu, Y | 1 |
| Ademuyiwa, FO; Dehdashti, F; Li, S; Roy, S; Shoghi, KI; Wahl, RL; Whitehead, TD | 1 |
| Baltzer, PAT; Clauser, P; Gibbs, P; Hacker, M; Helbich, TH; Kapetas, P; Pinker, K; Rasul, S; Romeo, V; Woitek, R | 1 |
| Chan, SC; Chang, PH; Hsieh, JC; Huang, JS; Lui, KW; Ng, SH; Su, TP | 1 |
| Aime, S; Anemone, A; Bracesco, M; Capozza, M; Della Peruta, M; Dhakan, C; Longo, DL; Terreno, E; Villano, D; Zullino, S | 1 |
| Afshar-Oromieh, A; Alberts, I; Fischlin, C; Mingels, C; Rominger, A; Wartenberg, J | 1 |
| Espié, M; Groheux, D; Hindié, E; Ulaner, GA | 1 |
| Byrd, DW; Doot, RK; Kinahan, PE; Krohn, KA; Kurland, BF; Linden, HM; Link, JM; Mankoff, DA; Muzi, M; Novakova-Jiresova, A; Peterson, LM; Romine, PE; Specht, JM | 1 |
| Cervino, AR; Conte, P; Evangelista, L; Ghiotto, C; Guarneri, V; Michieletto, S; Reccia, P; Saibene, T; Saladini, G | 1 |
| Amorim, B; Brito, AE; Cabello, C; Etchebehere, E; Lima, M; Mosci, C; Oliveira, P; Ramos, CD; Santos, A; Sasse, AD; Souza, T | 1 |
| Ahn, SG; Jeon, TJ; Jeong, J; Kim, KM; Kim, SI; Lee, HW; Lee, JH; Lee, SA; Ryu, YH; Sohn, J; Yun, M | 1 |
| Choi, EK; Kang, BJ; Kim, SH; O, JH; Park, SY; Yoo, IR | 1 |
| Baltzer, P; Dickler, M; Gönen, M; Jochelson, MS; McArthur, HL; Ong, LT; Pinker, K; Riedl, CC; Ulaner, GA; Weber, WA | 1 |
| Shih, TT; Wang, J; Yen, RF | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Kim, BT; Kim, S; Lee, EJ; Lee, J; Lee, KH; Moon, SH | 1 |
| Kim, BS; Yoo, J; Yoon, HJ | 1 |
| Donker, M; Koolen, BB; Rutgers, EJT; Straver, ME; Valdés Olmos, RA; van der Noordaa, MEM; Vrancken Peeters, MJTFD | 1 |
| Gilhuijs, KGA; Loo, CE; Pengel, KE; Rodenhuis, S; Rutgers, EJT; Schmitz, AMT; Sonke, GS; Teixeira, SC; Valdés Olmos, RA; Vogel, WV; Vrancken Peeters, MJTFD; Wesseling, J | 1 |
| Catalano, M; Catalano, OA; Catana, C; Daye, D; Filomena, M; Fuin, N; Iannace, C; Luongo, A; Mahmood, U; Mansi, L; Rosen, BR; Salvatore, M; Signore, A; Soricelli, A; Vangel, M | 1 |
| Faulhaber, P; Plecha, DM | 1 |
| Has Şimşek, D; Karanlik, H; Kiliç, B; Külle, CB; Kuyumcu, S; Önder, S; Özmen, V; Şanli, Y | 1 |
| Ishimori, T; Kanao, S; Miyake, KK; Nakamoto, Y; Nishimatsu, K; Togashi, K; Toi, M | 1 |
| Elboğa, U; Şahin, E | 1 |
| Aarnoutse, R; de Boer, M; Goorts, B; Keymeulen, KBMI; Kooreman, LFS; Lobbes, MBI; Mottaghy, FM; Smidt, ML; van Nijnatten, TJA; Vöö, S; Wildberger, JE | 1 |
| Das, PK; Jena, A; Negi, P; Sarin, R; Singh, A; Singhal, M; Taneja, S | 1 |
| Beiderwellen, K; Deuschl, C; Forsting, M; Grüneisen, J; Herrmann, K; Heusch, P; Kirchner, J; Lauenstein, TC; Sawicki, LM; Umutlu, L | 1 |
| Antunovic, L; Castiglioni, I; Chiti, A; Gallivanone, F; Invento, A; Kirienko, M; Manfrinato, G; Sagona, A; Sollini, M; Tinterri, C | 1 |
| Argon, AM; Avci, NC; Yararbas, U; Yeniay, L | 1 |
| Chung, J; Kim, BS; Yoo, J; Yoon, HJ | 2 |
| Gomi, N; Hatake, K; Ito, Y; Koizumi, M; Koyama, M; Sata, N; Sugihara, T; Terauchi, T | 1 |
| Fujii, T; Hirakata, T; Kurozumi, S; Kuwano, H; Nakazawa, Y; Obayashi, S; Tokuda, S; Yajima, R; Yanai, K | 1 |
| Al-Muqbel, KM | 1 |
| Akazawa, K; Araki, K; Hirota, S; Inoue, N; Katagiri, T; Kira, A; Kitajima, K; Miyoshi, Y; Morimoto, K; Nakamori, S; Nishimukai, A; Takeda, M; Watanabe, T | 1 |
| Amo-Salas, M; Bueno, G; Garcia-Vicente, AM; Martínez-González, A; Molina, D; Pérez-Beteta, J; Soriano-Castrejón, Á; Tello-Galán, MJ | 1 |
| Castro, GJ | 1 |
| de Boer, M; Goorts, B; Heuts, EM; Kooreman, LFS; Lobbes, MBI; Mottaghy, FM; Smidt, ML; van Nijnatten, TJA; Vöö, S; Wildberger, JE | 1 |
| Aguiar, P; Albaina, L; Argibay, S; Domínguez-Prado, I; Fernández-Ferreiro, A; Herranz, M; Moscoso, A; Pardo-Montero, J; Ruibal, Á; Silva-Rodríguez, J | 1 |
| Kang, BJ; Kim, H; Kim, SH; O, JH; Park, HL; Yoo, IR | 1 |
| Akimoto, E; Emi, A; Kadoya, T; Kajitani, K; Masumoto, N; Ohara, M; Okada, M; Shigematsu, H | 1 |
| Alvarez Ruiz, S; Caresia Aroztegui, AP; de Arcocha Torres, M; Delgado Bolton, RC; Garcia Garzon, JR; García Vicente, AM; Garcia-Velloso, MJ; Orcajo Rincon, J | 1 |
| Flamm, SD; Huang, SS; Jellis, C; Xu, B | 1 |
| Baldi, M; Carne, I; Castiglioni, I; D'Ambrosio, D; Fantinato, D; Gallivanone, F; Interlenghi, M | 1 |
| Huang, J; Qu, S; Wang, T | 1 |
| Dai, Q; Jiang, YX; Jin, XN; Li, F; Li, JC; Sun, Q; Wang, HY; Xu, Y; Zhu, QL; Zhu, ZH | 1 |
| Higuchi, T; Kitajima, K; Miyoshi, Y; Odawara, S; Yamakado, K; Yamano, T | 1 |
| An, YS; Jung, Y; Kang, DK; Kim, TH | 1 |
| Ahn, BC; Jeong, SY; Jung, JH; Kim, DH; Lee, J; Lee, SW; Park, HY; Son, SH | 1 |
| Kubota, K; Murakami, W; Ohi, Y; Oosako, S; Sagara, Y; Sasaki, M; Tozaki, M; Yotsumoto, D | 1 |
| Duan, X; Ishida, T; Itoh, M; Miyashita, M; Mori, N; Ohuchi, N; Suzuki, A; Tada, H; Watabe, H; Watanabe, G | 1 |
| Mammatas, LH; Menke-van der Houven van Oordt, CW; van Helden, EJ; Verheul, HMW | 1 |
| Kurland, BF; Linden, HM; Mankoff, DA; Peterson, LM | 1 |
| Bektasoglu, HK; Erdogan, EB; Ersoy, YE; Gucin, Z; Guzel, M; Kadioglu, H; Malya, FU; Yildiz, S; Yucel, S | 1 |
| Brunotte, F; Chardin, D; Cochet, A; Desmoulins, I; Humbert, O; Riedinger, JM | 1 |
| Amiot, HM; Cassou-Mounat, T; Jehanno, N; Laurence, V; Luporsi, M | 1 |
| An, YS; Jin Lee, S; Kang, SY; Park, S; Yim, H; Yoon, JK | 1 |
| Emi, A; Goda, N; Kadoya, T; Kajitani, K; Masumoto, N; Okada, M; Sasada, S | 1 |
| Calabrese, M; Houssami, N; Rossi, F; Tagliafico, AS; Valdora, F | 1 |
| Luo, R; Shi, H; Xiu, Y; Yin, H; Zhang, H | 1 |
| Bertaut, A; Brunotte, F; Cochet, A; Coutant, C; Fumoleau, P; Humbert, O; Lasserre, M | 1 |
| Chae, YS; Jeong, SY; Jung, JH; Kim, HJ; Kim, WH; Lee, SW; Lee, WK; Park, HY | 1 |
| Cha, J; Cho, YU; Kim, D; Kim, HJ; Kim, MJ; Park, HS; Yun, M | 1 |
| Kuji, I; Seto, A; Ueda, S; Yamane, T | 1 |
| Elkhuizen, PHM; Groen, EJ; Loo, CE; Russell, NS; Stokkel, M; Straver, ME; van der Noordaa, MEM; van Duijnhoven, FH; Vrancken Peeters, MTFD | 1 |
| Alavi, A; Emamzadehfard, S; Gholami, S; Paydary, K; Seraj, SM; Shamchi, SP; Werner, TJ; Zadeh, MZ | 1 |
| Fatima, N; Maseeh, UZ | 1 |
| Chung, J; Kim, BS; Kim, Y; Yoon, HJ | 1 |
| He, Y; Li, C; Shen, M; Tian, Y; Wen, B | 1 |
| Hamerla, G; Meyer, HJ; Purz, S; Surov, A | 1 |
| Aiello, M; Catalano, OA; Cavaliere, C; Ferbo, U; Grimaldi, AM; Incoronato, M; Inglese, M; Mirabelli, P; Monti, S; Nicolai, E; Salvatore, M; Soricelli, A | 1 |
| Xiao, C; Zhang, XH | 1 |
| Bai, X; Wang, X | 1 |
| Alavi, A; Baun, C; Falch, K; Gerke, O; Hansen, J; Hildebrandt, MG; Høilund-Carlsen, PF; Nguyen, T | 1 |
| Gadi, VK; Gralow, J; Jenkins, I; Kinahan, P; Lee, JH; Linden, HM; Mankoff, D; Montgomery, S; Muzi, M; Novakova-Jiresova, A; O'Sullivan, J; Peterson, LM; Shields, A; Specht, JM; Wu, QV | 1 |
| Hosoya, K; Ishibashi, M; Kaida, H; Kinoshita, T; Kitajima, K; Miyoshi, Y; Morita, T; Nakajo, M; Nakatani, K; Tani, A; Yamaguchi, K | 1 |
| Arihiro, K; Emi, A; Kadoya, T; Masumoto, N; Okada, M; Sasada, S | 1 |
| Besutti, G; Cecinato, P; Coiro, S; Di Grezia, G; Falco, G; Ferrari, G; Gatta, G; Mele, S; Vacondio, R; Zizzo, M | 1 |
| Byun, BH; Choi, CW; Choi, JH; Jang, S; Kim, BI; Kim, HA; Lim, I; Lim, SM; Moon, H; Noh, WC; Seol, H; Seong, MK | 1 |
| Ceyrat, Q; Fernandez, P; Meyer, M; Tlili, G; Ziade, C | 1 |
| Amo-Salas, M; García-Vicente, AM; Martínez-González, A; Molina-García, D; Pérez-Beteta, J; Pérez-García, VM; Soriano-Castrejón, Á; Tello-Galán, MJ | 1 |
| Diaz-Bode, A; Kuker, R; Manov, JJ | 1 |
| Arslan, E; Başaran, Ş; Çermik, TF; Talu, ECK; Trabulus, FDC | 1 |
| Braziewicz, J; Hołody, Ł; Kunikowska, J | 1 |
| Berriolo-Riedinger, A; Bertaut, A; Brunotte, F; Cochet, A; Depardon, E; Dygai-Cochet, I; Fumoleau, P; Humbert, O; Kanoun, S; Lasserre, M; Riedinger, JM; Tal, I; Toubeau, M; Vrigneaud, JM | 1 |
| Abramson, LL; Eisenberg, AM; Eppelheimer, CN; Fulop, TA | 1 |
| Chaudhuri, TK; Fleming, MR; Fleming, RM; McKusick, A | 1 |
| Asano, A; Hasebe, T; Hirokawa, E; Kuji, I; Osaki, A; Saeki, T; Shimada, H; Sugitani, I; Takeuchi, H; Ueda, S; Yamane, T | 1 |
| Bhambhvani, PG; Palot Manzil, FF | 1 |
| Alavi, A; Basu, S; Chakraborty, D; Kumar, R; Ulaner, GA | 1 |
| Fowler, AM; Linden, HM; Peterson, LM | 1 |
| Schuster, DM; Ulaner, GA | 1 |
| Borm, KJ; Combs, SE; Duma, MN; Düsberg, M; Oechsner, M; Vag, T; Voppichler, J; Weber, W | 1 |
| Brunotte, F; Cochet, A; Humbert, O | 1 |
| Annovazzi, A; Fabi, A; Rea, S; Sciuto, R; Vici, P | 1 |
| Afshar-Oromieh, A; Ahmadzadehfar, H; Essler, M; Rahbar, K | 1 |
| Fujioka, T; Ishiba, T; Kasaharak, M; Kikuchi, Y; Kubota, K; Nakagawa, T; Oda, G; Tateishi, U; Tsuchiya, J | 1 |
| Basher, RK; Mittal, BR; Parihar, AS; Singh, G; Sood, A | 1 |
| Shao, M; Wen, G; Zi, J | 1 |
| Gong, C; Li, Y; Liu, C; Wang, B; Wu, B; Xie, Y; Yang, Z; Zhang, Y; Zhao, Y | 1 |
| Bagetakos, I; Becker, M; Botsikas, D; Boudabbous, S; Da Cunha Afonso Barisits, AC; Kalovidouri, A; Lam, GT; Mainta, I; Montet, X; Picarra, M | 1 |
| Bruna-Muraille, C; Dejust, S; Eymard, JC; Morland, D; Papathanassiou, D; Savoye, AM; Yazbek, G | 1 |
| Axelrod, D; Kim, E; Melsaether, AN; Pujara, AC | 1 |
| Kao, CH; Lin, CL; Lin, CY | 1 |
| Alessi, S; Bellomi, M; Colleoni, MA; Iorfida, M; Petralia, G; Pricolo, P; Ruju, F; Zugni, F | 1 |
| Bozec, L; Cassou-Mounat, T; Champion, L; Huchet, V; Jehanno, N; Laurence, V; Luporsi, M | 1 |
| Jeong, HJ; Joo, J; Jung, SY; Kang, HS; Kim, SK; Kim, TS; Kong, SY; Kwon, YM; Lee, DE; Lee, ES; Lee, H; Lee, KS; Lee, S; Park, IH; Park, S; Sim, SH | 1 |
| Chen, W; Fu, Q; Wang, P; Xu, W; Yu, X; Zhu, L | 1 |
| Choi, YY; Chung, MS; Lee, SJ; Shin, SJ | 1 |
| Gross, MD; Singh, H; Viglianti, BL; Wale, DJ; Wong, KK | 1 |
| Anemona, L; Buonomo, OC; Caredda, E; Chiaravalloti, A; Marchese, PV; Orsaria, P; Palombi, L; Petrella, G; Portarena, I; Schillaci, O; Titka, B | 1 |
| Kiru, L; Naczynski, DJ; Pratx, G; Sasportas, LS; Türkcan, S | 1 |
| Diamond, T; Kumar, S | 1 |
| De Meulenaere, V; De Wever, O; Deblaere, K; Decrock, E; Descamps, B; Goethals, I; Leybaert, L; Mollet, P; Neyt, S; Vandeghinste, B; Vanhove, C | 1 |
| Cho, H; Kim, D; Kim, JH; Kim, SH; Lee, SH; Park, HS; Yun, M | 1 |
| Battista, J; Butler, J; deKemp, RA; El-Sherif, O; Gaede, S; Pickering, JG; Prato, FS; Renaud, J; Sullivan, R; Sykes, J; Wilk, B; Wisenberg, G; Xhaferllari, I; Yin, H | 1 |
| Duma, MN | 1 |
| Axelrod, D; Babb, J; Kim, E; Kim, SG; Melsaether, AN; Mema, E; Sigmund, E | 1 |
| Barthe, N; Cazeau, AL; Fernandez, P; Hindié, E; Macgrogan, G; Morgat, C; Schollhammer, R; Vélasco, V; Vimont, D | 1 |
| Emi, A; Goda, N; Kadoya, T; Kajitani, K; Masumoto, N; Okada, M; Sasada, S; Sueoka, S; Suzuki, E | 1 |
| Huang, G; Li, P; Liu, Q; Song, S; Wang, X | 1 |
| Doot, RK | 2 |
| Abd Alkhalik Basha, M; Al-Molla, RM; Awad, NM; Elkholy, E; Hussein, RS; Refaat, R; Sobhi Hassan, M | 1 |
| Bom, HS; Cho, SG; Kang, SR; Kim, J; Kwon, SY; Min, JJ; Song, HC; Yoo, SW | 1 |
| Anderson, CJ; Hahm, ER; Roy, R; Singh, SV; White, AG | 1 |
| Bergom, C; Vogel, WV | 1 |
| Byun, HK; Chang, JS; Kim, YB | 1 |
| Eun, YG; Hwang, JE; Jeong, YS; Joo, EW; Kang, S; Kim, EH; Lee, DJ; Lee, JS; Lee, SH; Lim, B; Shin, JH; Sohn, BH; Yim, SY | 1 |
| Dank, M; Kajáry, K; Lengyel, Z; TŐkÉs, T | 1 |
| Asano, Y; Hirakawa, K; Kashiwagi, S; Ohira, M; Ohsawa, M; Takada, K; Takashima, T; Tokimasa, S | 1 |
| Krombach, GA; Litzlbauer, D; Wörner, JM | 1 |
| Antunovic, L; Chiti, A; Cozzi, L; De Sanctis, R; Kirienko, M; Sagona, A; Santoro, A; Sollini, M; Tinterri, C; Torrisi, R; Zelic, R | 1 |
| Acar, E; Kaya, G; Turgut, B; Yiğit, S | 1 |
| Brunotte, F; Cochet, A; Coutant, C; Grapin, M; Humbert, O; Ladoire, S; Riedinger, JM | 1 |
| Abbyad, P; Kim, TJ; Mongersun, A; Mongersun, K; Pratx, G; Sengupta, D; von Eyben, R | 1 |
| Albano, D; Durmo, R; Giubbini, R | 1 |
| Bun, A; Fujimoto, Y; Fukui, R; Higuchi, T; Imamura, M; Kitajima, K; Miyagawa, Y; Miyoshi, Y; Ozawa, H; Yamakado, K | 1 |
| Dank, M; Kajáry, K; Kulka, J; Lengyel, Z; Tőkés, AM; Tőkés, T | 1 |
| de Greef, BTA; Jansen, FH; Maaskant-Braat, AJG; Nieuwenhuijzen, GAP; Poodt, IGM; Schipper, RJ; Voogd, AC; Vugts, G; Wyndaele, DNJ | 1 |
| Koizumi, M; Motegi, K; Umeda, T | 1 |
| Buda, A; Crivellaro, C; Elisei, F; Guerra, L; Guglielmo, P; Landoni, C; Paderno, M | 1 |
| Buchpiguel, CA; Carvalho, FM; Carvalho, JP; Nunes, RF; Queiroz, MA | 1 |
| Bago-Horvath, Z; Bickel, H; Bogner, W; Dubsky, P; Grabner, G; Gruber, S; Helbich, TH; Langs, G; Pinker, K; Vogl, WD | 1 |
| Eo, JS; Kim, WY; Lee, JB; Lee, S; Woo, SU | 1 |
| Kanao, S; Kataoka, M; Mikami, Y; Miyake, KK; Nakamoto, Y; Sakaguchi, R; Sugie, T; Togashi, K; Toi, M | 1 |
| Canaz, F; Dinçer, M; Entok, E; Erkasap, S; Işiksoy, S; Önner, H; Sivrikoz, İA | 1 |
| Blanc-Durand, P; Huchet, V; Itti, E; Luciani, A; Milliner, M | 1 |
| Arihiro, K; Emi, A; Goda, N; Kadoya, T; Kajitani, K; Masumoto, N; Okada, M; Sasada, S; Shiroma, N | 1 |
| Ashwathanarayana, AG; Kavanal, AJ; Kumar, S; Mittal, BR; Rana, N; Shukla, J; Singh, G; Vatsa, R | 1 |
| An, YS; Han, S; Jung, Y; Kim, JY; Kim, TH | 1 |
| Inaki, A; Kinuya, S; Mochizuki, T; Nakajima, K; Wakabayashi, H | 1 |
| Amersi, F; Chung, A; Giuliano, AE; Lee, M; Luu, M; Srour, MK; Walcott-Sapp, S | 1 |
| Chang, CC; Chang, SM; Chen, CJ; Hsu, WL; Huang, YF; Tyan, YC | 1 |
| Can, C; Komek, H | 1 |
| Billè, A; Girelli, L; Leo, F; Pastorino, U | 1 |
| Hu, XC; Jia, Z; Ragaz, J; Wang, BY; Wang, ZH; Zhang, J; Zhang, YJ; Zhang, YP; Zhou, M | 1 |
| Gilhuijs, KG; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; Vincent, AD; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Aukema, TS; Benlloch Baviera, JM; Caballero Ontanaya, L; González Martínez, AJ; Koolen, BB; Rutgers, EJ; Valdés Olmos, RA; Vogel, WV; Vrancken Peeters, MJ; Vroonland, CJ | 1 |
| Cintolo, JA; Pryma, DA; Tchou, J | 1 |
| Cheze-Le Rest, C; Cuvier, C; de Cremoux, P; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hatt, M; Hindié, E; Lehmann-Che, J; Martineau, A; Marty, M; Visvikis, D | 1 |
| Colletti, PM; Delord, M; Groheux, D; Hindié, E; Nguyen, ML; Rubello, D | 1 |
| Chang, CC; Chen, YW; Hou, MF; Huang, CJ; Lin, CY; Yang, WC | 1 |
| An, YS; Kim, BS; Kim, Y; Seok, JW | 1 |
| Bhattacharya, A; Bhoil, A; Manohar, K; Mittal, BR; Singh, G | 1 |
| Hong, S; Li, J; Wang, S | 1 |
| Dunne, RM; McDermott, R; O'Keeffe, SA; O'Mahony, D; Wilson, G | 1 |
| Caldarella, C; Muoio, B; Parapatt, GK; Treglia, G | 1 |
| Aravkin, AY; Beatty, JD; Eissa, MJ; Porter, BA; Rogers, JV; Wang, CL | 1 |
| Fujii, T; Hattori, S; Hayakawa, M; Hirose, Y; Ishibashi, M; Kage, M; Kaida, H; Kawahara, A; Kurata, S; Toh, U | 1 |
| Bravatà, V; Cammarata, FP; Gelfi, C; Gilardi, MC; Messa, C; Minafra, L; Nicolosi, S; Pulizzi, S; Russo, G; Stefano, A | 1 |
| Chacón López-Muñiz, I; Espinosa Aunión, R; García Vicente, AM; González Ageitos, A; León Martín, A; Muñoz Madero, V; Muñoz Sánchez, Mdel M; Palomar Muñoz, A; Soriano Castrejón, Á | 1 |
| Dobbs, NB; Latifi, HR | 1 |
| Cody, HS; D'Andrea, G; Ulaner, GA | 1 |
| Bamba, R; Chen, CT; Conzen, SD; Ikejimba, L; Makinen, MW; Wietholt, C | 1 |
| Cho, SB; Chung, CY; Joo, YE; Kim, JS; Lee, WS; Min, JJ; Myung, DS; Park, HC | 1 |
| Elkhuizen, PH; Koolen, BB; Rutgers, EJ; Valdés Olmos, RA; van der Leij, F; Vogel, WV; Vrancken Peeters, MJ | 1 |
| Byun, BH; Cho, AR; Choi, CW; Kim, BI; Kim, EK; Kim, HA; Kim, KM; Lee, SS; Lim, I; Lim, SM; Noh, WC; Park, JA | 1 |
| Bakari, KH; Lan, X; Li, C; Mghanga, FP; Zhang, Y | 1 |
| Lee, JH | 1 |
| Ding, Q; Rong, J; Wang, S; Ye, S; Yun, M; Zheng, Z | 1 |
| Fleming, IN; Smith, TA; Zanda, M | 1 |
| Avery, R; Kuo, PH | 1 |
| Banfield, KS; Behr, SC; Bolouri, MS; Elias, SG; Hawkins, RA; Hylton, NM; Joe, BN; Suzuki, SA; Wisner, DJ | 1 |
| Hama, Y | 1 |
| Allende-Riera, A; Cárdenas-Negro, C; De Sequera-Rahola, M; Muñoz-Iglesias, J; Uña-Gorospe, J | 1 |
| Fan, Q; Graves, E; Loo, B; Mazin, S; Nanduri, A; Yamamoto, T; Yang, J; Zhu, L | 1 |
| Gilhuijs, KG; Koolen, BB; Pengel, KE; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; Vincent, AD; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Coussy, F; Cuvier, C; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hatt, M; Hindié, E; Marty, M; Vercellino, L | 1 |
| Henzler, T; Kaiser, CG; Krammer, J; Schnitzer, A; Schoenberg, SO; Wasser, K | 1 |
| Elshof, LE; Koolen, BB; Loo, CE; Rutgers, EJ; Valdés Olmos, RA; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Elkhuizen, PH; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; Vogel, WV; Vrancken Peeters, MJ | 2 |
| Bourgeois, AC; Bradley, YC; Chang, TT; Embry, S; Hudson, K; Warren, LA | 1 |
| Fanti, S; Martoni, AA; Quercia, S; Santini, D; Taffurelli, M; Zamagni, C; Zucchini, G | 2 |
| Aliyev, A; Arslan, E; Ekmekcioglu, O; Erkan, ME; Halac, M; Kaya, R; Kocael, P; Sonmezoglu, K; Yilmaz, S | 1 |
| Aogi, K; Kadoya, T; Kiyoto, S; Masumoto, N; Okada, M; Sugawara, Y | 1 |
| Fan, W; Li, J; Wang, GH; Zhang, WD; Zhang, WG | 1 |
| Alavi, A; Alba, E; Jimenez-Hoyuela, JM; Sanchez-Muñoz, A; Sanz-Viedma, S; Scholz-Gutierrez, V | 1 |
| Kataoka, M; Kiyoto, S; Mochizuki, T; Nakajima, N; Ochi, T; Ohsumi, S; Sugawara, Y | 1 |
| Kenny, LM | 1 |
| Bassini, A; Bertola, M; Del Conte, A; Foltran, L; Gion, M; Lorenzon, M; Micheli, E; Saracchini, S; Sulfaro, S; Tuccia, F; Tumolo, S | 1 |
| Berg, WA; Kalinyak, JE; Madsen, KS; Narayanan, D; Schilling, K; Tartar, M | 1 |
| Aktan, G; Baselga, J; Coccia-Portugal, MA; Cortés, M; Cure, H; de Azambuja, E; Di Cosimo, S; Eidtmann, H; Fauria, K; Flamen, P; Gámez, C; Garcia, C; Gebhart, G; Holmes, E; Kim, SB; Piccart, M; Robles, J; Van Dooren, V; Vuylsteke, P | 1 |
| Khangembam, BC; Kumar, R; Naswa, N; Sahoo, MK; Sharma, P | 1 |
| Bae, MS; Chang, JM; Cho, N; Kang, KW; Kim, JY; Kim, MY; Kim, WH; Koo, HR; Lee, SH; Moon, WK; Park, JS; Seo, M | 1 |
| Arrazola García, J; Carreras Delgado, JL; Enrique Fuentes Ferrer, M; Furió, V; García García-Esquinas, M; García-Sáenz, JA; Rodriguez Rey, C; Román, JM | 1 |
| Jin, GH; Kim, HS; Lee, JY; Lee, TS; Lyu, KY; Park, HH; Shin, JY | 1 |
| Andrade, WP; Baiocchi, G; Bitencourt, AG; Damascena, AS; do Socorro Maciel, M; Fanelli, MF; Lima, EN; Osório, CA; Soares, FA | 1 |
| Byun, BH; Choi, CW; Kim, EK; Kim, HA; Lee, SS; Lim, SM; Noh, WC; Park, J | 1 |
| Kajáry, K; Lengyel, Z; Molnár, P; Szakáll, S | 1 |
| Ouvrier, MJ; Thariat, J; Vignot, S | 1 |
| Doot, RK; Kinahan, PE; Kurland, BF; Linden, HM; Mankoff, DA | 1 |
| Hirokawa, E; Kishino, O; Kuji, I; Matsuura, K; Nakamiya, N; Oda, M; Osaki, A; Saeki, T; Sano, H; Shigekawa, T; Shimada, H; Suzuki, H; Ueda, S; Yamashita, Y | 1 |
| Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Coudert, B; Coutant, C; Dygai-Cochet, I; Fumoleau, P; Guiu, S; Humbert, O; Riedinger, JM; Toubeau, M | 1 |
| Ahn, SH; Chae, SY; Gong, GY; Kim, HO; Lee, JJ; Lee, JW; Moon, DH; Park, SH; Ryu, JS; Seo, MJ; Son, BH | 1 |
| Alvarez, M; Debard, A; Mandegaran, R; Marchou, B; Massip, P; Wagner, T | 1 |
| Cheng, J; Shi, W; Sun, Y; Xu, J; Xue, J; Yang, Z; Yao, Z; Zhang, Y; Zhu, B | 1 |
| Chung, SK; Chung, YA; Jeon, HM; Kim, SH; Kim, YS; Oh, JK; Park, YH | 1 |
| An, YS; Jung, YS; Kang, DK; Kim, KS; Kim, TH; Lee, DH; Lee, SJ; Yim, H; Yoon, JK | 1 |
| Berriolo-Riedinger, A; Brunotte, F; Charon-Barra, C; Cochet, A; Coutant, C; Desmoulins, I; Dygai-Cochet, I; Fumoleau, P; Gauthier, M; Guiu, S; Humbert, O; Toubeau, M | 1 |
| Chao, JW; Otterburn, DM; Pitcher, AA; Swistel, AJ; Varma, S | 1 |
| Bernsdorf, M; Graff, J | 2 |
| Chuang, C; Feng, T; Geist, CL; Hansen, K; Hurria, A; Katheria, V; Luu, T; Mortimer, J; Patel, SK; Ramani, R; Silverman, DH; Somlo, G | 1 |
| Avril, N; Gaeta, CM; Kohan, A; Rubbert, C; Sher, AC; Vercher-Conejero, JL | 1 |
| Aiello, M; Catalano, OA; Luongo, A; Nicolai, E; Pace, L; Salvatore, M; Soricelli, A | 1 |
| Bertagna, F; Dognini, L; Giovanella, L; Giubbini, R; Orlando, E; Sadeghi, R; Treglia, G | 1 |
| Domenech, A; Escalera, S; Sampedro, F | 1 |
| Ozkan, E | 1 |
| De Carolis, V; Evangelista, L; Geuna, E; Ghiotto, C; Racca, M; Redana, S; Saladini, G; Varetto, T; Vinante, L; Zago, G | 1 |
| Eaton, A; Fazio, M; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; Lilienstein, J; Morris, PG; Patil, S; Ulaner, GA | 1 |
| Akiyoshi, T; Fujii, T; Fujisawa, T; Hirakata, T; Horikoshi, H; Iijima, M; Kinoshita, T; Kuwano, H; Miyamoto, T; Oya, N; Yanagita, Y | 1 |
| Augereau, P; Menei, P; Morel, O; Patsouris, A; Paumier, A; Rousseau, A; Tanguy, JY | 1 |
| Caldarella, C; Giordano, A; Treglia, G | 1 |
| Fan, M; Hu, S; Hu, X; Li, T; Shui, R; Zhang, Y | 1 |
| Agresti, R; Alessi, A; Barbara, P; Bianchi, G; Bombardieri, E; Carcangiu, ML; Crippa, F; Ferraris, C; Greco, M; Maccauro, M; Martelli, G; Maugeri, I; Moscaroli, A; Pellitteri, C; Rampa, M; Sandri, M; Tagliabue, E | 1 |
| Kessing, R | 1 |
| Chen, X; Kang, F; Li, L; Ma, W; Ma, X; Shao, Y; Wang, J; Yang, W | 1 |
| Andriu, A; Fleming, IN; Smith, TA | 1 |
| Furuta, T; Hosoi, M; Kiryu, S; Kurokawa, M; Morikawa, T; Ohtomo, K; Shibahara, J; Yamada, H | 1 |
| Abeyakoon, O; Baltzer, P; Bickel, H; Brader, P; Füger, B; Helbich, T; Magometschnigg, HF; Pinker, K; Polanec, S; Wengert, G | 1 |
| Aide, N; Allouache, D; Bellevre, D; Blanc Fournier, C; Crouet, H; Desmonts, C; Dugué, AE; Grellard, JM; Guilloit, JM; Levy, C; Switsers, O | 1 |
| Cao, Q; Chen, W; Dilsizian, V; Goloubeva, O; Hersl, J; Jenkins, J; Jones, L; La, H; Smith, M; Tkaczuk, K | 1 |
| Boers-Sonderen, MJ; de Geus-Oei, LF; Desar, IM; Ottevanger, PB; Oyen, WJ; van der Graaf, WT; van Herpen, CM | 1 |
| Baas, IO; Bulten, BF; de Haas, MJ; de Klerk, JM; Rodenburg, CJ; van Ooijen, B | 1 |
| Arnould, L; Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Coudert, B; Coutant, C; Desmoulins, I; Dygai-Cochet, I; Fumoleau, P; Guiu, S; Humbert, O; Riedinger, JM; Toubeau, M | 1 |
| Cho, N; Chun, IK; Chung, JK; Im, SA; Jeong, JM; Jeong, S; Jung, KC; Kang, KW; Lee, DS; Lee, S; Lee, YS; Moon, WK; Yoon, HJ | 1 |
| Abramson, VG; Arteaga, CL; Balko, JM; Cantley, LC; Forero, A; Isakoff, SJ; Kuba, MG; Li, Y; Mayer, IA; Sanders, ME; Van den Abbeele, AD; Winer, E; Yap, JT | 1 |
| Baba, S; Honda, H; Isoda, T; Kitamura, Y; Maruoka, Y; Sasaki, M; Yoshida, T | 1 |
| Jeong, YJ; Kang, DY; Son, HJ; Yoon, HJ | 1 |
| Benlloch Baviera, JM; Koolen, BB; Valdés Olmos, RA; Vidal-Sicart, S | 1 |
| Allevi, G; Ardine, M; Bertoni, R; Bottini, A; Brugnoli, G; Cappelletti, MR; Ferrero, G; Ferrozzi, F; Generali, D; Giatromanolaki, A; Harris, AL; Koukourakis, MI; Martinotti, M; Milani, M; Strina, C; Zanotti, L | 1 |
| Boubaya, M; Buvat, I; Eder, V; Orlhac, F; Soussan, M; Zelek, L; Ziol, M | 1 |
| Canevari, C; Castiglioni, I; Gallivanone, F; Gianolli, L; Gilardi, MC; Marassi, A; Messa, C; Picchio, M; Sassi, I; Zuber, V | 1 |
| Gallivanone, F; Gastiglioni, I; Gilardi, MC; Messa, C; Stefano, A | 1 |
| Cruz Mora, MÁ; Espinosa Aunión, R; García Vicente, AM; Jiménez Londoño, GA; León Martín, A; Muñoz Sánchez, Mdel M; Relea Calatayud, F; Soriano Castrejón, Á | 1 |
| Benedetti Panici, P; Fischetti, M; Lio, S; Pecorella, I; Perniola, G; Tomao, F | 1 |
| Gilhuijs, KG; Koolen, BB; Lips, EH; Loo, CE; Pengel, KE; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Abramson, RG; Abramson, VG; Arlinghaus, LR; Atuegwu, NC; Chakravarthy, AB; Li, X; Williams, JM; Yankeelov, TE | 1 |
| Cervino, AR; Evangelista, L | 1 |
| Benveniste, AP; Benveniste, MF; Marom, EM; Mawlawi, OR; Miranda, RN; Yang, W | 1 |
| Jeon, YK; Kim, BH; Kim, IJ; Kim, SJ; Kim, SS; Kim, YK; Lee, SH | 1 |
| Han, K; Hong, IK; Sohn, YM | 1 |
| Chae, BJ; Jung, NY; Kang, BJ; Kim, SH; Seo, YY; Yoo, IR | 1 |
| Fukukita, H; Hatazawa, J; Honda, N; Hosono, M; Ito, H; Ito, K; Jinnouchi, S; Kanaya, S; Kato, K; Kawamoto, M; Kawano, T; Kimura, Y; Kinuya, S; Kubota, K; Kumita, S; Maruno, H; Murakami, K; Ozawa, Y; Saga, T; Saji, H; Sasaki, M; Senda, M; Togawa, T; Uchiyama, M; Uno, K; Watanabe, H; Yamazaki, J; Yoshimura, M | 1 |
| Hirokawa, E; Kuji, I; Oda, M; Osaki, A; Saeki, T; Sano, H; Shigekawa, T; Shimada, H; Suzuki, H; Takeuchi, H; Ueda, S | 1 |
| Byun, BH; Choi, CW; Kim, BI; Kim, EK; Kim, HA; Kim, KM; Lee, SS; Lim, I; Lim, SM; Noh, WC; Park, J; Park, JA; Park, KW; You, EY | 1 |
| Andrade, WP; Bitencourt, AG; Chojniak, R; Guimarães, MD; Lima, EN; Marques, EF; Souza, JA | 1 |
| Choi, BB; Lee, YJ; Suh, KS | 1 |
| Bago-Horvath, Z; Baltzer, P; Bartsch, R; Bickel, H; Bogner, W; Brader, P; Dubsky, P; Gruber, S; Helbich, TH; Karanikas, G; Magometschnigg, H; Pinker, K; Trattnig, S; Weber, M | 1 |
| Ibe, T; Igai, H; Kamiyoshihara, M; Kawatani, N; Shimizu, K | 1 |
| Ding, L; Dong, L; Liu, B; Liu, M; Song, Y | 1 |
| Colletti, PM; Lisato, LC; Maffione, AM; Marzola, MC; Rasi, A; Rubello, D | 1 |
| Clark, AS; Lynch, MC; Mankoff, D; McDonald, E | 1 |
| Aydin, M; Erdogan, EB; Ergul, N; Gucin, Z; Kadioglu, H; Muslumanoglu, M; Yildiz, S; Yucel, SB | 1 |
| Borges, US; da Silva, BB; Gebrim, LH; Lopes-Costa, PV; Pires, AO | 1 |
| Ichikawa, T; Nambu, A; Onishi, H; Satoh, Y | 1 |
| Chan, KC; Fleisher, KE; Friedman, KP; Glickman, RS; Gupta, V; Janal, M; Mourtzikos, KA; Raad, RA; Rakheja, R | 1 |
| Kanao, S; Mikami, Y; Miyake, KK; Nakamoto, Y; Sugie, T; Tanaka, S; Togashi, K; Toi, M | 1 |
| Bae, SK; Jung, SJ; Kim, CK; Kim, TH; Lee, SM; Park, JS; Yoon, HK | 1 |
| Cho, J; Choe, JG; Eo, JS; Kim, C; Kim, S; Lee, E; Lee, S; Pahk, K; Park, KH; Park, S; Park, T; Rhee, S; Seo, M | 1 |
| Isomoto, I; Kojima, Y; Kubota, K; Kuroki, Y; Mukai, H; Ohnuki, K; Ohsumi, S; Tozaki, M | 1 |
| Borms, M; Cocquyt, V; Kruse, V; Maes, A; Pottel, H; Sathekge, M; Van de Wiele, C | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Kim, CY; Kim, DH; Lee, J; Lee, SW; Son, SH | 1 |
| Cruz Mora, MÁ; Espinosa Aunión, R; García Vicente, AM; Gonzalez Ageitos, A; León Martín, AA; Muñoz Sánchez, Mdel M; Relea Calatayud, F; Soriano Castrejón, A; Van Gómez López, O | 1 |
| Cho, YS; Choi, JY; Chung, DR; Kim, BT; Lee, KH | 1 |
| Dave, SR; Pucar, D; Samuel, TA; Savage, N; Williams, HT | 1 |
| Ahn, BC; Jeong, JY; Kim, DH; Lee, J; Lee, SW | 1 |
| Boirie, Y; Chadeyras, JB; Coudert, B; Durando, X; Gadea, E; Kwiatkowski, F; Merlin, C; Morio, B; Paulon, R; Thivat, E | 1 |
| Ahn, SG; Han, K; Jeon, TJ; Jeong, J; Lee, HM; Lee, M; Lee, SA; Ryu, YH; Son, EJ | 1 |
| Denburg, NL; Magnotta, VA; Menda, Y; Ponto, LL; Schultz, SK; Yamada, TH | 1 |
| Goldman, DA; Gonen, M; Jochelson, M; Morrow, M; Riedl, CC; Slobod, E; Ulaner, GA; Weber, WA | 1 |
| Baron, M; Berghian, A; Dubray, B; Edet-Sanson, A; Forestier-Lebreton, F; Gardin, I; Georgescu, D; Gouel, P; Hapdey, S; Martin, B; Modzelewski, R; Picquenot, JM; Vera, P | 1 |
| Bianchi, M; Cistaro, A; Coppolino, P; Cucinotta, M; Fagioli, F; La Delfa, V; Quartuccio, N | 1 |
| Goel, R; Jena, A; Kaul, S; Sarin, R; Taneja, S | 1 |
| Bundschuh, RA; Dregely, I; Haase, A; Kuschan, M; Lanz, T; Metz, S; Mueller, MF; Nekolla, SG; Nimbalkar, M; Schwaiger, M; Ziegler, SI | 1 |
| Borms, M; Cocquyt, V; Kruse, V; Maes, A; Pottel, H; VAN Belle, S; VAN DE Wiele, C | 1 |
| Doudouh, A; El Hammoumi, M; El Marjany, M; Kabiri, el H; Mansouri, H; Moussaoui, D | 1 |
| Bae, YT; Kang, T; Kim, JY; Kim, S; Lee, SH | 1 |
| Dank, M; Kajáry, K; Kulka, J; Lengyel, Z; Szakáll, S; Tőkés, T | 1 |
| Chang, CC; Chen, YW; Hou, MF; Lin, CY; Tu, HP | 1 |
| David, O; Lu, Y; Zivin, S | 1 |
| Andrade, WP; Bitencourt, AGV; Chojniak, R; Guimarães, MD; Lima, ENP; Marques, EF; Souza, JA | 1 |
| Errico, A | 1 |
| Jo, JE; Kang, T; Kim, JY; Kim, S; Lee, SH | 1 |
| de Roquancourt, A; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Merlet, P | 1 |
| Inoue, T; Jinnouchi, S; Minamimoto, R; Senda, M; Terauchi, T; Yoshida, T | 1 |
| Hildebrandt, MG; Jensen, PT; Kodahl, AR; Mogensen, O; Teilmann-Jørgensen, D | 1 |
| Arnould, L; Bachelot, T; Berriolo-Riedinger, A; Bougnoux, P; Coeffic, D; Coudert, B; Coudert, M; Dupré, PF; Ferrero, JM; Gabelle, P; Giard, S; Hernandez, J; Kerbrat, P; Kerrou, K; Mouret-Reynier, MA; Paintaud, G; Petit, T; Pierga, JY; Prevost, JB; Thibault, G | 1 |
| Beets-Tan, RGH; Lobbes, MBI; Moossdorff, M; Schipper, RJ; Smidt, ML | 1 |
| Cagnolini, A; Gruaz-Guyon, A; Lantry, LE; Montravers, F; Nataf, V; Nunn, AD; Prignon, A; Provost, C; Talbot, JN | 1 |
| Boughey, JC; Carey, LA; Carpenter, J; Connolly, RM; Davidson, NE; Fetting, JH; Gabrielson, E; Goetz, MP; Jacobs, LK; Jeter, SC; Khouri, N; Leal, JP; Mhlanga, J; Miller, RS; O, JH; Powers, P; Sideras, K; Stearns, V; Storniolo, AM; Wahl, RL; Walsh, B; Watkins, S; Wolff, AC; Zhang, Z; Zhou, XC; Zorzi, J | 1 |
| Ahn, HK; Cho, EY; Choi, JY; Hyun, SH; Im, YH; Kil, WH; Lee, JE; Nam, SJ; Park, YH | 1 |
| Avril, N; Muzic, RF; Plecha, D; Sher, A; Vercher-Conejero, JL | 1 |
| Avril, N; Muzic, RF; Plecha, D; Sher, A; Valls, L | 1 |
| Bozza, F; Cervino, AR; Evangelista, L; Ghiotto, C; Michieletto, S; Orvieto, E; Saibene, T | 1 |
| Chang, HT; Chiu, YL; Hu, C; Liu, RS; Peng, NJ | 1 |
| Allen, JA; Chan, SR; Dehdashti, F; Dence, CS; Fettig, NM; Fowler, AM; Katzenellenbogen, JA; Sharp, TL; Zhou, D | 1 |
| Acevedo-Báñez, I; Borrego-Dorado, I; Carrillo-Cruz, E; García-Gomez, FJ; Jiménez-Granero, P; Perez-Lopez, O | 1 |
| Jhaveri, K; Linden, H | 1 |
| Cho, A; Kang, WJ; Kim, YT; Lee, JD; Lee, JH; Lee, JW; Yun, M | 1 |
| Ahn, SG; Dong, SM; Han, K; Jeon, TJ; Jeong, J; Lee, HM; Lee, HW; Lee, SA; Park, JT; Ryu, YH; Son, EJ | 1 |
| Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Coudert, B; Fumoleau, P; Humbert, O; Kanoun, S | 1 |
| Cooper, AC; Fleming, IN; Phyu, SM; Smith, TA | 1 |
| Duan, F; Hanna, L; Hillner, BE; Quinn, B; Shields, AF; Siegel, BA | 1 |
| Chua, B; Cochet, A; David, S; Drummond, E; Dutu, G; Hicks, RJ; MacManus, M; Moodie, K | 1 |
| Aksu, R; Inal, A; Isikdogan, A; Kaplan, MA; Kucukoner, M; Tasdemir, B; Teke, F; Teke, M; Urakci, Z | 1 |
| Hansen, LB | 1 |
| Carra, BJ; Clemenshaw, MN | 1 |
| Lu, Y | 1 |
| Brade, J; Buesing, KA; Kaiser, CG; Krammer, J; Schnitzer, A; Schoenberg, SO; Sperk, E; Suetterlin, M; Sutton, EJ; Wasgindt, S; Wasser, K | 1 |
| Aogi, K; Kadoya, T; Kiyoto, S; Masumoto, N; Okada, M; Shigematsu, H; Sugawara, Y | 1 |
| Marangmei, C; Sharma, P | 1 |
| Asayama, Y; Baba, S; Fujita, N; Honda, H; Kitamura, Y; Kubo, Y; Morita, K; Nishie, A; Shirabe, K; Takayama, Y; Ushijima, Y | 1 |
| Bhambhvani, P; Cunningham, JR; O'Malley, JP | 1 |
| Beck-Sickinger, AG; Hofmann, S; Kuwert, T; Maschauer, S; Prante, O | 1 |
| Cahen-Doidy, L; Delaloge, S; Espié, M; Giacchetti, S; Groheux, D; Nikpayam, M; Rivera, S; Uzan, C | 1 |
| An, YS; Jung, YS; Kang, DK; Kim, TH; Lee, SJ; Yim, H; Yoon, JK | 1 |
| Adachi, S; Koizumi, M; Kojo, M; Kubota, K; Matsuno, S; Morioka, N; Nishimura, M; Nishioka, S; Seto, H; Yamamoto, H | 1 |
| He, X; Huo, Y; Ma, C; Shao, M; Sun, L | 1 |
| Greenspan, D; Lebron, L; Pandit-Taskar, N | 1 |
| Aronen, HJ; Auren, J; Huovinen, R; Jambor, I; Kajander, S; Kauppila, E; Kemppainen, J; Kuisma, A; Merisaari, H; Minn, H; Noponen, T; Ramadan, S; Sandell, M; Saunavaara, J; Seppänen, M | 1 |
| Chan, HP; Hu, C; Huang, TC; Peng, NJ; Yu, CC | 1 |
| Abramson, RG; Abramson, VG; Arlinghaus, LR; Chakravarthy, AB; Jones-Jackson, LB; Lambert, KF; Williams, J; Yankeelov, TE | 1 |
| Catalano, M; Catalano, OA; Guimaraes, A; Iannace, C; Luongo, A; Mahmood, U; Nicolai, E; Rosen, BR; Salvatore, M; Soricelli, A; Vangel, MG | 1 |
| Chang, HT; Chang, TH; Chiu, YL; Chou, CP; Fu, TY; Hu, C; Pan, HB; Peng, NJ | 1 |
| Amer, S; Dong, Y; Hou, H; Li, J; Tian, M; Wang, C; Yao, Q | 1 |
| Buskens, E; de Bock, GH; de Vries, EF; de Vries, EG; Feenstra, T; Glaudemans, AW; Greuter, MJ; Hospers, GA; Koleva-Kolarova, RG; van Kruchten, M; Vermeulen, KM | 1 |
| de Cremoux, P; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hatt, M; Hindié, E; Majdoub, M; Merlet, P; Resche-Rigon, M; Sanna, A; Teixeira, L; Visvikis, D | 1 |
| Asano, T; Futamura, M; Kanematsu, M; Kobayashi, K; Mori, R; Morikawa, A; Morimitsu, K; Nawa, M; Yoshida, K | 1 |
| An, YS; Han, S; Jung, YS; Kang, DK; Kim, TH | 1 |
| Choi, BB; Jung, NY; Kim, SH; Sung, MS | 1 |
| Dank, M; Györke, T; Kajáry, K; Kulka, J; Lengyel, Z; Molnár, BÁ; Szentmártoni, G; Tőkés, AM; Tőkés, T; Torgyík, L | 1 |
| de Cremoux, P; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hatt, M; Hindié, E; Majdoub, M; Martineau, A; Merlet, P; Resche-Rigon, M; Sanna, A; Visvikis, D | 1 |
| Fujiwara, Y; Hamada, A; Hashimoto, J; Kanayama, Y; Kodaira, M; Kurihara, H; Miyakita, Y; Shimizu, C; Tamura, K; Tani, H; Watanabe, Y; Yamamoto, H; Yonemori, K; Yoshida, M; Yunokawa, M | 1 |
| Benveniste, AP; Benveniste, MF; Fox, PS; Marom, EM; Mawlawi, O; Yang, W | 1 |
| Baek, JM; Kim, YH; Lee, DS; Lee, JA; Sung, GY; Won, JM | 1 |
| Choe, JG; Kim, S; Pahk, K | 1 |
| Ishii, S; Kikuchi, K; Miyajima, M; Sakuma, K; Shishido, F | 1 |
| Fukushima, K; Hirota, S; Igarashi, Y; Katsuura, T; Kitajima, K; Maruyama, K; Miyoshi, Y; Nishimukai, A | 1 |
| Ailianou, A; Giger, R; Karamitopoulou, E; Landis, BN; Nisa, L; Salmina, C | 1 |
| Corben, AD; Dashevsky, BZ; Goldman, DA; Gönen, M; Hudis, CA; Jochelson, MS; Morrow, M; Parsons, M; Ulaner, GA | 1 |
| Hasebe, T; Hirokawa, E; Kuji, I; Matsuura, K; Osaki, A; Saeki, T; Shigekawa, T; Shimada, H; Sugitani, I; Sugiyama, M; Takahashi, T; Takeuchi, H; Ueda, S; Yamane, T | 1 |
| Choi, EK; Chung, YA; Oh, JK | 1 |
| Cervino, AR; Conte, P; Evangelista, L; Fernando, B; Ghiotto, C; Guarneri, V; Michieletto, S; Orvieto, E; Saibene, T | 1 |
| Hashimoto, J; Hayashi, N; Imai, Y; Iwaisako, K; Iwamoto, T; Kazama, T; Koizumi, J; Morioka, T; Niikura, N; Ogiya, R; Okamura, T; Oshitanai, R; Saito, Y; Terao, M; Tokuda, Y; Tsuda, B | 1 |
| Kim, BS; Kim, Y; Yoon, HJ | 1 |
| Semiglazov, V | 1 |
| Cho, A; Kang, WJ; Park, JY; Park, YJ; Song, EH; Song, HT | 1 |
| Dershaw, DD; Gibbons, G; Goldman, DA; Jochelson, MS; Morris, EA; Moskowitz, CS; Sutton, EJ; Watson, EJ | 1 |
| Chisin, R; Freedman, N; Klein, M; Orevi, M; Peretz, T; Tahover, E; Uziely, B | 1 |
| An, YS; Jeon, GS; Jung, YS; Kang, DK; Kim, TH; You, S | 1 |
| Baltzer, PA; Dubsky, P; Fueger, B; Helbich, TH; Karanikas, G; Magometschnigg, HF; Pinker, K; Rudas, M; Weber, M | 1 |
| Abramson, RG; Arlinghaus, LR; Kang, H; Kinahan, PE; Lee, TC; Li, X; Linden, HM; MacDonald, LR; Partridge, SC; Rani, SD; Whisenant, JG; Williams, JM; Yankeelov, TE | 1 |
| de Roquancourt, A; Espié, M; Groheux, D; Hatt, M; Hindié, E; Le Rest, CC; Majdoub, M; Martineau, A; Merlet, P; Tixier, F; Visvikis, D | 1 |
| Cai, J; Dang, YH; Li, F; Li, X; Wang, L | 1 |
| Álvarez Cabellos, R; Amo-Salas, M; Espinosa Aunión, R; García Vicente, AM; López-Fidalgo, JF; Muñoz Sanchez, Mdel M; Soriano Castrejón, Á | 1 |
| Alberini, JL; Bertrand, F; Champion, L; Fourme, E; Gontier, E; Lerebours, F; Wartski, M | 1 |
| Higashi, M; Jinguji, M; Kajiya, Y; Nakajo, M; Yoshiura, T | 1 |
| Altrinetti, V; Bongioanni, F; DeCensi, A; Gennari, A; Gonella, R; Iacozzi, M; Massollo, M; Morbelli, S; Paparo, F; Piccardo, A; Puntoni, M; Sambuceti, G | 1 |
| Arteaga, CL; Barry, WT; Dees, EC; Falkson, CI; Guo, H; Hobday, TJ; Krop, IE; Lin, NU; Mayer, IA; Najita, JS; Nanda, R; Richardson, AL; Rimawi, MF; Ryabin, N; Van den Abbeele, AD; Winer, EP; Wolff, AC; Yap, JT | 1 |
| Dickler, MN; Jhaveri, K; Ulaner, GA | 1 |
| Bernards, N; Beynel, A; Boisgard, R; Bouet, S; Buvat, I; Kuhnast, B; Tavitian, B; Thézé, B | 1 |
| Ahn, BC; Chae, YS; Jeong, SY; Lee, J; Lee, SW; Son, SH; Song, BI | 1 |
| Chung, MH; Jung, NY; Kang, BJ; Kim, SH; Park, SY | 1 |
| Chen, S; Ibrahim, NK; Wang, H; Wong, FC; Wong, ST; Yan, Y | 1 |
| Leung, E; Martineau, P; Pelletier-Galarneau, M | 1 |
| Basu, S; Thapa, P | 1 |
| Alamgeer, M; David, S; Ganju, V; Ng, SP | 1 |
| Dashevsky, B; Goldman, DA; Gönen, M; Hogan, MP; Hudis, C; Jochelson, M; Morrow, M; Osborne, JR; Riedl, CC; Ulaner, GA | 1 |
| Weber, MA | 1 |
| Alsharif, A; Cervino, AR; Chiacchio, S; DI Martino, F; Evangelista, L; Filidei, E; Ghilli, M; Manca, G; Naccarato, AG; Negri, A; Puccini, G; Roncella, M; Tredici, M; Volterrani, D | 1 |
| Bao, X; Cheng, J; Geng, D; Liu, G; Mo, M; Wang, Y; Zhang, J; Zhang, Y | 1 |
| Chegai, F; Mannelli, L; Monti, S; Orlacchio, A | 1 |
| Aprile, G; Fanotto, V; Fontanella, C; Puglisi, F; Rihawi, K | 1 |
| Cho, N; Chun, IK; Im, SA; Kang, KW; Kim, TY; Lee, H; Lee, KH; Moon, WK; Park, IA; Song, IC; Yoon, HJ | 1 |
| Dershaw, DD; Jacobs, SS; Jochelson, MS; Lebron, L; Morris, EA; Moskowitz, CS; Powell, SN; Sacchini, V; Ulaner, GA; Zheng, J | 1 |
| Barkhodari, A; Gambhir, SS; Iagaru, A; Jackson, T; Jamali, M; Loening, A; Minamimoto, R; Mosci, C; Obara, P; Taviani, V; Vasanawala, S | 1 |
| Becker, CD; Becker, M; Bodmer, A; Botsikas, D; Copercini, M; Delattre, BM; Djema, DA; Garibotto, V; Kalovidouri, A; Monnier, S; Montet, X; Ratib, O; Tabouret-Viaud, C | 1 |
| Doot, RK; Kinahan, PE; Kurland, BF; Linden, HM; Mankoff, DA; Muzi, M; Peterson, LM; Wangerin, KA | 1 |
| Chang, JS; Keum, KC; Kim, HJ; Kim, KH; Kim, SI; Kim, YB; Lee, J; Suh, CO; Yun, M | 1 |
| Ha, AN; Kim, BS; Kim, HL; Kim, HN; Kim, Y; Yoon, HJ; Yun, Y | 1 |
| Alabed, YZ; Hassoun, H; Karls, S; Laufer, J; Probst, S | 1 |
| Chen, CL; Chen, NF; Chih-Chuan, H; Li, CC; Li, CZ; Lin, MC; Tang, CT | 1 |
| Baillet, C; Dewalle-Vignion, AS; Fechter, T; Gardin, I; Gibon, D; Massoptier, L; Modzelewski, R; Nemer, U; Nestle, U; Parcq, C; Schaefer, A; Vera, P; Vermandel, M | 1 |
| Adams, S; Paryani, B; Subbiah, V; Takalkar, A | 1 |
| Inoue, T; Kuwada, Y; Ozawa, Y; Tasaki, Y; Yamamoto, Y | 1 |
| Alavi, A; Grupe, P; Houshmand, S; Høilund-Carlsen, PF; Salavati, A; Segtnan, EA | 1 |
| Bagni, O; Cianni, R; Filippi, L; Pelle, G; Schillaci, O | 1 |
| Aftimos, P; Ameye, L; Awada, A; Brouwers, AH; de Vries, EG; Emonts, P; Flamen, P; Garcia, C; Gebhart, G; Guiot, T; Hoekstra, OS; Huizing, M; Lamberts, LE; Menke-van der Houven van Oordt, CW; Oyen, WJ; Schröder, CP; Stroobants, S; Tol, J; Vugts, DJ; Wimana, Z | 1 |
| Beatty, JD; Bender, LC; Cotter, EW; Hallam, PS; Haseley, DR; Hippe, DS; Kelly, MM; MacDonald, LR; Parikh, JR; Rogers, JV; Voria, PR; Wang, CL | 1 |
| Ahn, SG; Jeon, TJ; Jeong, J; Lee, JH; Ryu, YH; Seok, JW | 1 |
| Karan, B; Pourbagher, A; Torun, N | 1 |
| Doihara, H; Ito, M; Iwamoto, T; Kaji, M; Miyoshi, S; Mizoo, T; Motoki, T; Nogami, T; Shien, T; Taira, N | 1 |
| Haga, H; Kondo, T; Nakamoto, Y; Otsuka, Y; Takaori-Kondo, A | 1 |
| Koolen, BB; Rutgers, EJ; Stokkel, MP; Teixeira, SC; Valdés Olmos, RA; van der Noort, V; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Doi, H; Fukushima, K; Hirota, S; Igarashi, Y; Katsuura, T; Kawanaka, Y; Kitajima, K; Maruyama, K; Miyoshi, Y; Mouri, M; Yamakado, K; Yamano, T | 1 |
| Akabuogu, EU; Phyu, SM; Smith, TA | 1 |
| Fujii, T; Kuwano, H; Oosone, K; Tatsuki, H; Yajima, R | 1 |
| Kitajima, K; Miyoshi, Y | 1 |
| Bartenstein, P; Fendler, WP; Haug, AR; Jakobs, TF; Lechner, H; Lehner, S; Michl, M; Paprottka, KJ; Paprottka, PM; Todica, A | 1 |
| Espié, M; Groheux, D; Hindié, E; Mankoff, D | 1 |
| Artiko, V; Grozdic-Milojevic, I; Obradovic, V; Odalovic, S; Pavlovic, S; Sobic Saranovic, D; Stojiljkovic, M; Susnjar, S | 1 |
| Alaerts, H; Beels, L; D'hulst, L; Gheysens, O; Maes, A; Nicolaij, D; Van de Wiele, C | 1 |
| Antoch, G; Buchbender, C; Grueneisen, J; Kinner, S; Nagarajah, J; Sawicki, LM; Schaarschmidt, BM; Umutlu, L | 1 |
| Bae, YK; Cho, IH; Chun, KA; Kong, E | 1 |
| Al Bashir, S; Al-Muqbel, KM; Al-Omari, MH; Dagher, NM; Rousan, LA; Yaghan, RJ | 1 |
| Alberini, JL; Cochet, A; Groheux, D; Hindié, E; Humbert, O; Mankoff, D | 1 |
| Avril, N; Avril, S; Muzic, RF; Plecha, D; Traughber, BJ; Vinayak, S | 1 |
| Doherty, C; Muzaffar, R; Osman, MM; Parkar, ND; Raslan, OA | 1 |
| Kim, SJ; Pak, K; Park, DY; Shin, S | 1 |
| Aytac, HO; Hasbay, B; Nursal, GN; Nursal, TZ; Reyhan, M; Torun, N; Yapar, AF | 1 |
| Chen, X; Cheng, J; Fu, X; Guo, X; Luo, J; Shao, Z; Tuan, J; Yang, Z; Yu, X; Zhou, Z | 1 |
| Kuji, I; Ogura, H; Osaki, A; Saeki, T; Sakahara, H; Shigekawa, T; Takeuchi, H; Ueda, S; Ueda, Y; Yamane, T; Yoshizawa, N | 1 |
| Du, B; Li, N; Li, X; Li, Y; Yin, Y | 1 |
| Álvarez Cabellos, R; Amo-Salas, M; Espinosa Aunión, R; García Vicente, AM; Jiménez Londoño, GA; Muñoz Sánchez, Mdel M; Pena Pardo, FJ; Relea Calatayud, F; Soriano Castrejón, Á | 1 |
| Dong, A; Lu, J; Wang, Y; Zuo, C | 1 |
| Dank, M; Györke, T; Kajáry, K; Kulka, J; Lengyel, Z; Somlai, K; Szentmártoni, G; Tőkés, AM; Tőkés, T; Torgyík, L | 1 |
| Huang, G; Li, P; Liu, J; Liu, Q; Song, S; Wang, C | 1 |
| Kiser, J | 1 |
| Dickler, M; Gönen, M; Jochelson, M; McArthur, H; Ong, L; Pinker, K; Riedl, CC; Ulaner, GA; Weber, WA | 1 |
| Alavi, A; Baun, C; Bektas, S; Buskevica, I; Duvnjak, S; Ewertz, M; Falch, K; Farahani, ZA; Gerke, O; Hansen, JA; Hildebrandt, MG; Høilund-Carlsen, PF; Jylling, AM; Larsen, LB; Petersen, H; Søe, K | 1 |
| Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Wray, R; Wright, JL | 1 |
| Brenot-Rossi, I; Delarbre, B; Houvenaeghel, G; Jalaguier-Coudray, A; Thomassin-Naggara, I; Viens, P; Villard-Mahjoub, R | 1 |
| Babb, JS; Jhaveri, K; Kim, SG; Melsaether, AN; Moy, LA; Ponzo, FD; Pujara, AC; Pysarenko, KM; Raad, RA; Sigmund, EE | 1 |
| Ahn, SG; Choi, SE; Jeong, J; Jung, WH; Lee, HM; Lee, HW; Lee, MK; Yoo, H | 1 |
| Del Puig Cózar Santiago, M; Jurado, RS; Koolen, BB; Rebolleda, JF; Rutgers, EJ; Stokkel, MP; Teixeira, SC; Valdés Olmos, RA; van der Noort, V; Wesseling, J | 1 |
| Fujii, T; Kuwano, H; Tatsuki, H; Yajima, R | 1 |
| Jiang, S; Pogue, BW | 1 |
| Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Trahan, TJ | 1 |
| Doi, H; Fukushima, K; Hirota, S; Kawanaka, Y; Kitajima, K; Miya, M; Miyoshi, Y; Yamakado, K; Yamano, T | 1 |
| Freed, M; Kim, SG; Margolis, NE; McKellop, J; Melsaether, AN; Moy, L; Sigmund, EE | 1 |
| Fox, J; Krebs, S; Mannelli, L; Monti, S; Seshan, S | 1 |
| Ho, AM; Kalantari, BN | 1 |
| McConathy, J | 1 |
| An, HJ; Chang, JM; Cheon, GJ; Cho, N; Ha, S; Han, W; Im, SA; Kim, WH; Lee, JS; Lee, SH; Moon, WK; Ryu, HS | 1 |
| Deo, SV; Garg, PK; Gogia, A; Kumar, R; Mathur, SR; Sharma, DN; Shukla, NK; Thulkar, S | 1 |
| Al-Muqbel, KM; Yaghan, RJ | 1 |
| Fujii, T; Higuchi, T; Horiguchi, J; Kuwano, H; Nagaoka, R; Obayashi, S; Takata, D; Tokiniwa, H; Tsuboi, M; Yajima, R | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, EE; Kim, YI; Lee, DS; Moon, WK; Paeng, JC; Yoon, HJ | 1 |
| Kim, SH; Oh, JK; Park, SY; Seo, YY; Sohn, HS; Yoo, IR | 1 |
| Cammilleri, S; Dignat-George, F; Dubois, C; Guis, S; Mege, D; Mundler, O; Panicot-Dubois, L | 1 |
| Akdulum, I; Caglar, E; Cosar, ZS; Dilek, G; Kiziltepe, FT; Uylar, T | 1 |
| Currin, ER; Krohn, KA; Kurland, BF; Lee, JH; Linden, HM; Link, JM; Mankoff, DA; Peterson, LM; Schubert, EK | 1 |
| Connolly, RM; Mena, E; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Trahan, TJ; Xiao, J | 1 |
| He, L; Hu, G; Jiang, X; She, W; Wang, L; Xiao, Y | 1 |
| Cho, YS; Choe, YS; Jung, KH; Lee, JH; Lee, KH; Moon, SH; Park, JW | 1 |
| Choi, JS; Jeong, J; Kim, EK; Kim, MJ; Kim, S; Koo, JS; Moon, HJ; Park, VY; Yoon, D; Yoon, H; Yoon, JH; Yun, M | 1 |
| Aina, OH; Borowsky, AD; Brucker, S; Cardiff, RD; Chen, Q; Hahn, M; Hubbard, NE; Kohlhofer, U; la Fougère, C; Nikolaou, K; Pichler, BJ; Quintanilla-Martinez, L; Reischl, G; Schmid, AM; Schmitz, J; Schwab, J; Schwenck, J; Schwenzer, N; Staebler, A; Wietek, B | 1 |
| Cai, L; Chen, L; Chen, Y; Huang, H; Huang, Z | 1 |
| Aliyev, A; Ekmekçioğlu, Ö; Erkan, ME; Halaç, M; Kocael, PÇ; Özhan, M; Sağer, MS; Sönmezoğlu, K; Vatankulu, B; Yilmaz Aksoy, S | 1 |
| Cho, YS; Choe, YS; Im, YH; Kim, BT; Lee, KH; Lim, CH; Moon, SH | 1 |
| Engebraaten, O; Futsaether, C; Hernes, E; Holtedahl, JE; Kristian, A; Malinen, E; Mælandsmo, GM; Torheim, T | 1 |
| Abramson, RG; Abramson, VG; Arlinghaus, LR; Chakravarthy, AB; Gorge, WJ; Knowland, JG; Lattanze, RK; Pendyala, P; Perrin, SR; Rani, SD; Scarantino, CW; Shone, MD; Townsend, DW; Williams, JM; Yankeelov, TE | 1 |
| Fujimoto, Y; Fukushima, K; Higuchi, T; Imamura, M; Kitajima, K; Miyagawa, Y; Miyoshi, Y; Murase, K; Nishimukai, A; Ozawa, H; Takatsuka, Y; Yanai, A | 1 |
| Bitencourt, AG; Chojniak, R; Conrado, JL; Lima, EN; Macedo, BR; Marques, EF | 1 |
| Javadi, MS; Rowe, SP; Solnes, LB | 1 |
| Amiri-Kordestani, L; Balasubramaniam, S; Bates, SE; Bryla, C; Burotto, M; Choyke, P; Davarpanah, N; Figg, WD; Fojo, T; Gonzalez, EM; Liewehr, DJ; Lindenberg, M; O'Sullivan, CC; Patronas, N; Peer, CJ; Steinberg, SM | 1 |
| Dolak, W; Karanikas, G; Kiesewetter, B; Kletter, K; Lukas, J; Mayerhoefer, ME; Müllauer, L; Pones, M; Raderer, M; Rausch, I; Simonitsch-Klupp, I; Weber, M | 1 |
| Avanesov, M; Derlin, T | 1 |
| Adams, S; Boada, FE; Cho, GY; Faul, D; Feiweier, T; Geppert, C; Glielmi, C; Jackson, K; Jhaveri, K; Kim, SG; Melsaether, AN; Mikheev, A; Moy, L; Ostenson, J; Pujara, AC; Sigmund, EE | 1 |
| Ahn, HK; Choi, JY; Hyun, SH; Im, YH; Kim, BT; Lee, JE; Lee, JH; Lee, KH; Nam, SJ; Park, YH | 1 |
| Fujii, T; Higuchi, T; Horiguchi, J; Kurozumi, S; Kuwano, H; Nagaoka, R; Obayashi, S; Takata, D; Tokiniwa, H; Yajima, R | 1 |
| Bal, C; Karunanithi, S; Kumar, R; Naswa, N; Soundararajan, R; Walia, R | 1 |
| Elkhuizen, PH; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Stokkel, MP; Teixeira, SC; Valdés Olmos, RA; van der Noort, V; Vrancken Peeters, MT | 1 |
| Albano, D; Bertagna, F; Bertoli, M; Bosio, G; Morassi, ML; Orlando, E | 1 |
| Ahn, SH; Chae, SY; Kim, SB; Moon, DH | 1 |
| Elizalde, A; Fernandez-Montero, A; Garcia-Velloso, MJ; Idoate, MA; Martinez-Regueira, F; Pina, LJ; Prieto, E; Ribelles, MJ; Rodriguez, M; Rodriguez-Spiteri, N; Sancho, L; Santisteban, M | 1 |
| Albano, D; Bertagna, F; Bosio, G; Orlando, E | 1 |
| Iranmanesh, AM; Oates, ME; Wang, J | 1 |
| Bassa, P; Capdevila, L; Garcia, JR; Pérez, C; Ramos, F; Valenti, V | 1 |
| Bertheau, P; de Cremoux, P; Espié, M; Groheux, D; Lemarignier, C; Martineau, A; Merlet, P; Teixeira, L | 1 |
| Inoue, T; Ishikawa, T; Kaneta, T; Narui, K; Noritake, M; Sakamaki, K; Sugae, S | 1 |
| Chien, AJ; Esserman, LJ; Franc, BL; Hylton, NM; Joe, BN; Jones, EF; Li, W; Pampaloni, MH; Ray, KM; Seo, Y | 1 |
| Bremer, W; Lu, Y | 1 |
| Ichinose, M; Okamoto, K | 1 |
| Cai, Q; Liang, X; Wen, B; Xie, J; Yang, Q; Yu, J | 1 |
| Ishiyama, M; Matesan, MC | 1 |
| Healey, JH; Kim, TW; Ulaner, GA; Zheng, J; Zindman, AM | 1 |
| Espié, M; Groheux, D; Lemarignier, C; Martineau, A; Merlet, P; Teixeira, L; Vercellino, L | 1 |
| Kinahan, PE; Linden, HM; Mankoff, DA; Muzi, M; Novakova, A; Peterson, LM; Wangerin, KA | 1 |
| Leger, D; Metlaine, A; Ohnona, J; Talbot, JN | 1 |
| Cho, YY; Jeong, YJ; Jung, JW; Kang, S; Oh, HK; Park, SH | 1 |
| Catalano, M; Catalano, OA; Catana, C; Horn, GL; Iannace, C; Lehman, C; Lepore, M; Luongo, A; Mahmood, U; Rosen, BR; Salvatore, M; Signore, A; Soricelli, A; Vangel, M | 1 |
| Kohli, PS; Mittal, BR; Roop, MJ; Singh, B; Singh, G; Singh, H; Watts, A | 1 |
| Aktas, B; Forsting, M; Grueneisen, J; Kinner, S; Kirchner, J; Ruhlmann, V; Sawicki, LM; Umutlu, L; Wetter, A | 1 |
| Iesato, A; Ito, KI; Ito, T; Kanai, T; Maeno, K; Mochizuki, Y; Oba, T; Ono, M; Takayama, F; Yoshizawa, A | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Freudenberg, LS; Hauth, EA; Heusner, TA; Kuehl, H; Veit-Haibach, P | 1 |
| Ameshima, S; Demura, Y; Ishizaki, T; Mizuno, S; Morikawa, M; Okazawa, H | 1 |
| Abe, Y; Asakawa, H; Fukatsu, K; Hama, Y; Ishida, J; Kondo, N; Kondo, T; Mochizuki, H; Omata, J; Tamura, K; Tsuda, H; Ueda, S | 1 |
| Bergstrom, M; Ide, S; Josephsson, R; Langstrom, B; Monazzam, A; Razifar, P | 1 |
| Emmering, J; Hoekstra, OS; Krak, NC; Meijer, S; Pinedo, HM; Spreeuwenberg, MD; Twisk, JW; Van der Hoeven, JJ | 1 |
| Deng, HF; Feng, YL; He, XH; Huang, KM; Liu, DJ; Liu, SS; Wen, GH; Yang, M; Yu, FZ; Yuan, JW | 1 |
| Borkar, S; Pandit-Taskar, N | 1 |
| Inoue, Y; Nagata, T; Shimizu, M; Taguchi, Y; Takashima, S; Tanaka, K | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Freudenberg, LS; Hauth, EA; Heusner, TA; Kimmig, KR; Koeninger, A; Kuemmel, S; Umutlu, L | 1 |
| Kasami, M; Uematsu, T; Yuen, S | 1 |
| Balzarini, J; Berndsen, SC; Direcks, WG; Lammertsma, AA; Molthoff, CF; Peters, GJ; Proost, N; Spreeuwenberg, MD | 1 |
| Abe, S; Fukuma, E; Higa, K; Kawano, N; O'uchi, T; Ogawa, T; Oyama, Y; Ozaki, S; Sakamoto, M; Sakamoto, N; Suzuki, T; Tozaki, M; Yamashiro, N | 1 |
| Baggett, BK; Brown, KS; Gatenby, RA; Gillies, RJ; Robey, IF; Stephen, RM | 1 |
| Duch, J; Fontanillas, M; Fuster, D; Muñoz, M; Paredes, P; Pons, F; Santamaría, G; Velasco, M | 1 |
| Abraham, J; Hobbs, G; Kanate, A; Marano, G; Saad, A; Sehbai, A | 1 |
| Baba, K; Fuji, T; Hayabuchi, N; Ishibashi, M; Kaibara, H; Kaida, H; Kawamura, S; Kurata, S; Miyagawa, T; Ogo, E; Uchida, M | 1 |
| Ajisaka, H; Hoso, M; Ii, T; Matsuki, N; Miwa, K; Oba, M; Sasaki, M | 1 |
| Higure, A; Hirata, K; Inoue, Y; Katsuki, T; Konishi, T; Nagata, J; Nagata, N; Nagata, T; Nakayama, Y; Okamoto, K; Shibao, K; Tsurudome, Y; Yamaguchi, K | 1 |
| Csiki, Z; Garai, I; Sóvágó, J; Szabados, L; Tóth, C; Tóth, L | 1 |
| Britton, P; Ell, PJ; Gaskarth, M; Groves, AM; Iddles, S; Miles, KA; Moyle, P; Shastry, M; Warren, RM; Wishart, GC | 1 |
| Ham, BJ; Hwang, HS; Jon, DI; Kim, LS; Seok, JH | 1 |
| Binderup, T; Jensen, MM; Jørgensen, JT; Kjaer, A | 1 |
| El-Kholy, MR; El-Shorbagy, E; Murakami, K; Zytoon, AA | 1 |
| Caprio, MG; Capuano, E; De Falco, T; Imbriaco, M; Limite, G; Pace, L; Salvatore, M | 1 |
| Azuma, A; Fukuma, E; Ito, K; O'uchi, T; Tanaka, T; Tozaki, M | 1 |
| Aogi, K; Hara, F; Inoue, T; Nishimura, R; Ohsumi, S; Sugata, S; Taira, N; Takabatake, D; Takashima, S | 1 |
| Ebied, O; El-Kholy, MR; Murakami, K; Zytoon, AA | 1 |
| Avril, N; Brenner, W; Harbeck, N; Jaenicke, F; Kahlert, S; Lebeau, A; Mahner, S; Sassen, S; Schwaiger, M; Schwarz-Dose, J; Tiling, R; Untch, M | 1 |
| Arslan, N; Ataergin, S; Ozet, A; Ozguven, MA | 1 |
| Das, CJ; Kumar, R | 1 |
| Cristofanilli, M; Dawood, S; Gamez, C; Inoue, T; Macapinlac, HA; Tateishi, U; Yeung, HW | 1 |
| Chang, HR; Chung, D; Debruhl, N; Gornbein, JA; Minami, CA; Prati, R | 1 |
| Beorlegui, C; García-Velloso, MJ; Gil-Rendo, A; Martínez-Regueira, F; Rodriguez-Spiteri, N; Zornoza, G | 1 |
| Carkaci, S; Cristofanilli, M; Dawood, S; Gonzalez Angulo, AM; Le-Petross, HT; Macapinlac, HA; Mawlawi, O; Resetkova, E; Rohren, E; Yang, WT | 1 |
| Beheshti, M; Dirisamer, A; Flöry, D; Halpern, BS; Langsteger, W; Mayerhoefer, ME; Wolf, F | 1 |
| Conti, PS; Leahy, RM; Li, Q; Li, Z; Yu, X | 1 |
| Chawla, M; Gupta, SD; Kumar, A; Kumar, R; Malhotra, A; Mehta, SN; Seenu, V | 1 |
| Chang, E; Kim, J; Kim, S; Kim, Y; Lee, C; Lee, J; Song, I; Suh, K; Sul, J | 1 |
| Andradas, E; Blasco, JA; Escalona, S; Gómez, N; Reza, MM | 1 |
| Duch, J; Fernández, PL; Fontanillas, M; Fuster, D; Guzmán, F; Lomeña, FJ; Muñoz, M; Paredes, P; Pons, F; Rubí, S | 1 |
| Avril, N; Roylance, R; Sassen, S | 1 |
| D'Souza, M; Jaimini, A; Jain, N; Kaur, P; Mondal, A; Sharma, R; Singh, D; Singh, N; Tripathi, M | 1 |
| Basely, M; Bernard, P; Bussy, E; de Jaureguiberry, JP; Gisserot, O; Maszelin, P | 1 |
| Fox, JJ; Pandit-Taskar, N; Rohan, S | 1 |
| Gallimidi, Z; Gourevich, K; Israel, O; Litmanovich, D | 1 |
| Chua, SC; O'Connor, SR; Rozalli, FI | 1 |
| Chong, A; Jeong, SY; Min, JJ | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Kimmig, KR; Koeninger, A; Kuemmel, S; Otterbach, F; Stahl, A | 1 |
| Abraham, J; Almubarak, M; Marano, G; Osman, S | 1 |
| Aoki, R; Chin, T; Hyakusoku, H; Kobe, K | 1 |
| Baillet, G; Espié, M; Giacchetti, S; Groheux, D; Hindié, E; Misset, JL; Moretti, JL; Rubello, D | 1 |
| Andreopoulou, E; Cristofanilli, M; Dawood, S; De Giorgi, U; Doyle, GV; Fritsche, HA; Handy, BC; Hortobagyi, GN; Jackson, S; Macapinlac, HA; Miller, MC; Reuben, JM; Rohren, E; Ueno, NT; Valero, V | 1 |
| Hiyama, A; Kawakami, Y; Matsunaga, N; Suga, K | 1 |
| Damjanovich, L; Garai, I; Garami, Z; Hascsi, Z; Lukács, G; Tanyi, M | 1 |
| Che, WJ; Qiao, WL; Wang, TS; Xing, Y; Zhao, JH | 1 |
| Maguire, GQ; Noz, ME; Ponzo, F | 1 |
| Alexiou, J; Flamen, P; Garcia, C; Gil, T; Huyge, V; Vanderstappen, A | 1 |
| Li, S; Schuster, DM; Sepulveda, JN; Styblo, TM; Zeng, W | 1 |
| Fujiuchi, N; Matsuda, H; Matsuura, K; Misumi, M; Nakamiya, N; Okubo, K; Osaki, A; Saeki, T; Sakurai, T; Sano, H; Shigekawa, T; Takahashi, T; Takeuchi, H | 1 |
| Quon, A; Zissen, MH | 1 |
| Ansari, MS; Arteaga, CL; Baldwin, RM; Buck, JR; Gore, JC; Manning, HC; McKinley, ET; Miller, TW; Nolting, DD; Olivares, MG; Sanchez, V; Schiff, R; Shah, C; Wyatt, SK; Zhao, P | 1 |
| Dellapasqua, S | 1 |
| Hany, TF; Husmann, L; Schaefer, NG; Soyka, JD; Strobel, K; Treyer, V; Tschopp, A; Veit-Haibach, P | 1 |
| Cristofanilli, M; De Giorgi, U; Doyle, GV; Handy, BC; Hortobagyi, GN; Macapinlac, HA; Mego, M; Miller, MC; Reuben, JM; Rohren, E; Ueno, NT; Valero, V | 1 |
| Aukema, TS; Straver, ME; Valdés Olmos, RA; Vogel, WV | 1 |
| Inoue, T; Jinnouchi, S; Kawamoto, M; Minamimoto, R; Nakashima, R; Nishizawa, S; Senda, M; Terauchi, T; Yoshida, T | 1 |
| Alberini, JL; Cherel, P; Fourme, E; Gontier, E; Le Stanc, E; Lerebours, F; Madar, O; Pecking, AP; Wartski, M | 1 |
| Carey, LA; Crowder, R; Dehdashti, F; Dickler, MN; Ellis, MJ; Fleming, GF; Gao, F; Jamalabadi-Majidi, S; Jeffe, DB; Kommareddy, A; Marcom, PK; Siegel, BA; Silverman, P | 1 |
| Feng, X; Guan, Y; Hua, F; Huang, Z; Zhao, J | 1 |
| Futamata, Y; Ishibashi, M; Kaida, H; Kojima, K; Koufuji, K; Kurata, S; Kutami, R; Murakami, N; Ohki, S; Yamaguchi, R; Yano, H; Yoshimura, F | 1 |
| Fowler, AR; Leong, PM; Lin, M | 1 |
| Boin, C; Bousquet, G; Cuvier, C; Espié, M; Giacchetti, S; Groheux, D; Hindié, E; Misset, JL; Moretti, JL; Teyton, P | 1 |
| Jung, SY; Kang, HS; Kim, EA; Kim, SK; Kim, SW; Ko, KL; Kwon, Y; Lee, KS; Lee, S; Lee, SJ; Min, SY; Nam, BH; Park, C; Park, IH; Ro, J; Shin, KH | 1 |
| Conti, PS; Leahy, RM; Li, Q; Li, Z; Pantazis, D; Yu, X | 1 |
| Costantini, DL; Done, SJ; Fasih, A; Green, DE; McLarty, K; Reilly, RM; Scollard, DA; Vines, DC | 1 |
| Alavi, A; Gambhir, SS; Jadvar, H | 1 |
| Kubota, K; Kurata, A; Murata, Y; Osanai, T; Shibuya, H | 1 |
| Adachi, S; Hanioka, K; Hirokaga, K; Monzawa, S; Sakuma, T; Suzuki, K; Takao, S | 1 |
| Bronkhorst, C; de Graaf, H; de Rhoter, W; Gemmel, F; Tichelaar, V | 1 |
| Brouwers, AH; de Vries, EG; Hospers, GA; Lub-de Hooge, MN; Nagengast, WB; Oude Munnink, TH; Schröder, CP; van der Wall, E; van Diest, PJ | 1 |
| Avril, N; Avril-Sassen, S; Dose-Schwarz, J; Jänicke, F; Lebeau, A; Mahner, S; Schwaiger, M; Tiling, R; Untch, M; Weber, C | 1 |
| Avisar, E; Goodwin, WJ; Moffat, FL; Molina, MA; Serafini, AN; Sfakianakis, GN | 1 |
| Aukema, TS; Oldenburg, HS; Russell, NS; Rutgers, EJ; Teertstra, HJ; Valdés Olmos, RA; Vogel, WV; Vrancken Peeters, MT; Wesseling, J | 1 |
| Furukawa, H; Inokuchi, M; Kawashima, H; Kayahara, M; Kinuya, S; Ohta, T; Taki, J | 1 |
| Alavi, A; Basu, S; Bergey, MR; Schnall, M; Sonnad, SS; Tchou, J; Tomaszewski, J | 1 |
| Avitabile, G; Cangiano, A; Caprio, MG; Di Martino, G; Farina, A; Forestieri, P; Imbriaco, M; Pace, L; Salvatore, M; Soscia, F | 1 |
| Beets-Tan, RG; Boersma, LJ; de Ruysscher, D; Houben, R; Hupperets, P; Jager, JJ; Keymeulen, K; Lambin, P; van Kroonenburgh, M | 1 |
| Bernardi, A; Cacciari, N; Fanti, S; Martoni, AA; Musto, A; Quercia, S; Rosati, M; Santini, D; Taffurelli, M; Zamagni, C | 1 |
| Hama, Y; Nakagawa, K | 1 |
| Castiglione, F; Molino, C; Olivieri, S; Susini, T; Tavella, K; Viligiardi, R | 1 |
| Aukema, TS; Gilhuijs, KG; Olmos, RA; Peeters, MJ; Rutgers, EJ; Schot, ME; Straver, ME; Vogel, WV | 1 |
| Bal, CS; Halanaik, D; Kumar, R; Malhotra, A; Reddy, R; Santra, A | 1 |
| Heys, SD; Peare, R; Staff, RT | 1 |
| Alavi, A; Basu, S; Cermik, TF; Cucchiara, AJ; Mavi, A; Puskulcu, H; Urhan, M; Yu, JQ | 1 |
| Aukema, TS; Hoefnagel, CA; Valdés Olmos, RA; Vogel, WV | 1 |
| Chung, A; Morrow, M; Port, E; Sampson, M; Schoder, H | 1 |
| Buser, C; Clark, EA; Coppola, D; Draetta, GF; Efferson, CL; Giampaoli, S; Gibson, RE; Majumder, PK; Mesiti, G; Patel, S; Reilly, JF; Strack, PR; Sullivan, T; Tammam, J; Ware, C; Winkelmann, CT; Winter, C; Yeatman, T | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Koeninger, A; Kuemmel, S; Lauenstein, T; Quinsten, A; Stahl, A | 1 |
| Ivanov, VG; Kanaev, CV; Krivorot'ko, PV; Novikov, SN; Semiglazov, VF; Zomova, OV | 1 |
| Cook, JB; Doane, A; Gerald, W; Gonen, M; Larson, S; Osborne, JR; Port, E; Yeung, H | 1 |
| Li, H; Li, W; Liu, Y; Ren, R; Tang, Y; Wei, Z | 1 |
| Fotopoulos, A; Kyritsis, AP; Sioka, C | 1 |
| Hoshi, K; Tozaki, M | 1 |
| Berger, F; Pfluger, T; Reiser, MF; Schramm, N | 1 |
| Cheng, T; Liu, J; Liu, T; Xu, W; Yan, WL; Yang, HL | 1 |
| Inoue, T; Kiyoto, S; Nishimura, R; Ohsumi, S; Sugawara, Y; Takabatake, D | 1 |
| Bagnardi, V; Cardillo, A; Colleoni, M; De Cicco, C; Dellapasqua, S; Galimberti, V; Gilardi, L; Montagna, E; Paganelli, G | 1 |
| Al-Nahhas, A; Bonciarelli, G; Crepaldi, G; Facci, E; Fornasiero, A; Grassetto, G; Mandoliti, G; Marzola, MC; Minicozzi, AM; Nashimben, O; Otello, D; Pasini, F; Rossi, E; Rubello, D | 1 |
| Ginat, DT; Puri, S | 1 |
| Basu, S; Shet, T | 1 |
| Alexiou, J; Ameye, L; Awada, A; Bergmann, P; Body, JJ; Flamen, P; Garcia, C; Huyge, V; Lemort, M; Vanderlinden, B | 1 |
| Fox, J; Ganju, V; Hart, S; Hofman, M; Midolo, P; Schneider-Kolsky, ME; Stuckey, J | 1 |
| Cameron, D; Fleming, IN; Gilbert, FJ; Miles, KA | 1 |
| Kajiya, Y; Kaneko, T; Kaneko, Y; Koriyama, C; Nakajo, M; Takasaki, T; Tani, A; Ueno, M | 1 |
| Even-Sapir, E; Inbar, M | 1 |
| Abe, Y; Ishida, J; Moriya, T; Omata, J; Osaki, A; Saeki, T; Shigekawa, T; Tamura, K; Tsuda, H; Ueda, S; Yamamoto, J | 1 |
| Cristofanilli, M; De Giorgi, U; Handy, BC; Hortobagyi, GN; Liu, P; Macapinlac, HA; Mego, M; Reuben, JM; Rohren, EM; Ueno, NT | 1 |
| Ahn, JH; Jeong, J; Kim, EK; Kim, JA; Kwak, JY; Ryu, YH; Son, EJ; Youk, JH | 1 |
| Antoch, G; Bachmann, HS; Bockisch, A; Grabellus, F; Heusner, TA; Kimmig, R; Lehmann, N; Otterbach, F; Schmid, KW; Sheu, SY; Stahl, AR | 1 |
| Al-Nahhas, A; Gordon, F; Habib, N; Hodolic, M; Karunanithy, N; Tait, NP; Wasan, HS | 1 |
| Dalus, K; Pirich, C; Rendl, G; Rettenbacher, L | 1 |
| Davidson, T; Ell, PJ; Endozo, R; Groves, AM; Kelleher, T; Keshtgar, MR; Malhotra, A; Miles, KA; Rodriguez-Justo, M; Shastry, M | 1 |
| Aukema, TS; Gilhuijs, KG; Olmos, RA; Peeters, MJ; Russell, NS; Rutgers, EJ; Straver, ME; Vogel, WV | 1 |
| Aboagye, EO; Albarghach, NM; Cheze-Le Rest, C; Hatt, M; Kenny, LM; Metges, JP; Pradier, O; Rosso, L; Turkheimer, FE; Visvikis, D | 1 |
| Bouteille, C; Cimarelli, S; Heudel, P; Mognetti, T; Montella, A | 1 |
| Gilardi, L; Paganelli, G | 1 |
| Ayers, DC; Barthel, TK; Bouxsein, ML; Cheng, D; Hussain, S; Jones, MD; Lian, JB; Liu, JC; Lovria, E; Mukherjee, S; Mulay, S; Schoonmaker, JA; Stein, GS | 1 |
| Ambrózay, E; Forrai, G; Milics, M; Ormándi, K; Péntek, Z; Rajtár, M; Sinkovics, I; Szabó, E | 1 |
| Baretta, Z; Cervino, AR; Evangelista, L; Ghiotto, C; Gregianin, M; Saladini, G; Sotti, G; Vinante, L | 1 |
| Jung, KH; Ko, BH; Lee, KH; Paik, JY | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Jonkmanns, C; Kuemmel, S; Otterbach, F; Stahl, AR | 1 |
| Chai, X; Doot, RK; Dunnwald, LK; Eby, PR; Kurland, BF; Lehman, CD; Mankoff, DA; Partridge, SC; Schubert, EK; Specht, JM; Vanantwerp, RK | 1 |
| Schönberg, S | 1 |
| Cuvier, C; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Lehmann-Che, J; Moretti, JL; Porcher, R; Vercellino, L | 1 |
| Espié, M; Giacchetti, S; Groheux, D; Hindié, E; Moretti, JL; Rubello, D | 1 |
| Berg, WA; Kalinyak, JE; Larsen, LH; Madsen, KS; Miller, JP; Narayanan, D; Ozonoff, A; Pisano, ED; Schilling, K; Tartar, M | 1 |
| Aerts, J; Giacomelli, F; Grayet, B; Hustinx, R; Jerusalem, G; Mella, C; Mievis, F; Rorive, A; Tancredi, T; Waltregny, D; Withofs, N | 1 |
| Choi, WH; Chung, SK; Kim, SH; O, JH; Yoo, IR | 1 |
| Andreou, J; Filippi, V; Georgiou, E; Laspas, F; Malamitsi, J; Prassopoulos, V; Vlachou, F | 1 |
| Antoch, G; Bockisch, A; Hahn, S; Hartung, V; Heusner, TA; Jentzen, W; Nagarajah, J; Stahl, AR | 1 |
| Ariyoshi, K; Matsunaga, N; Nakazora, T; Suga, K; Yasuhiko, K; Yujiri, T | 1 |
| Brower, V | 1 |
| Kim, J; Visioni, A | 1 |
| Arya, S; Basu, S; Pruthi, A; Ramani, SK | 1 |
| Bronstein, Y; Rohren, E; Tummala, S | 1 |
| Christensen, T; Ewertz, M; Fisker, R; Fründ, ET; Grankvist, J; Iyer, V; Larsson, EM; Simonsen, C; Stenbygaard, L | 1 |
| Choi, YY; Kim, YH | 1 |
| Chen, X; Gao, H; Mohamedali, KA; Niu, G; Quan, Q; Rosenblum, MG; Sun, X; Yan, Y; Yang, M; Zhang, W | 1 |
| Kita, M; Kitajima, K; Maeda, T; Ohno, Y; Onishi, Y; Senda, M; Sugimura, K; Suzuki, K; Yoshikawa, T | 1 |
| Aboagye, EO; Al-Nahhas, A; Kenny, LM | 1 |
| Bridji, B; Campion, L; Campone, M; Devillers, A; Ferrer, L; Kraeber-Bodéré, F; Ricaud, M; Rousseau, C; Sagan, C | 1 |
| Allen-Auerbach, MS; Benz, MR; Czernin, J | 1 |
| Dalus, K; Holzmannhofer, J; Kronberger, C; Pirich, C; Reitsamer, R; Rendl, G; Rettenbacher, L | 1 |
| Doot, RK; Dunnwald, LK; Ellis, GK; Gadi, VK; Gralow, JR; Kurland, BF; Linden, HM; Livingston, RB; Mankoff, DA; Muzi, M; Schubert, EK; Specht, JM | 1 |
| Cermik, TF; Ciftçi, H; Ergül, N; Güner, SI; Huq, GE; Sağer, S | 1 |
| Berg, WA; Kalinyak, JE; Madsen, KS; Narayanan, D | 1 |
| Alessio, AM; Kinahan, PE; Liu, H; Shi, P; Tong, S | 1 |
| Bluemke, DA; Gabrielson, E; Jacobs, MA; Jeter, S; Ouwerkerk, R; Stearns, V; Wahl, R; Warzecha, H; Wolff, AC | 1 |
| Alberini, JL; Bellet, D; Brain, E; Champion, L; Edeline, V; Giraudet, AL; Le Stanc, E; Madar, O; Pecking, A; Wartski, M | 1 |
| Baretta, Z; Bozza, F; Cervino, AR; Evangelista, L; Ghiotto, C; Gregianin, M; Saladini, G; Vinante, L | 1 |
| Cheyne, RW; McLaughlin, A; Smith, TA; Trembleau, L | 1 |
| Cho, N; Chung, JK; Kang, KW; Lyou, CY; Moon, WK; Park, JS | 1 |
| Lindskog, DM; Nikkhou, K; Talusan, P | 1 |
| Hayabuchi, N; Hirose, Y; Ishibashi, M; Kaida, H; Kawahara, A; Kobayashi, M | 1 |
| Andreopoulos, D; Frangos, S; Giannopoulou, E; Lutz, S; Tselis, N; Vassiliou, V | 1 |
| Chen, YW; Hou, MF; Hou, PN; Lee, CS; Lin, CY; Tsai, EM | 1 |
| Lam, WW; Loi, HY; Loke, KS; Padhy, AK | 1 |
| Ito, H; Tahara, E; Toi, M; Yasui, W | 1 |
| Aogi, K; Hara, F; Inoue, T; Kiyoto, S; Ohsumi, S; Takabatake, D; Takahashi, M; Takashima, S | 1 |
| Clapp, AJ; Peller, PJ; Subramaniam, RM | 1 |
| Baghel, NS; Basu, S | 1 |
| Costelloe, CM; Hayashi, N; Hortobagyi, GN; Liu, J; Madewell, JE; Niikura, N; Palla, SL; Theriault, RL; Tokuda, Y; Ueno, NT; Yu, TK | 1 |
| Ciarallo, A; Derbekyan, V; Hickeson, M; Makis, W | 1 |
| Machado, M; Santos-Oliveira, R | 1 |
| Brennan, C; Campos, C; Graeber, TG; Heguy, A; Huse, JT; Kastenhuber, ER; Komisopoulou, E; Larson, SM; Linkov, I; Mellinghoff, IK; Osborne, JR; Palaskas, N; Phelps, ME; Plaisier, SB; Port, E; Rohle, D; Sander, C; Schultz, N; Taschereau, R; Tran, C; Wong, J; Wu, H; Yannuzzi, N | 1 |
| Ewertz, M; Hildebrandt, MG; Kristensen, B; Warning, K | 1 |
| Yang, WT | 1 |
| Aravkin, A; Beatty, JD; Haseley, DR; MacDonald, LR; Rogers, JV; Wang, CL | 1 |
| Choi, JJ; Jeong, SH; Kang, BJ; Kim, SH; Lee, JH; Yim, HW; Yoo, IeR | 1 |
| Hand, F; Kell, MR; Robertson, IJ | 1 |
| Ciarallo, A; Lisbona, R; Makis, W | 1 |
| Abe, Y; Fujiuchi, N; Imabayashi, E; Ishida, J; Kuji, I; Matsuda, H; Misumi, M; Moriya, T; Omata, J; Osaki, A; Saeki, T; Sakurai, T; Shigekawa, T; Takeuchi, H; Tamura, K; Tsuda, H; Ueda, S; Yamamoto, J | 1 |
| Chang, JM; Cho, N; Han, W; Im, SA; Kang, KW; Moon, WK; Noh, DY; Park, IA; Park, SH | 1 |
| Leitzin, L; Peer, A; Shai, A; Shalom, RB; Srour, S; Steiner, M | 1 |
| Aboagye, EO; Al-Nahhas, A; Challapalli, A; Contractor, KB; Coombes, RC; De Nguyen, Q; Hogben, K; Kenny, LM; Lewis, JS; Palmieri, C; Shousha, S; Stebbing, J | 1 |
| Berenger, N; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Misset, JL; Toubert, ME; Vercellino, L | 1 |
| De Cicco, C; Gilardi, L; Paganelli, G | 1 |
| Dunnwald, LK; Krohn, KA; Kurland, BF; Lee, JH; Linden, HM; Link, JM; Mankoff, DA; Peterson, LM; Schubert, EK | 1 |
| Aukema, TS; Hoefnagel, CA; Koolen, BB; Loo, CE; Oldenburg, HS; Rodenhuis, S; Rutgers, EJ; Stokkel, MP; Valdés Olmos, RA; van der Hage, JA; Vogel, WV; Vrancken Peeters, MJ | 1 |
| Damjanovich, L; Dinya, T; Galuska, L; Garai, I; Garami, Z; Hascsi, Z; Tanyi, M; Varga, J | 1 |
| Cheyne, RW; Smith, TA | 1 |
| Fioole-Bruining, A; Hoefnagel, CA; Koolen, BB; Rutgers, EJ; Stokkel, MP; Valdés Olmos, RA; Vegt, E; Vogel, WV; Vrancken Peeters, MJ | 1 |
| Huang, G; Liu, J; Wang, Y; Zhang, C | 1 |
| Antoch, G; Bockisch, A; Boy, C; Forsting, M; Hahn, S; Heusner, T; Köninger, A; Kümmel, S; Müller, S; Nagarajah, J; Stahl, A | 1 |
| Chan, C; Guha, A; Houle, S; McLarty, K; McLaurin, J; Moran, MD; Mukherjee, J; Nitz, M; Reilly, RM; Sabha, N; Scollard, DA; Vasdev, N; Wilson, AA | 1 |
| Bang, YJ; Cho, N; Chung, JK; Han, SW; Han, W; Im, SA; Kang, KW; Keam, B; Kim, JH; Kim, TY; Koh, Y; Moon, WK; Noh, DY; Oh, DY; Park, IA | 2 |
| Adrada, BE; Carkaci, S; Whitman, GJ | 1 |
| Baranzelli, MC; Bonneterre, J; Carpentier, P; Fournier, C; Kolesnikov-Gauthier, H; Servent, V; Vanlemmens, L; Vennin, P | 1 |
| Cochet, A; Ferrozzi, F; Fox, SB; Generali, D; Hicks, RJ | 1 |
| Hakozaki, K; Iida, S; Ishihara, K; Kiriyama, T; Kumita, S; Murakami, R; Tsuchiya, S; Yanagihara, K; Yoshida, T | 1 |
| Bekis, R; Kozgus, O; Medine, EI; Ozkaya, F; Sakarya, S; Timur, S; Unak, G; Unak, P | 1 |
| Archambault, M; Bénard, F; Croteau, É; Lecomte, R; Ouellet, R; Paquette, M | 1 |
| Altrinetti, V; Corradengo, D; De Censi, A; Gennari, A; Piccardo, A; Villavecchia, G | 1 |
| Holloway, CM; Ma, G; Simpson, JS | 1 |
| Kim, BS; Sung, SH | 1 |
| Bae, YT; Kim, BH; Kim, IJ; Kim, SJ; Kim, SS; Kim, YK; Lee, JY | 1 |
| Alberini, JL; Bellet, D; Champion, L; Edeline, V; Giraudet, AL; Le Stanc, E; Lerebours, F; Madar, O; Mortazavi-Jehanno, N; Pecking, AP | 1 |
| Evangelista, L; Rubello, D; Saladini, G | 1 |
| Panfilenko, AA | 1 |
| Berg, WA; Kalinyak, JE; Larsen, LH; Madsen, KS; Narayanan, D; Pisano, ED; Schilling, K; Tartar, M | 1 |
| Eirini, L; Emmanouil, L; Hans-Günther, M; Liodaki, E; Liodakis, E; Machens, HG; Nikolaos, PA; Othonas, P; Papadopoulos, O; Papadopulos, NA | 1 |
| Altrinetti, V; Bacigalupo, L; Biscaldi, E; Cabria, M; DeCensi, A; Gozza, A; Iacozzi, M; Morbelli, S; Pasa, A; Piccardo, A; Puntoni, M; Villavecchia, G | 1 |
| Berenger, N; de Roquancourt, A; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Marty, M; Vercellino, L | 1 |
| Bae, MS; Chang, JM; Cho, N; Kang, KW; Kim, MY; Moon, WK; Yun, BL | 1 |
| Deng, S; Wan, W; Wu, Y; Yen, TC; Yu, C; Zhang, B | 1 |
| Adrada, BE; Buchholz, TA; Carkaci, S; Mawlawi, O; Quraishi, MA; Rohren, E; Wei, W; Yang, W | 1 |
| de Geus-Oei, LF; Disselhorst, JA; Oyen, WJ; Visser, EP; Vriens, D | 1 |
| Bartenstein, P; Hacker, M; Haug, AR; Heinemann, V; Laubender, RP; Michl, M; Tiega Donfack, BP; Trumm, C; Uebleis, C; Zech, CJ | 1 |
| Bhattacharya, A; Kashyap, R; Manohar, K; Mittal, BR; Senthil, R; Singh, G | 1 |
| Kimura, H; Kiyono, Y; Maeda, H; Mori, T; Okazawa, H; Tsuchida, T; Tsujikawa, T; Yoshida, Y | 1 |
| Arnould, L; Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Coudert, B; Dygai-Cochet, I; Fumoleau, P; Humbert, O; Khoury, B; Pigeonnat, S; Toubeau, M; Touzery, C; Vrigneaud, JM | 1 |
| Andersson, M; Bernsdorf, M; Berthelsen, AK; Binderup, T; Graff, J; Kjær, A; Kroman, N; Loft, A; Tange, UB; Teilum, D; Wielenga, VT | 1 |
| Anak, Ö; Baselga, J; Birle, D; Chen, LC; Hackl, W; Krop, I; Markman, B; Melendez Cuero, M; Mita, M; Shapiro, GI; Siu, L; Stutvoet, S; Tabernero, J | 1 |
| Adejolu, M; Huo, L; Rohren, E; Santiago, L; Yang, WT | 1 |
| Guzelbey, B; Işik, G; Karanlik, H; Kuyumcu, S; Mudun, A; Ozel, S; Ozkan, ZG; Sanli, Y; Turkmen, C; Yavuz, E | 1 |
| Aras, M; Dane, F; Dede, F; Erdil, TY; Inanir, S; Ones, T; Turoglu, HT | 1 |
| Antoch, G; Bockisch, A; Hahn, S; Hecktor, J; Herrmann, J; Heusner, TA; Kuemmel, S; Lauenstein, T; Nagarajah, J; Otterbach, F; Riegger, C | 1 |
| Eubank, WB; Kessler, L; Mankoff, DA; Specht, JM | 1 |
| Bodurtha, A; Down, N; Elavathil, L; George, R; Gulenchyn, KY; Hodgson, N; Holloway, CM; Julian, JA; Levine, MN; Lovrics, P; McCready, D; O'Malley, FP; Perera, F; Pritchard, KI; Shelley, W | 1 |
| Daisaki, H; Kinoshita, T; Kubota, K; Macapinlac, HA; Miyake, M; Nagaoka, T; Tateishi, U; Terauchi, T | 1 |
| Becerra Nakayo, EM; Castrejón, ÁS; Cordero García, JM; Del Mar Muñoz Sánchez, M; García Vicente, AM; León Martín, AA; López-Muñiz, IC; Muñoz, AP; Relea Calatayud, F | 1 |
| Chu, LY; Hsieh, TC; Kao, CH; Sun, SS; Wu, YC; Yen, KY | 1 |
| Chen, KY; Chiu, JS; Hung, GU; Kao, CH; Lee, YC | 1 |
| Katayama, T; Kubota, K; Machida, Y; Shibuya, H; Toriihara, A | 2 |
| Arnould, L; Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Coudert, B; Fumoleau, P; Humbert, O; Loustalot, C; Riedinger, JM | 1 |
| Han, A; Hu, M; Wang, X; Xue, J; Zheng, J | 1 |
| Eaton, A; Evangelista, L; Fazio, M; Howard, J; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; McArthur, HL; Morris, PG; Park, JY; Patil, S; Serna-Tamayo, C; Ulaner, GA | 1 |
| Ben-Haim, S; Davidson, T; Ell, PJ; Groves, AM; Holloway, B; Kayani, I; Kelleher, T; Keshtgar, MR; Malhotra, A; Meagher, M; Shastry, M; Warren, RM; Whittaker, D | 1 |
| Antoch, G; Forsting, M; Grabellus, F; Hahn, S; Hartung, V; Hecktor, J; Heusner, TA; Kimmig, R; Pöppel, T | 1 |
| Cristofanilli, M; De Giorgi, U; Giordano, A; Giuliano, M; Hortobagyi, GN; Mego, M; Reuben, JM; Scarpi, E; Ueno, NT; Valero, V | 1 |
| Cha, JH; Chae, EY; Kim, HH; Kim, HJ; Koh, YH; Moon, DH; Oh, HY; Shin, HJ | 1 |
| Akashi-Tanaka, S; Daisaki, H; Kano, D; Kinoshita, T; Macapinlac, HA; Murano, T; Tateishi, U; Terauchi, T; Tsuda, H | 1 |
| Gatsonis, C; Shiu, SY | 1 |
| Schillaci, O | 1 |
| Domènech, B; Duch, J; Fernández, PL; Fontanillas, M; Fuster, D; Lomeña, F; Muñoz, M; Paredes, P; Pons, F; Skaltsa, K | 1 |
| Botta, F; Botteri, E; De Cicco, C; Di Dia, GA; Fracassi, SL; Gilardi, L; Lombardo, D; Paganelli, G; Prisco, G; Rotmensz, N; Veronesi, U | 1 |
| Bao, L; Cheng, X; Li, Y; Liu, B; Wang, J; Xu, Z | 1 |
| Correa, PD; Han, S; Rizwanullah, M; Shrimali, RK | 1 |
| Choi, BB; Jeong, SH; Kang, BJ; Kim, SH; Lee, JH; Song, BJ; Yim, HW | 1 |
| Antoch, G; Bockisch, A; Buchbender, C; Forsting, M; Heusner, TA; Hoffmann, O; Kimmig, R; Koeninger, A; Kuemmel, S; Ladd, S; Otterbach, F; Stahl, AR | 1 |
| Beets-Tan, RG; Groenendaal, G; Houweling, AC; Lambin, P; van der Heide, UA | 1 |
| Ahn, BC; Chae, YS; Jeong, SY; Lee, J; Lee, SW; Lee, WK; Song, BI | 1 |
| Akkas, BE; Ucmak Vural, G | 1 |
| Kasami, M; Uematsu, T | 1 |
| Aukema, TS; Gilhuijs, KG; Koolen, BB; Lips, EH; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; van Werkhoven, E; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Henderson, R; Ho, L; Luong, T; Malkhassian, S; Wassef, H | 1 |
| Ahn, JH; Ahn, SH; Gong, G; Jin, S; Jung, KH; Kim, HO; Kim, SB; Lee, JW; Moon, DH; Son, BH | 1 |
| Chen, JY; Feng, Y; Guo, XM; Hu, SL; Hu, WG; Orecchia, R; Pan, ZQ; Shao, ZM; Wang, JZ; Yu, XL; Zhang, Q; Zhang, YJ; Zhang, Z | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hartung, V; Heusner, TA; Kimmig, R; Koeninger, A; Otterbach, F; Riegger, C | 1 |
| Dogan, BE; Turnbull, LW | 1 |
| Baretta, Z; Bezzon, E; Cervino, AR; De Carolis, V; Evangelista, L; Ghiotto, C; Gregianin, M; Muzzio, PC; Pomerri, F; Saladini, G; Vinante, L | 1 |
| Chacón López-Muñiz, I; Cordero García, JM; Cruz Mora, MA; Espinosa Aunión, R; García Vicente, AM; González Ageitos, A; Jiménez Londoño, GA; León Martín, A; Muñoz Madero, V; Muñoz Sánchez, Mdel M; Relea Calatayud, F; Soriano Castrejón, A | 1 |
| Kim, CG; Kim, DW | 1 |
| Costelloe, CM; Hamaoka, T; Hayashi, N; Hortobagyi, GN; Madewell, JE; Niikura, N; Theriault, RL; Ueno, NT; Wei, C | 1 |
| Noroozian, M; Patterson, SK | 1 |
| Bae, YT; Jeon, YK; Kim, BH; Kim, IJ; Kim, SJ; Kim, SS; Kim, YK; Lee, JY | 1 |
| Dank, M; Galgóczy, H; Györke, T; Kulka, J; Lengyel, Z; Somlai, K; Székely, B; Szentmártoni, G; Tőkés, T; Torgyík, L | 1 |
| Espié, M; Giacchetti, S; Groheux, D; Hindié, E | 1 |
| Bäuerle, T; Bretschi, M; Cheng, C; Dimitrakopoulou-Strauss, A; Semmler, W; Strauss, LG; Witt, H | 1 |
| DeMichele, A; Mankoff, DA; Pryma, DA | 1 |
| de Bazelaire, C; de Roquancourt, A; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Merlet, P; Toubert, ME; Vercellino, L | 1 |
| Alavi, A; Kwee, TC; Torigian, DA | 1 |
| Ben-Nun, A; Simansky, D; Soudack, M; Yelin, A | 1 |
| Chen, SA; Godette, K; Liu, T; Mister, D; Schuster, DM; Torres, MA | 1 |
| Cheze-Le Rest, C; de Roquancourt, A; Espié, M; Giacchetti, S; Groheux, D; Hatt, M; Hindié, E; Martineau, A; Visvikis, D | 1 |
| Cameron, AG; Gao, X; Ke, S; Li, M; Lin, J; Qiu, X; Wang, W; Yallampalli, S; Yu, D; Yustein, JT; Zhang, F; Zhang, S; Zou, C | 1 |
| Kon, M; Kuwana, K; Sueoka, N; Tsubota, Y; Yamamoto, D | 1 |
| Pai, M; Yoon, SN | 1 |
| Ceccarelli, S; Lacanfora, A; Schillaci, O; Simonetti, G; Travascio, L | 1 |
| Hu, XC; Jia, Z; Li, G; Ragaz, J; Wang, BY; Wang, ZH; Zhang, J; Zhang, YJ; Zhang, YP; Zhou, M | 1 |
| Bal, C; Bandopadhyaya, GP; Damle, NA; Kumar, L; Kumar, P; Lata, S; Malhotra, A | 1 |
| Cheng, J; Lei, L; Liu, G; Pan, L; Shao, Z; Sun, Y; Wang, X; Xu, J; Zhang, Y | 1 |
| Bombardieri, E; Crippa, F; Pauwels, EK; Stokkel, MP; Ugrinska, A | 1 |
| Carreras, JL; Domper, M; Jiménez, A; Montz, R; Pérez-Castejón, MJ; Ruiz, G; Suárez, M | 1 |
| Dehdashti, F; Siegel, BA | 1 |
| Aufschnaiter, M; Heinisch, M; Jörg, L; Langsteger, W; Panholzer, PJ; Rechberger, E; Sega, W; Tausch, C; Wieser, B | 1 |
| Aronson, N; Flamm, CR; Pisano, ED; Samson, DJ | 1 |
| Dunnwald, LK; Gralow, JR; Livingston, RB; Mankoff, DA; Rinn, KJ; Schubert, EK; Stafford, SE | 1 |
| Bachmann, S; Berger, J; Bleckmann, C; Bohuslavizki, KH; Dose, J; Habermann, CR; Jãnicke, F; Jenicke, L | 1 |
| Cheng, KY; Kao, CH; Lin, WY; Tsai, SC; Yen, RF | 1 |
| Cabrera Villegas, A; Gámez Cenzano, C; García Velloso, MJ | 1 |
| Aloj, L; Bacharach, SL; Carrasquillo, JA; Chow, C; Danforth, DN; Galen, B; Merino, M; Neumann, RD; Whatley, M; Zujewski, J | 1 |
| Buck, A; Dankerl, A; Glatting, G; Kalker, T; Kotzerke, J; Kühn, T; Mattfeldt, T; Reske, S; Schirrmeister, H; Shen, C | 1 |
| Kao, CH; Lin, CC; Liu, CS; Shen, YY; Yen, RF | 1 |
| Agoston, P; Esik, O; Fekésházy, A; Galuska, L; Kálvin, B; Lengyel, E; Lengyel, Z; Szakáll, S; Székely, J; Trón, L | 1 |
| Joyce, JM; Myers, DT; Petursson, SR; Pohland, ML | 1 |
| Bednarczyk, EM; Mayer, D | 1 |
| Boom, RP; Comans, EF; Hoekstra, OS; Lammertsma, AA; Meijer, S; Pijpers, R; Teule, GJ; van der Hoeven, JJ; van Geldere, D | 1 |
| Biersack, HJ; Hensel, J; Matthies, A; Palmedo, H; Reinhardt, M; Von Mallek, D | 1 |
| Siggelkow, W; Zimny, M | 1 |
| Tatsumi, M; Wahl, RL; Zasadny, KR | 1 |
| Ho, CL; Yeung, DW; Yu, SC | 1 |
| Delbeke, D; Pinson, CW | 1 |
| Goldsmith, SJ; Kostakoglu, L | 1 |
| Cohade, C; Leal, JP; Marshall, LT; Nakamoto, Y; Osman, MM; Wahl, RL | 1 |
| Garcia, CA; Rosenberg, RJ; Spencer, RP | 1 |
| Hoekstra, OS; Krak, NC; Lammertsma, AA; Twisk, JW; van der Hoeven, JJ; van der Wall, E | 1 |
| Fehr, MK; Goerres, GW; Kamel, EM; von Schulthess, GK; Wyss, MT | 1 |
| Bourguet, P | 1 |
| Gallowitsch, HJ; Gasser, J; Igerc, I; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P | 1 |
| Gambhir, SS; Wu, D | 1 |
| Fehr, MK; Goerres, GW; Kaim, AH; Kubik-Huch, RA; Michel, SC; Seifert, B; Steinert, HC; von Schulthess, GK | 1 |
| Goering, UJ; Krahe, T; Kugel, H; Pietrzyk, U; Scharl, A; Scheidhauer, K; Theissen, P; Walter, C | 1 |
| Antoine, M; Barranger, E; Grahek, D; Montravers, F; Talbot, JN; Uzan, S | 1 |
| Beaulieu, S; Dunnwald, LK; Kinahan, P; Lewellen, B; Mankoff, DA; Pham, P; Schubert, EK; Tseng, J | 1 |
| Hatazawa, J; Higuchi, I; Nakamura, H | 1 |
| Guller, U; Moch, H; Nitzsche, E; Zuber, M | 1 |
| Alavi, A; Kicska, G; Zhuang, H | 1 |
| Bakheet, R; Bakheet, SM; Baslaim, MM; El-Foudeh, M; Ezzat, A; Tulbah, A | 1 |
| Nakamoto, Y | 1 |
| Hurwitz, R | 1 |
| Mortimer, JE; Taylor, ME | 1 |
| Blaufox, MD; Dadachova, E; Lin, EY; Lu, P; Mani, J; Moadel, RM; Nguyen, AV; Pollard, JW | 1 |
| Kransdorf, MJ; O'Connor, MI; Peterson, JJ | 1 |
| Dunnwald, LK; Ellis, GK; Gralow, JR; Lawton, TJ; Linden, HM; Livingston, RB; Mankoff, DA; Schubert, EK; Tseng, J | 1 |
| Biersack, HJ; Palmedo, H | 1 |
| Forsthuber, EP; Gallowitsch, HJ; Gasser, J; Gomez, I; Heinisch, M; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P; Umschaden, HW | 1 |
| Ahearn, TS; Gilbert, FJ; Heys, SD; Hutcheon, AW; Miller, ID; Redpath, TW; Semple, SI; Smith, IC; Smyth, EH; Welch, AE | 1 |
| Bohdiewicz, PJ; Dworkin, HJ; Gaskill, M; Kondas, D; Wong, CY | 1 |
| DePeri, ER; McDonough, MD; Mincey, BA | 1 |
| Meyer, MA | 1 |
| Granov, AM; Kostenikov, NA; Ryzhkova, DV; Savello, VE; Stanzhevskiĭ, AA; Tiushin, LA; Tlostanova, MS | 1 |
| Kawahara, K; Naito, A; Nishio, M; Tamaki, T | 1 |
| Coleman, RE; Gatsonis, CG; Siegel, BA; Wahl, RL | 1 |
| Beorlegui, C; Garcia-Velloso, MJ; Pina, L; Regueira, FM; Sola, J; Zornoza, G | 1 |
| Donckier, V; Feron, P; Gelin, M; Goldman, S; Ickx, B; Van Gansbeke, D; Van Laethem, JL; Wikler, D | 1 |
| Böhm, B; Geoghegan, J; Gottschild, D; Hellfritzsch, H; Petrovich, A; Scheele, J; Voth, M | 1 |
| Inoue, T; Noguchi, S; Shiba, E; Taguchi, T; Tamaki, Y; Yutani, K | 1 |
| Bares, R; Dittmann, H; Dohmen, BM; Fersis, N; Machulla, HJ; Reischl, G; Smyczek-Gargya, B; Vogel, U; Wallwiener, D | 1 |
| Boom, RP; Buter, J; Comans, EF; Hoekstra, OS; Krak, NC; Lammertsma, AA; Meijer, S; Pinedo, HM; Teule, GJ; van der Hoeven, JJ; van der Wall, E; van Geldere, D | 1 |
| Beyer, T; Hausegger, K; Igerc, I; Lind, P; Reinprecht, P | 1 |
| Hoekstra, OS; Krak, NC; Lammertsma, AA | 1 |
| Bender, H; Biersack, HJ; Palmedo, H | 1 |
| Huglo, D; Vinatier, D | 1 |
| Buck, AK; Mattfeldt, T; Reske, SN; Schirrmeister, H | 1 |
| Aide, N; Grahek, D; Kerrou, K; Lotz, JP; Montravers, F; Talbot, JN | 1 |
| Agresti, R; Alessi, A; Bombardieri, E; Crippa, F; Gerali, A | 1 |
| Scheidhauer, K; Seemann, MD; Walter, C | 1 |
| Fazio, F; Gianolli, L; Landoni, C; Messa, C; Picchio, M; Zangheri, B | 1 |
| Buell, U; Rath, W; Siggelkow, W; Zimny, M | 1 |
| Alavi, A; Talati, E; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
| Jain, M; Katz, DS; Trow, T; Yung, E | 1 |
| Alavi, A; Bhargava, P; Charron, M; Kumar, R; Zhuang, H | 1 |
| Fujita, T; Higashi, T; Ishimori, T; Ishizu, K; Kato, H; Konishi, J; Mamede, M; Matsumoto, K; Mukai, T; Saga, T; Sato, S; Senda, M; Yamaoka, Y | 1 |
| Coebergh, JW; Hoekstra, OS; van de Poll-Franse, LV; van der Hoeven, JJ; van Oost, FJ; Voogd, AC | 1 |
| Eubank, WB; Mankoff, DA | 3 |
| El-Sheemy, M; Eremin, JE; Eremin, O; Griffiths, PA; Jibril, JA; Marshall, C; Mustafa, S; Wheatley, DC | 1 |
| Austin-Seymour, M; Bhattacharya, M; Ellis, G; Eubank, WB; Gralow, J; Linden, H; Lindsley, S; Livingston, R; Mankoff, D | 1 |
| Bellon, JR; Dunnwald, LK; Ellis, GK; Eubank, WB; Gralow, JR; Livingston, RB; Mankoff, DA | 1 |
| Bacharach, SL; Carrasquillo, JA; Carson, JM; Freedman, NM; Libutti, SK; Sellers, D; Sundaram, SK; Whatley, M | 1 |
| Alavi, A; Kumar, R; Mitchell, S | 1 |
| Cody, HS; Port, ER | 1 |
| Ahearn, TS; Chaturvedi, S; Gilbert, FJ; Heys, SD; Hutcheon, AW; Redpath, TW; Semple, SI; Smyth, EH; Staff, RT; Welch, AE | 1 |
| Kang, Sh; Kim, SJ; Kim, SK; Lee, ES; Ro, J | 1 |
| Halkar, RK; Schuster, DM | 1 |
| Antoine, JC; Cinotti, L; Cottin, V; Honnorat, J; Janier, MF; Ternamian, PJ; Tronc, F; Trouillas, P; Younes-Mhenni, S | 1 |
| Harling, H; Laoutliev, B; Neergaard, K; Simonsen, L | 1 |
| Alavi, A; Kumar, R | 1 |
| Canniff, KM; Donnelly, EF; Fleischer, AC; Hallahan, DE; Niermann, KJ; Rothenberg, ME; Yankeelov, TE | 1 |
| Dunnwald, LK; Link, JM; Mankoff, DA; Minoshima, S; Muzi, M; Schubert, EK; Tseng, J | 1 |
| Bouhnik, JP; Even-Sapir, E; Lerman, H; Levin, C; Lievshitz, G; Miller, E; Yuzefovich, B; Zak, O | 1 |
| Aigner, RM; Krippl, P; Langsenlehner, U; Renner, W; Samonigg, H; Schaffler, G; Wolf, G; Yazdani-Biuki, B | 1 |
| Cerfolio, RJ; Chen, VK; Desmond, R; Eloubeidi, MA; Ojha, B; Syed, S | 1 |
| Kim, EK; Kim, MJ; Oh, KK; Park, SY; Yun, M | 1 |
| Baker, JA; Coleman, RE; Rosen, EL; Soo, MS; Turkington, TG | 1 |
| Badve, S; Calley, C; Emerson, RE; Goulet, R; Hutchins, GD; Kopecky, K; Miller, KD; Sledge, GW; Soule, SE; Storniolo, A | 1 |
| Antoch, G; Bier, U; Freudenberg, L; Frings, M; Knorn, P; Maschke, M; Timmann, D | 1 |
| Gambhir, SS; Quon, A | 1 |
| Mansberg, R; Mansberg, V; Nguyen, QH; Szeto, E | 1 |
| Alavi, A; Dhurairaj, T; Kumar, R; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
| Cook, G; Fogelman, I; Israel, O; Van der Wall, H | 1 |
| Kang, KW; Kim, SK; Lee, ES; Park, SY; Roh, JW; Sim, JS | 1 |
| Aramaki, T; Endo, M; Furukawa, H; Morimoto, N; Uchida, Y; Uematsu, T; Watanabe, J; Yuen, S; Yukisawa, S | 1 |
| Boellaard, R; Hoekstra, CJ; Hoekstra, OS; Krak, NC; Lammertsma, AA; Twisk, JW | 1 |
| Blaufox, MD; Isasi, CR; Moadel, RM | 1 |
| Kim, MW; Lee, NR; Lim, ST; Sohn, MH; Song, EK; Yim, CY | 1 |
| Barranger, E; Daraï, E; Grahek, D; Talbot, JN; Uzan, S | 1 |
| Lidner, TK; Nguyen, BD | 1 |
| Bénard, F; Turcotte, E | 1 |
| Avril, N; Bader, M; Dose Schwarz, J; Hemminger, G; Jänicke, F; Jenicke, L | 1 |
| Collins, JM; Mangner, TJ; Muzik, O; Shields, AF; Sun, H | 1 |
| Fujii, T; Mochizuki, T; Morishige, I; Shigesawa, T; Shinohara, I; Sugawara, Y | 1 |
| Aparici, F; Aznar, DL; Flores, D; Garcia, EU; Martínez, C; Ojeda, R; Sánchez, PA; Sopena, R | 1 |
| Fogelman, I | 1 |
| García, JR; Lomeña, F; López, S; Pérez, G; Simó, M; Soler, M | 1 |
| Kubota, T; Nakai, T; Nishimura, T; Okuyama, C; Suzuki, T; Taniike, K; Ushijima, Y; Yamada, K | 1 |
| Asakura, H; Haba, R; Mitani, M; Ohkawa, M; Seo, R; Takashima, H; Toyama, Y; Yokoe, K | 1 |
| Czernin, J; Khatibi, B; Phelps, ME; Pio, BS; Silverman, DH; Tran, A | 1 |
| Adler, LP; Berg, WA; Beylin, D; Cheng, Z; Dolinsky, S; Freimanis, RL; Keen, R; Levine, E; Lobrano, MB; Lovelace, J; Narayanan, D; Ross, E; Sawyer, K; Shen, P; Staab, E; Stein, W; Stewart, J; Tafra, L; Uddo, J; Van Geffen, J; Weinberg, IN; Yarnall, S | 1 |
| Caride, VJ; Wasyliw, CW | 1 |
| Capirci, C; Casara, D; Giometto, B; Muzzio, PC; Rampin, L; Rigoni, MT; Rubello, D; Shapiro, B; Vitaliani, R; Zavagno, G; Zonzin, GC | 1 |
| Hall, FM | 1 |
| Klinkenbijl, JH; Landheer, ML; Oyen, WJ; Steffens, MG; Westenberg, AH | 1 |
| Comte, F; Eberlé, MC; Lamy, PJ | 1 |
| Alavi, A; Chauhan, A; Kumar, R; Loving, VA; Mitchell, S; Zhuang, H | 1 |
| Smith, S; Williams, HT | 1 |
| Hoksch, B; Jüngling, F; Körner, M; Schmid, RA; Weber, T | 1 |
| Choi, AY; Wax, BN; Yung, E | 1 |
| Fogelman, I; Heinisch, M; Langsteger, W | 1 |
| Abe, K; Baba, S; Hayashi, K; Honda, H; Koga, H; Kuwabara, Y; Sasaki, M; Takahashi, N | 1 |
| Chu, JS; Hsu, CH; Wu, CH | 1 |
| Cornide, M; de las Heras, PM; Domínguez, ML; García-Bernardo, L; García-Rico, E; Maldonado, A; Ortega, F; Serna, JA; Suárez, JP | 1 |
| Gong, HY; Yu, JM | 1 |
| Hayanga, AJ | 1 |
| Alberini, JL; Collignon, MA; Corone, C; Gutman, F; Pecking, AP; Pichon, MF; Rouëssé, J; Wartski, M | 1 |
| Mankoff, D | 1 |
| Beresford, M; Makris, A; Sanghera, B; Wong, WL | 1 |
| Kubo, A; Suzuki, T; Uno, K | 1 |
| Newman, LA | 1 |
| Borgen, P; Caravelli, J; Gonen, M; Larson, S; Liberman, L; Port, ER; Yeung, H | 1 |
| Briest, S; Kluge, R; Scheid, R; Voltz, R; von Cramon, DY | 1 |
| Bhargava, P; Ghesani, M; Glass, E | 1 |
| Alavi, A; Chandra, P; Chauhan, A; Kumar, R; Schnall, M; Zhuang, H | 1 |
| Gonen, M; Larson, S; Macapinlac, H; Santiago, JF; Yeung, H | 1 |
| Cho, SY; Engles, JM; Ishimori, T; Mambo, E; Quarless, SA; Wahl, RL | 1 |
| Bourbouloux, E; Bridji, B; Campion, L; Campone, M; Chatal, JF; Fleury, N; Resche, I; Rousseau, C | 1 |
| Abreu, MC; Almeida, P; Balau, F; Ferreira, NC; Fetal, S; Fraga, F; Martins, M; Matela, N; Moura, R; Ortigão, C; Peralta, L; Rato, P; Ribeiro, R; Rodrigues, P; Santos, AI; Trindade, A; Varela, J | 1 |
| Ghesani, N; Liu, Y; Mirani, N; Zuckier, LS | 1 |
| Beorlegui, C; Cervera, M; García-Velloso, MJ; Gil-Rendo, A; Regueira, FM; Zornoza, G | 1 |
| López-López, R; Luna-Vega, V; Punal-Vidal, L; Ruibal-Morell, A; Sánchez-Salmon, A | 1 |
| Bourgain, C; Everaert, H; Lamote, J; Makkat, S; Sacré, R; Stadnik, TW | 1 |
| Grahek, D; Talbot, JN | 1 |
| Bonichon, F; Bosquet, L; Bourguet, P; Corone, C; Giard-Lefèvre, S; Hitzel, A; Houvenaeghel, G; Morett, JL; Touboul, E; Vinatier, D | 1 |
| Fischman, AJ; Kuter, I; Scott, JA; Wade, AA | 1 |
| Ampil, F; Burton, G; Chu, QD; Johnson, LW; Li, BD; Lilien, D; Turnage, RH; Wolfort, RM | 1 |
| Cachin, F; Hicks, RJ; Hogg, A; Prince, HM; Ware, RE | 1 |
| El Khoury, C; Ollivier, L; Tardivon, AA; Thibault, F | 1 |
| Engles, JM; Ishimori, T; Jacene, HA; Leboulleux, S; Stearns, V; Wahl, RL | 1 |
| Aikou, T; Kijima, Y; Natsugoe, S; Owaki, T; Uenosono, Y; Yoshinaka, H; Yoshioka, T | 1 |
| Jacene, HA; Stearns, V; Wahl, RL | 1 |
| Bénard, F; Langlois, MF; Leboeuf, R | 1 |
| Luthra, K; Medhi, S; Purandare, N; Rangarajan, V; Samuel, AM; Shah, S | 1 |
| Ahearn, TS; Gilbert, FJ; Heys, SD; Hutcheon, A; Redpath, TW; Semple, SI; Staff, RT; Welch, AE | 1 |
| Drumm, D; Korn, RL; Kovalsky, ER; Layton, TA; May, CC; Orth, KM; Yost, AM | 1 |
| Bosquet, L; Bourguet, P; Hitzel, A; Houvenaeghel, G; Vinatier, D | 1 |
| Basu, S; Nair, N | 1 |
| Gilbert, FJ; Heys, SD; Hutcheon, AW; McDermott, GM; Miller, ID; Schweiger, L; Semple, SI; Smith, IC; Smith, TA; Staff, RT; Welch, A | 1 |
| Chang, U; Cheon, GJ; Gwak, HS; Kim, HJ; Kim, K; Lee, DH; Rhee, CH; Youn, SM | 1 |
| Chung, A; Fujimoto, K; Hagiike, M; Karlan, S; Liou, D; Phillips, EH; Waxman, A | 1 |
| Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Koyama, K; Miyakubo, M; Oriuchi, N | 1 |
| Alavi, A; Cermik, TF; Czerniecki, B; Houseni, M; Mavi, A; Schnall, M; Thiruvenkatasamy, D; Urhan, M; Yu, JQ; Zhuang, H | 1 |
| Paulin, FE; Sharma, RI; Smith, TA; Thompson, AM | 1 |
| Chi, DY; Kil, HS; Moon, DH; Mosdzianowski, C; Oh, SJ; Ryu, JS | 1 |
| Fukuda, H; Iwasaki, T; Katsura, H; Kawahara, K; Nakagawa, K; Nakane, S | 1 |
| Alavi, A; Cohen, AB; Dalmau, J; Galetta, SL; Mathew, RM | 1 |
| Balduzzi, A; Cardillo, A; Colleoni, M; De Cicco, C; Ghisini, R; Goldhirsch, A; Intra, M; Luini, A; Paganelli, G; Peruzzotti, G; Rotmensz, N; Veronesi, P | 1 |
| Bar-Shalom, R; Ben-Haim, S; Guralnik, L; Israel, O; Radan, L | 1 |
| Tafra, L | 1 |
| Couturier, O; Hustinx, R; Jerusalem, G; N'Guyen, JM | 1 |
| Awasare, S; Malhotra, G; Nair, N | 1 |
| Gayed, I; Kim, EE; Macapinlac, H; Won, KS | 1 |
| Berrettini, A; De Cicco, C; Fernandez, JR; Galimberti, VE; Intra, M; Luini, A; Paganelli, G; Rotmensz, N; Spano, G; Veronesi, P; Veronesi, U; Viale, G | 1 |
| Alvarez Pérez, RM; Borrego Dorado, I; López Martín, J; Vázquez Albertino, R | 1 |
| Nguyen, BD | 1 |
| Gulec, SA | 1 |
| Dunnwald, LK; Ellis, GK; Gralow, JR; Kurland, BF; Linden, HM; Livingston, RB; Mankoff, DA; Schubert, EK; Specht, JM; Tam, SL | 1 |
| Basu, S; Nair, N; Shet, T; Thorat, M | 1 |
| Chang, CC; Chen, YW; Hou, MF | 1 |
| Hollett, PD; Mathews, M; Sloka, JS | 1 |
| Arens, AI; Beets-Tan, RG; Ramtahalsing, R; Teule, GJ; van den Ende, PL; Vliegen, RF | 1 |
| Conti, PS; Iagaru, A; Keesara, S; Masamed, R | 1 |
| Hayasaka, K; Ishigaki, T; Ito, K; Itou, T; Kato, R; Nihashi, T; Okae, T | 1 |
| Deans, AE; Kitazono, MT; Kramer, EL; Maguire, GQ; Moy, L; Murphy-Walcott, AD; Noz, ME; Ponzo, F; Travascio, L | 1 |
| Doot, RK; Dunnwald, LK; Kinahan, PE; Kurland, BF; Mankoff, DA; Muzi, M; Peterson, LM; Schubert, EK | 1 |
| Advani, RH; Allred, C; Benson, AB; Brown, E; Burstein, HJ; Carlson, RW; Coleman, RE; Czuczman, MS; Delbeke, D; Edge, SB; Ettinger, DS; Grannis, FW; Hillner, BE; Hoffman, JM; Kiel, K; Komaki, R; Larson, SM; Mankoff, DA; Podoloff, DA; Rosenzweig, KE; Skibber, JM; Yahalom, J; Yu, JM; Zelenetz, AD | 1 |
| Baird, GS; Kanne, JP; Livingston, RB; Mankoff, DA; Minoshima, S | 1 |
| Abdel-Dayem, H; Altinyay, ME; Castellon, I; Heiba, S; Libes, R; Piperkova, E; Raphael, B; Sandella, N | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Hauth, EA; Schleucher, R; Stergar, H; Veit-Haibach, P | 1 |
| Arnould, L; Berriolo-Riedinger, A; Boichot, C; Brunotte, F; Cochet, A; Coudert, B; Fumoleau, P; Riedinger, JM; Toubeau, M; Touzery, C | 1 |
| Al-Kutoubi, A; Arabi, M; Kinge, AR; Otrock, ZK; Shamseddine, A | 1 |
| Cullum, I; Du, Y; Ell, PJ; Illidge, TM | 1 |
| Alavi, A; Basu, S; Cermik, TF; Czerniecki, B; Mavi, A; Puskulcu, H; Urhan, M; Yu, JQ; Zhuang, H | 1 |
| Aydin, C; Cakir, B; Dirikoc, A; Ersoy, R; Topaloglu, O | 1 |
| Li, JG; Li, YM; Zhao, TT | 1 |
| Chin, K; Finger, PT; Kurli, M; Reddy, S; Tena, LB | 1 |
| Blaylock, MG; Smith, TA | 1 |
| Fujii, T; Kaida, Y; Shirouzu, K; Tayama, K; Toh, U | 1 |
| Ichikawa, Y; Ishikawa, T; Katayama, A; Momiyama, N; Ozawa, Y; Shimada, H | 1 |
| Ceriani, L; Crippa, S; Giovanella, L; Mazzucchelli, L | 1 |
| Honma, Y; Koga, S; Nakano, S; Ogasawara, N | 1 |
| Hayashi, M; Murakami, K; Oyama, T; Shimoda, W; Sunagawa, M | 1 |
| Bubeck, B; Klaeser, B; Koeberle, D; Mueller, A; Thuerlimann, B; Wiederkehr, O | 1 |
| Chen, JH; Li, D; Ling, R; Wang, J; Wang, L; Yao, Q | 1 |
| Adler, LP; Avril, N | 1 |
| Eubank, WB | 1 |
| Schirrmeister, H | 1 |
| Espié, M; Giacchetti, S; Groheux, D; Hindie, E; Misset, JL; Moretti, JL; Toubert, ME; Vercellino, L | 1 |
| Brink, I; Hentschel, M; Mix, M; Moser, E; Nitzsche, EU; Paulus, T | 1 |
| Chen, J; Li, D; Li, L; Wang, L; Yao, Q | 1 |
| Alavi, A; Kumar, R; Lal, N | 1 |
| Collins, CD | 1 |
| Alavi, A; Basu, S; Cermik, TF; Mavi, A | 1 |
| Chuthapisith, S; El-Sheemy, M; Eremin, JM; Eremin, O; Griffiths, PA; Jibril, JA; Marshall, C; Mustafa, S; Wheatley, DC | 1 |
| Collie-Duguid, ES; Schweiger, LF; Sharma, RI; Smith, TA; Wang, WG; Welch, AE | 1 |
| Haug, A; Sommer, HL; Tiling, R | 1 |
| Grohé, C; Ko, Y; Palmedo, H; Tasci, S | 1 |
| Belohlavek, O | 1 |
| Bauerfeind, I; Baur-Melnyk, A; Haug, A; Heinemann, V; Reiser, MF; Schmidt, GP; Schoenberg, SO | 1 |
| Hayashi, T; Ikenaga, N; Nishikawa, K; Otomo, N; Tanaka, M; Toyoda, K; Toyofuku, A; Ueda, Y | 1 |
| Alavi, A; Basu, S; Cermik, T; Chen, W; Czerniecki, B; Mavi, A; Schnall, M; Tchou, J | 1 |
| Aulmann, S; Buchmann, I; Haberkorn, U; Hoffner, S; Mack, U; Riedmüller, K | 1 |
| Ehrlich, L; Kahn, HJ; Mackenzie, R; Nofech-Mozes, S; Raphael, SJ | 1 |
| Bedrosian, I; Buchholz, TA; Cavalcanti, JL; Macapinlac, HA; Oh, JL; Perkins, GH; Reed, VK; Strom, EA; Tereffe, W; Whitman, GJ; Woodward, WA; Yeung, H; Yu, TK | 1 |
| Bom, HS; Chung, TW; Kang, HK; Kim, JK; Lim, HS; Park, JG; Yoon, JH; Yoon, W | 1 |
| Eubank, WB; Mankoff, DA; Rosen, EL | 1 |
| Chen, YW; Chou, SH; Hou, MF; Hsieh, JS; Huang, MY; Lin, CL | 1 |
| Akin, ML; Filiz, AI; Kurt, Y; Sücüllü, I; Urhan, M | 1 |
| Abdulrahim, N; Brandon, D; Cardarelli, R; Erdman, W; Shie, P | 1 |
| Gulenchyn, KY; Hodgson, NC | 1 |
| Bral, S; De Coninck, P; Everaert, H; Storme, G; Vinh-Hung, V | 1 |
| Aogi, K; Inoue, T; Nishimura, R; Ohsumi, S; Taira, N; Takabatake, D; Takashima, S | 1 |
| Davis, D; Dockery, KF; Puri, S; Qazi, R | 1 |
| Fujii, T; Hayabuchi, N; Ishibashi, M; Kaida, H; Kurata, S; Ogo, E; Tanaka, M | 1 |
| Bonomo, G; Chiappa, A; Della Vigna, P; Ferrari, M; Mallia, A; Monfardini, L; Orsi, F; Paganelli, G; Ravasi, L; Travaini, LL; Trifirò, G | 1 |
| Avril, N; Brenner, W; Dose-Schwarz, J; Habermann, CR; Jenicke, L; Mahner, S; Schirrmacher, S | 1 |
| Khatcheressian, J; Swainey, C | 1 |
| Cristofanilli, M; Dawood, S; Gamez, C; Macapinlac, HA; Tateishi, U; Yeung, HW | 1 |
| Barandela, J; González-Alenda, J; Maldonado, A; Ruibal, A; Sánchez Salmón, A | 1 |
| Asrari, F; Ford, EC; Frassica, DA; Lavely, WC; Myers, LT; Wahl, RL; Zellars, RC | 1 |
| Ebied, O; El-Kholy, MR; El-Shorbagy, E; Murakami, K; Zytoon, AA | 1 |
| Abe, Y; Asakawa, H; Fukatsu, K; Hama, Y; Ishida, J; Kondo, N; Mochizuki, H; Shigekawa, T; Tamura, K; Tsuda, H; Ueda, S; Yamamoto, M | 1 |
| El-Haddad, G; Lilien, DL; Mathew, AS; Takalkar, AM | 1 |
| Balakrishnan, VB; Chawla, M; Das, CJ; Kumar, R; Malhotra, A | 1 |
| Baillet, G; Cuvier, C; Espie, M; Filmont, JE; Giacchetti, S; Groheux, D; Hennequin, C; Hindie, E; Misset, JL; Moretti, JL; Sarandi, F; Toubert, ME; Vilcoq, JR | 1 |
| Castell, F; Cook, GJ | 1 |
| Hsu, PK; Hsu, WH | 1 |
| Brenner, W; Dose-Schwarz, J; Habermann, CR; Jenicke, L; Mahner, S; Müller, V; Schirrmacher, S | 1 |
| Bonasera, TJ; Cutler, PD; Dehdashti, F; Detert, DD; Fusselman, MJ; Griffeth, LK; Katzenellenbogen, JA; Mortimer, JE; Siegel, BA; Welch, MJ | 1 |
| Brown, RS; Ethier, SP; Fisher, SJ; Raylman, RR; Wahl, RL | 1 |
| Pietrzyk, U; Scharl, A; Scheidhauer, K; Schicha, H; Schuster, A | 1 |
| Ell, PJ | 1 |
| Alavi, A; Buchpiguel, C; Chin, BB; Zukerberg, BW | 1 |
| Ahlström, H; Bergh, J; Jansson, T; Långström, B; Lilja, A; Westlin, JE | 1 |
| BenYounes, H; Bruce, DM; Eremin, O; Evans, NT; Heys, SD; Mikecz, P; Needham, G; Sharp, F; Smith, FW | 1 |
| Adler, LP; Crowe, JP; Shenk, RR; Sunshine, J | 1 |
| Andersson, I; Chang, AE; Helvie, MA; Wahl, RL | 1 |
| Cody, R; Helvie, M; Hutchins, GD; Wahl, RL; Weber, B; Zasadny, K | 1 |
| Wahl, RL; Zasadny, KR | 1 |
| Hortobagyi, GN; Kim, EE; Nieweg, OE; Singletary, SE; Wong, WH | 1 |
| Glaspy, JA; Hawkins, R; Hoh, CK; Phelps, ME | 1 |
| Dalbohm, NM; Glaspy, JA; Hawkins, RA; Hoh, CK; Moser, EA; Nitzsche, EU; Phelps, ME | 1 |
| Broussard, WF; Hortobagyi, GN; Kim, EE; Nieweg, OE; Singletary, SE; Tilbury, RS; Wong, WH | 1 |
| Choi, NC; Fischman, AJ; Hunter, GJ; McLoud, TC | 1 |
| Chaiken, L; Choi, Y; Hawkins, R; Hoh, C; Jabour, B; Juillard, G; Parker, R; Rege, S | 1 |
| Adler, LP; al-Kaisi, NK; Crowe, JP; Sunshine, JL | 1 |
| Allgayer, B; Avril, N; Bense, S; Dose, J; Graeff, H; Herz, M; Jänicke, F; Laubenbacher, C; Nathrath, W; Pache, H; Römer, W; Schwaiger, M; Ziegler, S | 1 |
| Göhring, UJ; Pietrzyk, U; Scharl, A; Scheidhauer, K; Schicha, H; Schomäcker, K; Wagner, R | 1 |
| Aloj, L; Berg, W; Chang, V; Chow, C; Cowan, K; Danforth, D; Frank, J; Jones, E; Majewski, L; Majewski, S; Markowitz, A; Mulshine, J; Weinberg, I; Weisenberger, A; Zujewski, J | 1 |
| Bassa, P; Buzdar, AU; Hicks, KW; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Holle, LH; Lung-Kurt, S; Oberhausen, E; Püschel, W; Schmidt, S; Trampert, L; Villena-Heinsen, CE | 1 |
| Larcos, G; Maisey, MN | 1 |
| Miyauchi, T; Wahl, RL | 1 |
| Wagner, HN | 2 |
| Avril, N; Dose, J; Graeff, H; Herz, M; Jänicke, F; Nathrath, W; Römer, W; Schwaiger, M; Weber, W; Ziegler, S | 1 |
| Bassa, P; Hicks, K; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Tansey, W; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Ficaro, EP; Raylman, RR; Wahl, RL | 1 |
| Utech, CI; Winter, PF; Young, CS | 1 |
| Krenning, EP; Kvols, LK; Van Eijck, CH | 1 |
| Göhring, UJ; Pietrzyk, U; Scharl, A; Scheidhauer, K; Schomäcker, K | 1 |
| Maublant, J | 1 |
| Adler, LP; Al-Kasi, NL; Faulhaber, PF; Schnur, KC; Shenk, RR | 1 |
| Hoekstra, HJ; Kole, AC; Nieweg, OE; Paans, AM; Plukker, JT; Pruim, J; Schraffordt Koops, H; Vaalburg, W | 1 |
| Ali, A; Alibazoglu, H; Fordham, E; LaMonica, G; Patel, PM | 1 |
| Powe, JE | 1 |
| Avril, N; Bense, S; Dose, J; Jänicke, F; Laubenbacher, C; Römer, W; Schwaiger, M; Weber, W; Ziegler, SI | 1 |
| Bender, H; Biersack, HJ; Kozak, B; Oehr, P; Ruhlmann, J; Schräder, M; Willkomm, P | 1 |
| Bender, H; Biersack, HJ; Grünwald, F; Krebs, D; Mallmann, P; Palmedo, H; Zamora, P | 1 |
| Buscombe, JR; Cwikla, JB; Hilson, AJ; Thakrar, DS | 1 |
| Carreras Delgado, JL | 1 |
| Baker, LH; Fisher, SJ; Kison, PV; Sugawara, Y; Wahl, RL; Zasadny, KR | 1 |
| Agresti, R; Bogni, A; Bombardieri, E; Chiesa, C; Crippa, F; De Sanctis, V; Delledonne, V; Greco, M; Leutner, M; Pascali, C; Salvadori, B; Seregni, E | 1 |
| Glaspy, JA; Hoh, CK; Maddahi, J; Moon, DH; Phelps, ME; Silverman, DH | 1 |
| Boxt, LM; Fawwaz, R; Plutchok, JJ; Sherman, WH; Van Heertum, RL; Weinberger, J | 1 |
| Recker, B; Torizuka, T; Wahl, RL; Zasadny, KR | 1 |
| Hashimoto, H; Imazeki, K; Nagashima, T; Nakajima, N; Oshida, M; Shishikura, T; Suzuki, M; Uno, K; Yagata, H | 1 |
| Carreras, JL; Gorospe, E; Maldonado, A; Montz, R; Nieto, C; Ortega, F; Pérez-Castejón, MJ; Ruiz, JA | 1 |
| Wahl, RL | 2 |
| Agresti, R; Giovanazzi, R; Greco, M | 1 |
| Agresti, R; Bombardieri, E; Chiti, A; Crippa, F; Draisma, A; Greco, M; Maffioli, L | 1 |
| Fujiwara, T; Fukuda, H; Imran, MB; Itoh, M; Kubota, K; Yamada, K; Yamada, S | 1 |
| Allgayer, B; Avril, N; Freitag, K; Graeff, H; Hoess, C; Kolben, M; Laemmer-Skarke, I; Nathrath, WB; Roemer, W; Schwaiger, M | 1 |
| Ah-See, AK; Eremin, O; Heys, SD; Jibril, JA; Miller, ID; Norton, M; Ogston, KN; Sharp, P; Smith, FW; Smith, IC; Whitford, P | 1 |
| Al Suhaibani, H; Bakheet, SM; Ezzat, A; Powe, J; Rostom, A; Tulbah, A | 1 |
| Bakheet, SM; Bakri, Y; Ezzat, A; Powe, J | 1 |
| Cook, GJ; Fogelman, I; Houston, S; Maisey, MN; Rubens, R | 1 |
| Dehdashti, F; Flanagan, FL; Siegel, BA | 1 |
| Bakheet, SM; Ezzat, A; Powe, J; Rostom, A | 1 |
| Fujii, H; Ide, M; Shohtsu, A; Takagi, S; Takahashi, W; Yasuda, S | 1 |
| Dehdashti, F; Fracasso, P; Katzenellenbogen, JA; Mortimer, JE; Siegel, BA; Welch, MJ | 1 |
| Agresti, R; Bogni, A; Bombardieri, E; Chiesa, C; Crippa, F; Daidone, MG; De Sanctis, V; Decise, D; Greco, M; Pascali, C; Seregni, E | 1 |
| Basic, M; Cherry, SR; Doshi, NK | 1 |
| Dehdashti, F; Flanagan, FL; Katzenellenbogen, JA; Mortimer, JE; Siegel, BA; Welch, MJ | 1 |
| Hoh, CK; Schiepers, C | 1 |
| Cook, GJ; Fogelman, I | 1 |
| Ahmad, A; Barrington, S; Maisey, M; Rubens, RD | 1 |
| Ivancevic, V | 1 |
| Audretsch, W; Bender, HG; Boerner, AR; Herzog, H; Mueller-Gaertner, HW; Nitz, U; Schmitz, T; Weckesser, M | 1 |
| Austin-Seymour, MM; Cortese, AA; Ellis, GK; Gralow, JR; Hathaway, PB; Hayes, CE; Mankoff, DA; Maravilla, KR; Moe, RE | 1 |
| Kusuoka, H; Nishimura, T; Shiba, E; Tatsumi, M; Yutani, K | 1 |
| Coel, MN; Johnson, DS; Wong, JT | 1 |
| Baker, LH; Kison, PV; Sugawara, Y; Wahl, RL; Zasadny, KR | 1 |
| Aloj, L; Caracó, C; Eckelman, WC; Jagoda, E; Neumann, RD | 1 |
| Fujii, H; Ide, M; Kubota, M; Shohtsu, A; Tajima, T; Takahashi, W; Umemura, S; Yasuda, S | 1 |
| Delbeke, D | 1 |
| Choe, KJ; Chung, JK; Kang, HS; Kim, JS; Kim, YC; Lee, DS; Lee, MC; Moon, WK; Noh, DY; Oh, SK; Youn, YK; Yun, IJ | 1 |
| Nishimura, T; Tatsumi, M; Uehara, T; Yutani, K | 1 |
| Neuhoff, AW; Sugawara, Y; Wahl, RL; Zasadny, KR | 1 |
| Diederichs, C; Elsner, K; Glatting, G; Guhlmann, A; Kotzerke, J; Kreienberg, R; Kühn, T; Messer, P; Neumaier, B; Nüssle, K; Reske, SN; Santjohanser, C; Schirrmeister, H; Träger, H | 1 |
| Bleckmann, C; Bohuslavizki, KH; Buchert, R; Clausen, M; Dose, J; Jänicke, F; Klutmann, S; Mester, J | 1 |
| Amartey, J; Bakheet, SM; Ezzat, A; Kandil, A; Powe, J; Rostom, A | 1 |
| Al-Amro, A; Bakheet, SM; Larsson, SG; Mahassin, Z; Powe, J; Saleem, M | 1 |
| Aznar, M; Bergman, AM; Gagnon, JH; Lisbona, R; Loutfi, A; Murthy, K; Robar, JL; Thompson, CJ | 1 |
| Avril, N; Dose, J; Graeff, H; Jänicke, F; Kuhn, W; Nährig, J; Römer, W; Sattler, D; Schelling, M; Schwaiger, M; Werner, M | 1 |
| Ah-See, AK; Chilcott, F; Eremin, O; Gilbert, FJ; Heys, SD; Hutcheon, AW; Miller, ID; Payne, S; Sharp, PF; Smith, IC; Waikar, S; Welch, AE; Whitaker, T | 1 |
| O'Doherty, MJ | 1 |
| Brix, G; Doll, J; Haberkorn, U; Henze, M; Knopp, MV; Lucht, R; Trojan, H; Zaers, J | 1 |
| Brenner, W; Czech, N; Henze, E; Kampen, WU | 1 |
| Ali, A; Dowlatshahi, K; Fan, M; Lamonica, G; Nair, N | 1 |
| Nishimura, T; Yutani, K | 1 |
| Kubota, M; Makuuchi, H; Ohta, M; Okumura, A; Saitoh, Y; Shohtsu, A; Suzuki, Y; Tajima, T; Tokuda, Y; Yasuda, S | 1 |
| Enomoto, K; Fujii, H; Hojo, T; Ide, M; Ikeda, T; Kameyama, K; Kubo, A; Shohtsu, A; Yasuda, S | 1 |
| Avril, N; Bense, S; Dose, J; Graeff, H; Kuhn, W; Rosé, CA; Schelling, M; Schwaiger, M; Weber, W; Ziegler, S | 1 |
| Ak, I; Pauwels, EK; Stokkel, MP | 1 |
| Aznar, M; Gagnon, JH; Lisbona, R; Loutfi, A; Murthy, K; Thompson, CJ | 1 |
| van Dongen, AJ; van Rijk, PP | 1 |
| Fujibayashi, Y; Itoh, H; Sadato, N; Sugimoto, K; Takahashi, N; Tsuchida, T; Waki, A; Welch, MJ; Yonekura, Y | 1 |
| Mechelany-Corone, C; Pecking, AP; Pichon, MF | 1 |
| Burgman, P; Humm, JL; Ling, CC; Odonoghue, JA | 1 |
| Avril, N; Dose, J; Jänicke, F; Menzel, M; Nathrath, W; Schelling, M; Schwaiger, M; Weber, W | 1 |
| Bakheet, R; Bakheet, SM; Durakovic, A; Ezzat, A; Hussain, S; Tulbah, A | 1 |
| Agresti, R; Asero, S; Bombardieri, E; Cascinelli, N; Crippa, F; Ferraris, C; Gennaro, M; Gerali, A; Giovanazzi, R; Greco, M; Micheli, A; Seregni, E | 1 |
| Buck, AC; Glatting, G; Guhlmann, A; Hörster, T; Koretz, K; Kreienberg, R; Kühn, T; Nüssle, K; Reske, SN; Rieber, A; Santjohanser, C; Schirrmeister, H | 1 |
| Alavi, A; Liu, Y; Pourdehnad, M; Sinha, P; Yamamoto, AJ; Zhuang, H | 1 |
| Pauwels, EK; Stokkel, MP; van der Hiel, B | 1 |
| Dehdashti, F; Katzenellenbogen, JA; Mortimer, JE; Siegel, BA; Trinkaus, K; Welch, MJ | 1 |
| Brinkbäumer, K; Fieber, S; Hahn, K; Linke, R; Richter, A; Tatsch, K; Tiling, R; Untch, M | 1 |
| Chandra, S; Lorey, DR | 1 |
| Kubota, M; Makuuchi, H; Nasu, S; Ohta, M; Shohtsu, A; Suzuki, Y; Tajima, T; Tokuda, Y; Yasuda, S | 1 |
| Austin-Seymour, MM; Charlop, A; Eary, JF; Ellis, GK; Eubank, WB; Funkhouser, CP; Gralow, JR; Lindsley, KL; Livingston, RB; Mankoff, DA; Shanley, TJ; Takasugi, J; Vesselle, H | 1 |
| Binns, D; Hicks, RJ; Stabin, MG | 1 |
| Alberini, JL; Belhocine, T; Bolle, S; Daenen, F; Rigo, P; Rutten, I | 1 |
| Bacharach, SL; Carrasquillo, JA; Carson, RE; Danforth, DN; Libutti, SK; Riddell, C; Whatley, M | 1 |
| Czernin, J; Gambhir, SS; Phelps, ME; Rao, J; Schiepers, C; Seltzer, MA; Valk, PE; Yap, CS | 1 |
| Choe, KJ; Chung, JK; Kim, TS; Lee, DS; Lee, MC; Moon, WK; Noh, DY; Oh, SK; Youn, YK | 1 |
| Haberkorn, U | 1 |
| Hoekstra, OS; Licht, J; Meijer, S; Torrenga, H; van der Hoeven, JJ; van Diest, PJ | 1 |
| Brix, G; Doll, J; Haberkorn, U; Hawighorst, H; Henze, M; Junkermann, H; Knopp, MV; Lucht, R | 1 |
| Fujino, K; Hashikawa, K; Nishimura, T; Paul, AK; Tatsumi, M; Yutani, K | 1 |
| Bos, R; Comans, EF; Hoekstra, OS; Joshi, U; Lammertsma, AA; Molthoff, CF; Semenza, GL; van Der Groep, P; van Der Hoeven, JJ; van Der Wall, E; van Diest, PJ | 1 |
| Bombardieri, E; Crippa, F | 1 |
| Baum, RP; Przetak, C | 1 |
| Collins, M; Dunigan, K; Jacobs, M; Kraus, G; Mantil, J; Padma, MV | 1 |
| Burcombe, RJ; Emmott, J; Lowe, J; Makris, A; Pittam, M; Wong, WL | 1 |
| Hellman, P; Juhlin, C; Ladjevardi, S; Sörensen, J; Wärnberg, F | 1 |
| Guller, U; Harder, F; Langer, I; Marti, WR; Moch, H; Nitzsche, EU; Oertli, D; Schirp, U; Torhorst, J; Viehl, CT; Zuber, M | 1 |
| Czernin, J; Filmont, JE; Meta, J; Phelps, ME; Rao, J; Silverman, DH; Valk, PE; Vranjesevic, D | 1 |
| Alberini, JL; Bertrand-Kermorgant, F; Floiras, JL; Goupil, A; Mechelany-Corone, C; Pecking, AP; Pichon, MF | 1 |
| Conte, PF; Dani, D; Donati, S; Gennari, A; Giorgetti, A; Landucci, E; Mariani, G; Pisani, P; Poli, M; Puccini, G; Salvadori, B; Salvadori, PA; Sorace, O | 1 |
| Charlop, A; Dunnwald, LK; Ellis, GK; Gralow, JR; Lawton, TJ; Livingston, RB; Mankoff, DA; Schubert, EK; Tseng, J | 1 |
| Brown, RS; Goodman, TM; Greenson, JK; Wahl, RL; Zasadny, KR | 1 |
| Kao, CH; Lee, CC; Liang, JA; Lin, CC; Lin, FJ; Yang, SN | 1 |
| Agoston, P; Esik, O; Fekésházy, A; Galuska, L; Kálvin, B; Lengyel, E; Lengyel, Z; Szakáll, S; Székely, J; Trón, L; Várady, E | 1 |
| Prats, E | 1 |
| Avril, N; Dose, J; Rosé, C | 1 |
| Altmann, A; Berger, MR; Dimitrakopoulou, A; Haberkorn, U; Oberdorfer, F; Reinhardt, M; Strauss, LG; van Kaick, G; Wallich, R | 1 |
| Brunicardi, FC; Choi, Y; Dahlbom, M; Glaspy, JA; Hawkins, RA; Hoh, CK; Maddahi, J; Phelps, ME; Tse, NY; Zinner, MJ | 1 |
| Cody, R; Hutchins, G; Mudgett, E; Wahl, RL | 1 |
| Cody, RL; Hutchins, GD; Mudgett, EE; Wahl, RL | 1 |
| Minn, H; Soini, I | 1 |
211 review(s) available for fluorodeoxyglucose f18 and Breast Cancer
| Article | Year |
|---|---|
Effect of metformin on
Topics: Animals; Breast Neoplasms; Carcinoma, Hepatocellular; Colonic Neoplasms; Diabetes Mellitus, Type 2; Energy Intake; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Kidney; Liver Neoplasms; Metformin; Mice; Myocardium; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Thyroid Neoplasms; White Matter | 2022 |
COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT.
Topics: Axilla; Breast Neoplasms; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; SARS-CoV-2; Vaccines | 2021 |
Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients: a narrative review.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
The Future Role of PET Imaging in Metastatic Breast Cancer.
Topics: Artificial Intelligence; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography | 2022 |
FDG PET/CT Volume-Based Quantitative Data and Survival Analysis in Breast Cancer Patients: A Systematic Review of the Literature.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Survival Analysis | 2023 |
A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Whole Body Imaging | 2022 |
18F-FES PET/CT Improves the Detection of Intraorbital Metastases in Estrogen-Receptor-Positive Breast Cancer: Two Representative Cases and Review of the Literature.
Topics: Breast Neoplasms; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Quality of Life; Receptors, Estrogen | 2022 |
Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.
Topics: Axilla; Breast Neoplasms; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphadenopathy; Positron Emission Tomography Computed Tomography; Vaccination | 2022 |
Imaging for Radiation Planning in Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
A role of FDG-PET/CT for response evaluation in metastatic breast cancer?
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Quality of Life; Radiopharmaceuticals; Retrospective Studies | 2022 |
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
PET Imaging of Estrogen Receptors for Gynecological Tumors.
Topics: Breast Neoplasms; Endometrial Neoplasms; Estradiol; Estrogens; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Receptors, Estrogen | 2022 |
Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers.
Topics: Breast Neoplasms; Estradiol; Female; Fluorodeoxyglucose F18; Glucose; Humans; Molecular Imaging; Positron-Emission Tomography | 2022 |
Novel applications of molecular imaging to guide breast cancer therapy.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals | 2022 |
Imaging for illuminating actionable pathways in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Integrins; Ligands; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Tumor Microenvironment | 2022 |
Breast PET/MRI Hybrid Imaging and Targeted Tracers.
Topics: Artificial Intelligence; Breast Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Quality of Life; Receptor, ErbB-2; Trastuzumab | 2022 |
Current research topics in FAPI theranostics: a bibliometric analysis.
Topics: Bibliometrics; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Precision Medicine; Quinolines | 2023 |
Diagnostic Performance of PET/MRI in Breast Cancer: A Systematic Review and Bayesian Bivariate Meta-analysis.
Topics: Bayes Theorem; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Prediction of pathological response after neoadjuvant chemotherapy using baseline FDG PET heterogeneity features in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2023 |
Effectiveness of PET/CT and VATS for detecting and treating internal mammary lymph node metastasis: a case series.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thoracic Surgery, Video-Assisted | 2023 |
Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer.
Topics: Breast Neoplasms; Female; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Genital Neoplasms, Female; Humans; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2023 |
Breast Cancer Systemic Staging (Comparison of Computed Tomography, Bone Scan, and 18F-Fluorodeoxyglucose PET/Computed Tomography).
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Evaluation of Treatment Response in Patients with Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography | 2023 |
Metabolic Positron Emission Tomography in Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2023 |
Bone metastases with "false negative" findings on 18F-FDG PET/CT in patients with angiosarcoma: A case series with literature review.
Topics: Adult; Bone Marrow Diseases; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Mastectomy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
18F-fluoroestradiol positron emission tomography in patients with breast cancer: a systematic review and meta-analysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Patients; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2023 |
Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with breast cancer: A systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Tumor Burden | 2019 |
Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer: a case report and review of the literature.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aortitis; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Female; Fever; Filgrastim; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Polyethylene Glycols; Positron Emission Tomography Computed Tomography; Trastuzumab | 2019 |
PET/CT radiomics in breast cancer: Mind the step.
Topics: Breast; Breast Neoplasms; Consensus; Datasets as Topic; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Prognosis; Radiology; Radiopharmaceuticals; Workflow | 2021 |
PET/CT and MRI for Identifying Axillary Lymph Node Metastases in Breast Cancer Patients: Systematic Review and Meta-Analysis.
Topics: Axilla; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity | 2020 |
Application of PET Tracers in Molecular Imaging for Breast Cancer.
Topics: Biomarkers; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron Emission Tomography Computed Tomography | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Prognostic value of
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2020 |
Impact of 18F-FDG PET, PET/CT, and PET/MRI on Staging and Management as an Initial Staging Modality in Breast Cancer: A Systematic Review and Meta-analysis.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2021 |
Management of Incidental Breast Lesions Detected at Nuclear Medicine Examinations.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Diagnostic role of 18F-FDG PET/MRI in the TNM staging of breast cancer: a systematic review and meta-analysis.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
PET/CT Variants and Pitfalls in Breast Cancers.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2021 |
PET/MRI of the breast.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Guidelines as Topic; Humans; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2017 |
Rapid review: radiomics and breast cancer.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Positron-Emission Tomography; Prognosis; Ultrasonography | 2018 |
The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity | 2019 |
Diagnostic Value of Nineteen Different Imaging Methods for Patients with Breast Cancer: a Network Meta-Analysis.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Positron-Emission Tomography; Tomography, Emission-Computed; Ultrasonography, Doppler, Color | 2018 |
Diagnostic Role of Fluorodeoxyglucose PET in Breast Cancer: A History to Current Application.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Role of Fludeoxyglucose in Breast Cancer: Treatment Response.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome | 2018 |
Clinical Potential of Estrogen and Progesterone Receptor Imaging.
Topics: Breast Neoplasms; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone | 2018 |
Amino Acid Metabolism as a Target for Breast Cancer Imaging.
Topics: Amino Acids; Breast; Breast Neoplasms; Carboxylic Acids; Cyclobutanes; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pain; Patient Care Planning; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium | 2018 |
PET/MRI in Breast Cancer.
Topics: Adult; Algorithms; Axilla; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Receptor, ErbB-2 | 2019 |
Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dideoxynucleosides; Early Detection of Cancer; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2013 |
Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Topics: Adult; Bone Marrow Neoplasms; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2013 |
18FDG PET-CT for diagnosis of distant metastases in breast cancer patients. A meta-analysis.
Topics: Bone and Bones; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Meta-Analysis as Topic; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a meta-analysis.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2013 |
Radionuclide methods for breast cancer staging.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radionuclide Imaging; Tomography, X-Ray Computed | 2013 |
Comparison of 18 FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis.
Topics: Bone and Bones; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Meta-Analysis as Topic; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Role of positron emission tomography/computed tomography in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Precision Medicine; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
[State of the art in nuclear imaging for the diagnosis of bone metastases].
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sodium Fluoride; Thyroid Neoplasms | 2013 |
Clinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mammography; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Prevalence and clinical significance of incidental F18-FDG breast uptake: a systematic review and meta-analysis.
Topics: Aged; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Positron emission tomography/computed tomography in locally advanced breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
Molecular imaging for the characterization of breast tumors.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Molecular Imaging; Multimodal Imaging; Positron-Emission Tomography; Proton Magnetic Resonance Spectroscopy; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2014 |
[FDG-PET/CT in staging of breast carcinoma: use in tumour stage III and locoregional recurrent breast carcinoma].
Topics: Aged; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Metastases to the breast from extramammary malignancies - PET/CT findings.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Using nuclear medicine imaging in clinical practice: update on PET to guide treatment of patients with metastatic breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Estrogen | 2014 |
[¹⁸F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers: a literature review.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Positron emission tomography/magnetic resonance imaging of the breast.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Whole-body positron emission tomography-magnetic resonance in breast cancer.
Topics: Breast; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2014 |
Role of positron emission tomography for the monitoring of response to therapy in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiography; Receptor, ErbB-2 | 2015 |
Intracranial Leptomeningeal Carcinomatosis from Breast Cancer Detected on 18F-FDG PET.
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Meningeal Carcinomatosis; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Inflammatory Pseudotumor-like Follicular Dendritic Cell Tumor of the Spleen: Case Report and Review of the Literature.
Topics: Aged; Breast Neoplasms; Contrast Media; Dendritic Cells, Follicular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Granuloma, Plasma Cell; Histiocytic Disorders, Malignant; Humans; Image Enhancement; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron-Emission Tomography; Spleen; Splenic Diseases; Splenic Neoplasms; Tomography, X-Ray Computed | 2015 |
PET Imaging of Breast Cancer: Role in Patient Management.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Molecular imaging using PET for breast cancer.
Topics: Bevacizumab; Breast Neoplasms; Carcinoma, Ductal, Breast; Cetuximab; Dideoxynucleosides; ErbB Receptors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Norprogesterones; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, Progesterone; Receptors, Vascular Endothelial Growth Factor; Trastuzumab | 2016 |
Incidental primary breast cancer detected on PET-CT.
Topics: Biopsy; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Incidental Findings; Mammography; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Warthin's tumor of the larynx: a very rare case and systematic review of the literature.
Topics: Adenolymphoma; Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngoscopy; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.
Topics: Bone Marrow; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; RANK Ligand | 2015 |
Dual-time-point Imaging and Delayed-time-point Fluorodeoxyglucose-PET/Computed Tomography Imaging in Various Clinical Settings.
Topics: Atherosclerosis; Breast Neoplasms; Crohn Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
Present and future role of FDG-PET/CT imaging in the management of breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals | 2016 |
¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Monitoring, Physiologic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2016 |
The Role of (18)F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography | 2016 |
Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
Topics: Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
[Case of antiamphiphysin antibody-positive stiff-person syndrome with breast cancer diagnosed by FDG-PET].
Topics: Adenocarcinoma; Autoantibodies; Biomarkers; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Nerve Tissue Proteins; Paraneoplastic Syndromes; Positron-Emission Tomography; Radiopharmaceuticals; Stiff-Person Syndrome | 2008 |
[Metabolic imaging--PET, PET/CT--in oncologic surgery].
Topics: Breast Neoplasms; Cost-Benefit Analysis; Endocrine Gland Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Surgical Procedures, Operative; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Hybrid PET-dynamic CECT in the management of breast cancer.
Topics: Breast Neoplasms; Contrast Media; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
A systematic review of FDG-PET in breast cancer.
Topics: Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Response to therapy in breast cancer.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Imaging features of primary extranodal lymphomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Digestive System Neoplasms; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed; Urogenital Neoplasms | 2009 |
Role of positron-emission tomography scan in the diagnosis and management of breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Should FDG PET/CT be used for the initial staging of breast cancer?
Topics: Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Investigations after adjuvant therapy.
Topics: Breast Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Genetic Counseling; Humans; Mammography; Neoplasm Recurrence, Local; Radiotherapy | 2009 |
[PET/CT in breast cancer: an update].
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Dideoxynucleosides; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Treatment Outcome | 2009 |
18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.
Topics: Animals; Breast Neoplasms; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Molecular Biology; Radionuclide Imaging | 2009 |
Molecular imaging of breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Tomography, Emission-Computed, Single-Photon; Vascular Endothelial Growth Factor A | 2009 |
Ovarian cancer initially presenting as intramammary metastases and mimicking a primary breast carcinoma: a case report and literature review.
Topics: Adult; Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
FDG PET-CT in the management of primary breast lymphoma.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature.
Topics: Area Under Curve; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2010 |
[Perspectives of the use of nuclear medicine methods for breast cancer patients].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Paraneoplastic neurological syndromes and the role of PET imaging.
Topics: Breast Neoplasms; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lambert-Eaton Myasthenic Syndrome; Magnetic Resonance Imaging; Ovarian Neoplasms; Paraneoplastic Syndromes; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography; Radiopharmaceuticals; Seizures; Tomography, X-Ray Computed | 2010 |
A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radionuclide Imaging | 2011 |
Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
PET in women with high risk for breast or ovarian cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2010 |
Positron emission tomography for benign and malignant disease.
Topics: Breast Neoplasms; Colorectal Neoplasms; Dermatitis, Contact; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Bone metastases: assessment of therapeutic response through radiological and nuclear medicine imaging modalities.
Topics: Absorptiometry, Photon; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Nuclear Medicine; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2011 |
Pitfalls with radiopharmaceuticals.
Topics: Breast Neoplasms; Case-Control Studies; Clinical Trials as Topic; Cohort Studies; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Surveys and Questionnaires; Technetium | 2011 |
Utility of 18FDG-PET/CT in breast cancer diagnostics--a systematic review.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Emerging techniques and molecular imaging in breast cancer.
Topics: Adult; Aged; Breast; Breast Neoplasms; Cone-Beam Computed Tomography; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Spectroscopy, Near-Infrared | 2011 |
FDG-PET/CT in the staging of local/regional metastases in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Predicting tumour response to anti-HER1 therapy using medical imaging: a literature review and in vitro study of [18F]-FDG incorporation by breast cancer cells responding to cetuximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cetuximab; Colony-Forming Units Assay; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glucose; Hexokinase; Humans; Lactic Acid; Positron-Emission Tomography; Tetrazolium Salts; Thiazoles | 2011 |
Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Publication Bias; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2012 |
PET scanning in plastic and reconstructive surgery.
Topics: Breast Neoplasms; Diabetic Foot; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Keloid; Male; Melanoma; Multimodal Imaging; Neoplasm Staging; Plastic Surgery Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Surgical Flaps; Tomography, X-Ray Computed | 2012 |
False-positive lesions mimicking breast cancer on FDG PET and PET/CT.
Topics: Biopsy; Breast Diseases; Breast Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Incidental Findings; Lactation; Mastitis; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity.
Topics: Breast Neoplasms; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity | 2012 |
18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Odds Ratio; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Functional MRI for radiotherapy dose painting.
Topics: Breast Neoplasms; Diagnostic Imaging; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Microcirculation; Neoplasms; Oxygen; Positron-Emission Tomography; Prostatic Neoplasms; Radiation Oncology; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Reproducibility of Results | 2012 |
Imaging of triple-negative breast cancer.
Topics: Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Ultrasonography, Mammary | 2012 |
Performance of FDG PET/CT in the clinical management of breast cancer.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2013 |
Oncological applications of positron emission tomography for evaluation of the thorax.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphoma; Mesothelioma; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thorax; Thymus Gland; Thymus Neoplasms | 2013 |
Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Ovarian Neoplasms; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
Evaluation of breast and gynecologic cancers by positron emission tomography.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Should FDG PET be used to decide whether a patient with an abnormal mammogram or breast finding at physical examination should undergo biopsy?
Topics: Biopsy; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Physical Examination; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Positron emission tomography (PET) in clinical oncology [Part III]].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
[Cost-effective PET investigations in oncology].
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Cost-Benefit Analysis; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Lymphoma; Medicare; Melanoma; Neoplasm Staging; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 2002 |
Interaction of colony-stimulating factors and fluorodeoxyglucose f(18) positron emission tomography.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Case-Control Studies; Drug Interactions; Female; Fluorodeoxyglucose F18; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Middle Aged; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2002 |
Positron emission tomography scanning in gynecologic and breast cancers.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in gynecological neoplasms].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms | 2003 |
Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives.
Topics: Breast Neoplasms; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Risk Assessment; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; United States | 2003 |
[Positron emission tomography in oncology].
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients?
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2003 |
[Clinical application of FDG-PET for cancer diagnosis].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Diagnosis of occult bone metastases: positron emission tomography.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms, Unknown Primary; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
The role of positron emission tomographic imaging in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Women's Health | 2004 |
Advantages and limitations of FDG PET in the follow-up of breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Technology Assessment, Biomedical; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Decision Support Systems, Clinical; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2004 |
FDG-PET in monitoring therapy of breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Decision Support Systems, Clinical; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2004 |
[Utilization of PET scan in breast and gynaecologic cancers].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2004 |
Biological characterisation of breast cancer by means of PET.
Topics: Biomarkers, Tumor; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron-Emission Tomography; Proto-Oncogene Mas; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
FDG-PET for axillary lymph node staging in primary breast cancer.
Topics: Axilla; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2004 |
FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions.
Topics: Breast Neoplasms; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2004 |
PET/CT and breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Technology Assessment, Biomedical; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2004 |
Current and future uses of positron emission tomography in breast cancer imaging.
Topics: Axilla; Biomarkers, Tumor; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Molecular imaging in breast cancer.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiation Dosage; Radioimmunodetection; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Fluorodeoxyglucose-PET in the management of breast cancer.
Topics: Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2004 |
Sonographic depiction of microvessel perfusion: principles and potential.
Topics: Animals; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Microbubbles; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Radiopharmaceuticals; Regional Blood Flow; Ultrasonography, Doppler, Color | 2004 |
FDG-PET and beyond: molecular breast cancer imaging.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2005 |
Evolving role of positron emission tomography in breast cancer imaging.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Treatment Outcome | 2005 |
Positron emission tomography and bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
[Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Uterine Cervical Neoplasms; Uterine Neoplasms | 2005 |
Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography.
Topics: Amino Acids; Breast Neoplasms; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ligands; Lymphatic Metastasis; Neoplasm Recurrence, Local; Nucleosides; Positron-Emission Tomography; Protein Biosynthesis; Radiopharmaceuticals; Receptors, Estrogen; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2005 |
[Combined role of tumor markers and 18fluoro-deoxyglucose-positron emission tomography (18FDG-PET) in follow-up of cancer patients].
Topics: Biomarkers, Tumor; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
[Contribution of positron emission tomography to the detection and staging of breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
[Current status of 18F-FDG PET in predicting outcome of cancer therapy].
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Treatment Outcome | 2004 |
[FDG (18 fluorodeoxyglucose) positron emission tomography and breast cancer].
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
[Usefulness of 18F-FDG PET in the diagnosis for breast cancer patients].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis | 2006 |
Monitoring therapeutic efficacy in breast carcinomas.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Monitoring, Physiologic; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome; Ultrasonography, Mammary | 2006 |
PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.
Topics: Breast Neoplasms; Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Tomography, Emission-Computed; Whole Body Imaging | 2006 |
Positron Emission Tomography (PET) and Mammography (PEM) for breast cancer: importance to surgeons.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Dysplasia | 2007 |
Current and future use of positron emission tomography (PET) in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2006 |
A quantitative review of the use of FDG-PET in the axillary staging of breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Staging; Positron-Emission Tomography | 2007 |
[Usefulness of 18F-FDG-PET in breast cancer imaging].
Topics: Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
[Early prediction of response to primary chemotherapy by sequential FDG -PET in patients with advanced breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mastectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Mammography; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Diagnosis of recurrent and metastatic disease using f-18 fluorodeoxyglucose-positron emission tomography in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Detection of bone metastases in breast cancer by positron emission tomography.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2007 |
[Interests and perspectives of PET-CT for breast cancer: review of the literature].
Topics: Bone Neoplasms; Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
PET/CT in oncology: for which tumours is it the reference standard?
Topics: Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
FDG-PET and FDG-PET/CT in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
PET and PET/CT with F-18 fluoride in bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
FDG PET/CT for the detection and evaluation of breast diseases: usefulness and limitations.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2007 |
FDG PET, PET/CT, and breast cancer imaging.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Meta-analysis: comparison of F-18 Fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastases in patients with breast cancer.
Topics: Area Under Curve; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Is there a role for positron emission tomography in breast cancer staging?
Topics: Antineoplastic Agents; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy | 2008 |
Breast cancer follow-up in the adjuvant setting.
Topics: Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Breast Neoplasms; Breast Self-Examination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Risk Reduction Behavior; Tomography, X-Ray Computed | 2008 |
Quantitative techniques in 18FDG PET scanning in oncology.
Topics: Breast Neoplasms; Data Interpretation, Statistical; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Male; Medical Oncology; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Regression Analysis; Solitary Pulmonary Nodule; Stomach Neoplasms | 2008 |
Thallium-201 uptake in lung cancer.
Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Indium Radioisotopes; Iodine Radioisotopes; Lung Neoplasms; Middle Aged; Octreotide; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Use of positron emission tomography in oncology.
Topics: Brain Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Tomography, Emission-Computed | 1993 |
Nuclear medicine imaging of breast cancer.
Topics: Biopsy; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Mammography; Octreotide; Reproducibility of Results; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed | 1996 |
Scintigraphic imaging of breast tumors.
Topics: Breast Neoplasms; Clinical Trials as Topic; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed | 1997 |
Positron emission tomography (PET) scanning in breast cancer.
Topics: Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Tomography, Emission-Computed | 1997 |
Scintigraphic imaging of breast cancer: a review.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Organophosphorus Compounds; Organotechnetium Compounds; Receptors, Estrogen; Receptors, Somatostatin; Reproducibility of Results; Technetium Tc 99m Sestamibi; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed | 1997 |
Overview of the current status of PET in breast cancer imaging.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carbon Radioisotopes; Copper; Copper Radioisotopes; Diagnosis, Differential; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Methionine; Neoplasm Metastasis; Neoplasm Staging; Organometallic Compounds; Oxygen Radioisotopes; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thiosemicarbazones; Tomography, Emission-Computed | 1998 |
Impact of the diagnostic methods on the therapeutic strategies.
Topics: Age Factors; Breast Neoplasms; Chemotherapy, Adjuvant; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Magnetic Resonance Imaging; Mammography; Mass Screening; Mastectomy, Segmental; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Radiographic Image Enhancement; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Nuclear medicine approaches for detection of axillary lymph node metastases.
Topics: Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Colloids; Cost-Benefit Analysis; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplastic Cells, Circulating; Prognosis; Radioimmunodetection; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Survival Rate; Tomography, Emission-Computed | 1998 |
PET in breast cancer.
Topics: Breast Neoplasms; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Receptors, Steroid; Tomography, Emission-Computed | 1998 |
18-FDG imaging in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Skeletal metastases from breast cancer: imaging with nuclear medicine.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Radiopharmaceuticals; Technetium Compounds; Tomography, Emission-Computed; Treatment Outcome | 1999 |
[Positron emission tomography (PET) in diagnosis of breast carcinoma].
Topics: Blood Glucose; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Tomography, Emission-Computed | 1998 |
Oncological applications of FDG PET imaging.
Topics: Breast Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
PET in oncology I--lung, breast, soft tissue sarcoma.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed | 2000 |
[Diagnostic value of positron emission tomography (PET) in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Diagnosis, Differential; Digestive System Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Urogenital Neoplasms | 2000 |
[Positron emission tomography for diagnosis of breast cancers].
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Central Nervous System Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Rats; Tomography, Emission-Computed | 2001 |
[The role of diagnostic PET in treatment planning before tumor surgery].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Prospective Studies; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Thyroid Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
PET imaging in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2001 |
Evaluation of therapy response in breast and ovarian cancer patients by positron emission tomography (PET).
Topics: Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2001 |
[Cost-effective PET scans in oncology].
Topics: Breast Neoplasms; Colorectal Neoplasms; Cost-Benefit Analysis; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Lymphoma; Medicare; Melanoma; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; United States | 2002 |
Positron emission tomography for the diagnosis of breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
129 trial(s) available for fluorodeoxyglucose f18 and Breast Cancer
| Article | Year |
|---|---|
Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung; Middle Aged; Prospective Studies; Radiosurgery | 2022 |
Intra-individual comparison of
Topics: Bone Neoplasms; Breast Neoplasms; Canada; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Sodium Fluoride; Tomography, Emission-Computed, Single-Photon | 2022 |
Impact of
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Patient Selection; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinolines; Radiopharmaceuticals; Receptor, ErbB-2; Response Evaluation Criteria in Solid Tumors; Treatment Outcome | 2019 |
Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Isoflavones; Ki-67 Antigen; Middle Aged; Mitochondria; Neoplasm Staging; Patient Safety; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Succinate Dehydrogenase; Treatment Outcome | 2020 |
Radiomics based on
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphoma; Machine Learning; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2020 |
Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cyclin-Dependent Kinases; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Letrozole; Middle Aged; Neoplasm Metastasis; Outcome Assessment, Health Care; Piperazines; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Pyridines; Receptors, Estrogen; Young Adult | 2020 |
A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients.
Topics: Adipose Tissue, Brown; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Trastuzumab; Treatment Outcome; Weight Gain | 2020 |
Brown Adipose Tissue in Breast Cancer Evaluated by [
Topics: Adipose Tissue, Brown; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Evaluation of primary breast cancers using dedicated breast PET and whole-body PET.
Topics: Adult; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography | 2020 |
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Time Factors; Trastuzumab; Treatment Outcome; United States | 2021 |
Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer.
Topics: Bayes Theorem; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Reproducibility of Results; Triple Negative Breast Neoplasms | 2022 |
CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged | 2017 |
Breast Cancer Blood Flow and Metabolism on Dual-Acquisition
Topics: Adult; Aged; Aged, 80 and over; Blood Circulation; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Phenotype; Positron-Emission Tomography; Prospective Studies; Treatment Outcome; Young Adult | 2018 |
Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer.
Topics: Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies; Time Factors; Whole Body Imaging | 2018 |
Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2- Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Fulvestrant; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies; Survival Rate | 2018 |
Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mastectomy; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2018 |
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Single Photon Emission Computed Tomography Computed Tomography; Time Factors; Trastuzumab; Treatment Outcome; United States | 2019 |
The SUVmax for (18)F-FDG correlates with molecular subtype and survival of previously untreated metastatic breast cancer.
Topics: Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Proportional Hazards Models; Radionuclide Imaging | 2013 |
Variation of liver SUV on (18)FDG-PET/CT studies in women with breast cancer.
Topics: Adult; Age Factors; Aged; Blood Glucose; Body Weight; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Middle Aged; Multimodal Imaging; Multivariate Analysis; Radiography; Radionuclide Imaging | 2013 |
Axillary lymph node characterization in breast cancer patients using magnetic resonance mammography: a prospective comparative study with FDG PET-CT and healthy women.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Does the pretreatment tumor sampling location correspond with metabolic activity on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy?
Topics: Adult; Aged; Biopsy, Large-Core Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Netherlands; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sample Size; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplification.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Polyethylene Glycols; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Taxoids; Tomography, X-Ray Computed; Trastuzumab | 2013 |
18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lapatinib; Neoadjuvant Therapy; Positron-Emission Tomography; Quinazolines; Receptor, ErbB-2; Time Factors; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome | 2013 |
Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Polyethylene Glycols; Positron-Emission Tomography; Protein Kinase Inhibitors; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Treatment Outcome; Young Adult | 2014 |
Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Topics: Adult; Aged; Aminopyridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Letrozole; Middle Aged; Morpholines; Multimodal Imaging; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Tomography, X-Ray Computed; Triazoles | 2014 |
Evaluating heterogeneity of primary tumor (18)F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI): a feasibility study based on correlation with PET/CT.
Topics: Adult; Aged; Biological Transport; Breast; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Early and delayed prediction of axillary lymph node neoadjuvant response by (18)F-FDG PET/CT in patients with locally advanced breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER):
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Survival Rate; Taxoids; Trastuzumab | 2014 |
TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Biomarkers, Tumor; Breast Neoplasms; Carboplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Positron-Emission Tomography; Preoperative Period; Receptor, ErbB-2; Safety; Time Factors; Treatment Outcome; Young Adult | 2015 |
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Prostatic Neoplasms; Registries; Sodium Fluoride; Treatment Outcome | 2015 |
Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.
Topics: Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Middle Aged; Nanoparticles; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Taxoids; Treatment Outcome | 2015 |
Is (18)F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed; Young Adult | 2015 |
Basal ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer.
Topics: Biological Transport; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Epirubicin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography I
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lapatinib; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Quinazolines; Receptor, ErbB-2; Trastuzumab; Treatment Outcome | 2015 |
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial.
Topics: Ado-Trastuzumab Emtansine; Adult; Aged; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; In Situ Hybridization, Fluorescence; Maytansine; Middle Aged; Positron-Emission Tomography; Receptor, ErbB-2; Trastuzumab; Treatment Outcome | 2016 |
Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Molecular Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging; Young Adult | 2016 |
Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.
Topics: Absorption, Physiological; Breast Neoplasms; Computer Systems; Drug Monitoring; Equipment Design; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Humans; Injections; Metabolic Clearance Rate; Radiation Dosage; Radiopharmaceuticals; Reproducibility of Results; Scintillation Counting; Sensitivity and Specificity; Tissue Distribution | 2016 |
ANG1005 for breast cancer brain metastases: correlation between
Topics: Adult; Antineoplastic Agents; Biomarkers; Biomarkers, Tumor; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Middle Aged; Paclitaxel; Peptides; Positron-Emission Tomography; Treatment Outcome | 2016 |
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Receptors, Estrogen; Tumor Burden | 2017 |
A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sodium Fluoride | 2017 |
The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2009 |
Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Insulin-Like Growth Factor I; Middle Aged; Positron-Emission Tomography; Postmenopause; Predictive Value of Tests; Quality of Life; Radiopharmaceuticals; Receptors, Estrogen; Survival Analysis | 2009 |
Prognostic Impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Taxoids; Treatment Outcome; Young Adult | 2010 |
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Mammography; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Mammary | 2010 |
FDG-PET-CT for staging of high-risk breast cancer patients reduces the number of further examinations: A pilot study.
Topics: Adult; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients.
Topics: Adult; Aged; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
FDG PET-CT in the management of primary breast lymphoma.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
The effect of age, menopausal state, and breast density on (18)F-FDG uptake in normal glandular breast tissue.
Topics: Adult; Aged; Aging; Analysis of Variance; Biological Transport; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Mammography; Menopause; Middle Aged; Radionuclide Imaging | 2010 |
Prevention of brown adipose tissue activation in 18F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy.
Topics: Adipose Tissue, Brown; Administration, Oral; Adult; Aged; Aged, 80 and over; Biological Transport; Breast Neoplasms; Cohort Studies; Diazepam; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Seasons; Temperature; Tomography, X-Ray Computed | 2010 |
Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging.
Topics: Adult; Aged; Breast Neoplasms; Diffusion; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Reference Standards; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genomics; Glucose; Humans; Immunohistochemistry; Middle Aged; Neoplasm Invasiveness; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Receptors, Estrogen | 2010 |
Investigation of 18F-FDG PET in the selection of patients with breast cancer as candidates for sentinel node biopsy after neoadjuvant therapy.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Patient Selection; Positron-Emission Tomography; Prospective Studies; Sentinel Lymph Node Biopsy | 2010 |
The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Taxoids; Treatment Outcome | 2010 |
Early metabolic response to neoadjuvant letrozole, measured by FDG PET/CT, is correlated with a decrease in the Ki67 labeling index in patients with hormone receptor-positive primary breast cancer: a pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Letrozole; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Nitriles; Pilot Projects; Positron-Emission Tomography; Postmenopause; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed; Treatment Outcome; Triazoles | 2011 |
¹⁸F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer.
Topics: Aged; Biological Transport; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography | 2011 |
Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Prognosis; Radionuclide Imaging; Tumor Burden; Tumor Suppressor Protein p53 | 2011 |
Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mastectomy, Segmental; Middle Aged; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
¹⁸F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Reference Standards; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Treatment Outcome | 2011 |
Interpretation of positron emission mammography and MRI by experienced breast imaging radiologists: performance and observer reproducibility.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Breast Neoplasms; Clinical Competence; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inservice Training; Magnetic Resonance Imaging; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiology; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiography; Radiopharmaceuticals; Sodium Isotopes; Taxoids; Treatment Outcome | 2011 |
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Phenotype; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Survival Analysis; Treatment Failure | 2012 |
Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hormones; Humans; Middle Aged; Mucin-1; Multimodal Imaging; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2012 |
Triple-negative breast cancer: early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathologic complete response and are at a high risk of early relapse.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Patient Selection; Positron-Emission Tomography; Recurrence; Risk; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors.
Topics: Adult; Aged; Biomarkers, Tumor; Blood Circulation; Breast Neoplasms; Cell Proliferation; Endothelial Cells; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Prospective Studies; Tomography, X-Ray Computed | 2012 |
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Diarrhea; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; TOR Serine-Threonine Kinases; Treatment Outcome; Young Adult | 2012 |
Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biopsy, Needle; Breast Neoplasms; Confidence Intervals; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Ontario; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2012 |
18F-FDG retention index and biologic prognostic parameters in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Prognosis; Radionuclide Imaging | 2012 |
PET/CT with [18F] fluorodeoxyglucose in the assessment of metabolic response to neoadjuvant chemotherapy in locally advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Semi-quantitative lymph node assessment of (18)F-FDG PET/CT in locally advanced breast cancer: correlation with biological prognostic factors.
Topics: Adult; Aged; Breast Neoplasms; Cell Proliferation; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Receptor, ErbB-2; Receptors, Steroid; Statistics, Nonparametric; Tomography, X-Ray Computed; Tumor Suppressor Protein p53 | 2013 |
Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Topics: Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone; Reproducibility of Results; Statistics as Topic; Tissue Distribution; Tomography, Emission-Computed | 2002 |
FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers.
Topics: Adult; Aged; Blood Flow Velocity; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Models, Biological; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic | 2003 |
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.
Topics: Adult; Aged; Algorithms; Antineoplastic Agents; Breast Neoplasms; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2003 |
Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2003 |
Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
[F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
Topics: Breast Neoplasms; Catheter Ablation; Colonic Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver; Liver Neoplasms; Neoplasm Recurrence, Local; Postoperative Period; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study.
Topics: Adult; Aged; Breast Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Patient Care Management; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
What is the most appropriate scan timing for intraoperative detection of malignancy using 18F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Enhancement; Injections, Intravenous; Intraoperative Care; Middle Aged; Phantoms, Imaging; Pilot Projects; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Surgery, Computer-Assisted; Time Factors | 2004 |
A comparison of 18F-FDG gamma camera PET, mammography and ultrasonography in demonstrating primary disease in locally advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Equipment Failure Analysis; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Mammography; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Mammary | 2004 |
Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kidney Neoplasms; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Radioisotope Dilution Technique; Radioisotope Renography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
18F-FDG uptake and breast density in women with normal breast tissue.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Organ Specificity; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed | 2004 |
18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy.
Topics: Antineoplastic Agents; Blood Flow Velocity; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Kinetics; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic; Treatment Outcome | 2004 |
Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Image Enhancement; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Topics: Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Endometrial Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Granuloma; Histiocytosis; Histoplasmosis; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Silicosis; Tomography, X-Ray Computed; Ultrasonography, Interventional; Urinary Bladder Neoplasms | 2005 |
Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Drug Administration Schedule; Female; Fibroblast Growth Factor 2; Fluorodeoxyglucose F18; Humans; Microcirculation; Middle Aged; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome; Ultrasonography, Doppler, Color | 2005 |
Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Outcome Assessment, Health Care; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity | 2005 |
Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2005 |
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.
Topics: Arabinofuranosyluracil; Bone Marrow; Breast Neoplasms; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Kidney; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution | 2006 |
Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2005 |
Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Single-Blind Method | 2005 |
Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET.
Topics: Adult; Aged; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Time Factors | 2005 |
Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging | 2005 |
Brown fat in breast cancer patients: analysis of serial (18)F-FDG PET/CT scans.
Topics: Adipose Tissue, Brown; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2006 |
Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
Topics: Adult; Aged; Axilla; Bayes Theorem; Breast Neoplasms; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Iron; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Middle Aged; Neoplasm Staging; Oxides; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2006 |
Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Stem Cell Transplantation; Survival Analysis | 2006 |
Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Delivery Systems; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Treatment Outcome; Tumor Burden | 2006 |
Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiographic Image Enhancement; Radiographic Image Interpretation, Computer-Assisted; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique | 2006 |
[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2007 |
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for d
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
The use of molecular imaging to evaluate radiation fields in the adjuvant setting of breast cancer: a feasibility study.
Topics: Adult; Aged; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiometry; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Computer-Assisted | 2008 |
Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbon Radioisotopes; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Methionine; Tomography, Emission-Computed | 1995 |
Preliminary results for positron emission mammography: real-time functional breast imaging in a conventional mammography gantry.
Topics: Breast; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Phantoms, Imaging; Time Factors; Tomography, Emission-Computed | 1996 |
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multivariate Analysis; Radiopharmaceuticals; Receptors, Cell Surface; Thymidine; Tomography, Emission-Computed; Tumor Suppressor Protein p53 | 1998 |
Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients.
Topics: Adult; Aged; Brachial Plexus; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Nervous System Neoplasms; Pain; Pilot Projects; Radiotherapy; Tomography, Emission-Computed | 1999 |
Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction.
Topics: Body Weight; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
Topics: Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed | 2001 |
Metabolic flare: indicator of hormone responsiveness in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Receptors, Estrogen; Tamoxifen; Tomography, Emission-Computed | 2001 |
18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Radiopharmaceuticals; Reference Standards; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Prevalence; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Pattern of uptake and excretion of (18)F-FDG in the lactating breast.
Topics: Adult; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Half-Life; Humans; Lactation; Milk, Human; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Effects of iterative reconstruction on image contrast and lesion detection in gamma camera coincidence imaging in lung and breast cancers.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Models, Anatomic; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
Expression of hexokinase II and Glut-1 in untreated human breast cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Excitatory Amino Acid Transporter 2; Fluorodeoxyglucose F18; Hexokinase; Humans; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method | 2002 |
Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Medronate | 2002 |
1126 other study(ies) available for fluorodeoxyglucose f18 and Breast Cancer
| Article | Year |
|---|---|
Comparison of nodal staging between CT, MRI, and [
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Detection of clinically silent brain lesions in [18F]FDG PET/CT study in oncological patients: analysis of over 10,000 studies.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Brain; Brain Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neuroimaging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Hidden breast cancer after breast augmentation, not presenting as a hypoechoic mass lesion, diagnosed using colour Doppler ultrasound.
Topics: Aged, 80 and over; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammaplasty; Ultrasonography, Doppler, Color | 2021 |
Clustering subtypes of breast cancer by combining immunohistochemistry profiles and metabolism characteristics measured using FDG PET/CT.
Topics: Breast Neoplasms; Cluster Analysis; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Monitoring of Programmed Cell Death Ligand-1 Blockade Using FDG PET/CT for Microsatellite Instability-High Metastatic Breast Cancer.
Topics: Adult; Apoptosis; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Ligands; Mastectomy; Microsatellite Instability; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2022 |
18F-FDG PET/CT in a Patient With Matrix-Producing Carcinoma of the Breast.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
PET of Fibroblast-Activation Protein for Breast Cancer Diagnosis and Staging.
Topics: Breast Neoplasms; Female; Fibroblasts; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography | 2022 |
ER Imaging for Estrogen-Related Tumors Is Bothersome but Useful.
Topics: Breast Neoplasms; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Neoplasms; Receptors, Progesterone | 2022 |
Non-18F-FDG-Avid Intrahepatic Metastasis of Breast Cancer Revealed by 68Ga-FAPI PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Analysis of the Mechanism of Breast Metastasis Based on Image Recognition and Ultrasound Diagnosis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
Prognostic value of metabolic activity of the psoas muscle evaluated by preoperative
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Insulin Resistance; Liver; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Psoas Muscles; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Triple Negative Breast Neoplasms | 2021 |
Feasibility, Safety and Impact of (18F)-FDG PET/CT in patients with pregnancy-associated cancer: experience of the French CALG (Cancer Associé à La Grossesse) network.
Topics: Breast Neoplasms; Child; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Infant, Newborn; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Retrospective Studies | 2022 |
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.
Topics: Bone and Bones; Bone Neoplasms; Breast; Breast Neoplasms; Diagnostic Tests, Routine; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2021 |
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Paraneoplastic Cerebellar Syndrome Presented as Cerebellar Hypermetabolism in a Patient With Occult Breast Carcinoma.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Paraneoplastic Cerebellar Degeneration; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Four Patterns of Abnormal Ring-Like Uptakes on Dedicated Breast PET.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2022 |
18F-FDG PET/CT in Bilateral Breasts Metastasis From Ovarian Carcinoma.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Survival Rate | 2022 |
FDG PET/CT of Primary Breast Lymphoma in a Man.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Malignant prediction of incidental findings using ring-type dedicated breast positron emission tomography.
Topics: Breast; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment | 2022 |
68Ga-DOTA-FAPI-04 Uptake of Accessory Breast in a Patient With Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Evaluation of clinically involved lymph nodes with deformable registration in breast cancer radiotherapy.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Deep learning for image classification in dedicated breast positron emission tomography (dbPET).
Topics: Breast; Breast Neoplasms; Deep Learning; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Retrospective Studies | 2022 |
[
Topics: BNT162 Vaccine; Breast Neoplasms; Cohort Studies; COVID-19; COVID-19 Vaccines; Deltoid Muscle; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lymph Nodes; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Retrospective Studies; RNA, Messenger; Vaccination | 2022 |
The Effect of FDG-PET/CT on Clinical Prognostic Staging of Breast Cancer Patients being Planned Neoadjuvant Treatment.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies | 2022 |
Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Assessing the correlation between FDG PET findings of IDC breast carcinoma and histopathology of coexisting ductal carcinoma in-situ.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Different glucose metabolism behavior relating to histotypes in synchronous breast cancers evaluated by [18F]FDG PET-CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptors, Estrogen | 2022 |
Intraductal Papilloma With Carcinoma of the Breast Described by Dedicated Breast 18F-FDG PET.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Papilloma, Intraductal | 2022 |
Positive FAPI PET/CT in a Bilateral Mammary Angiosarcoma Patient With Less Impressive FDG PET/CT Images.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Mastectomy; Positron Emission Tomography Computed Tomography | 2022 |
Comparison of Ultrasound Features With Maximum Standardized Uptake Value Assessed by 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Prognosis of Estrogen Receptor+/Human Epithelial Growth Factor Receptor 2- Breast Cancer.
Topics: Breast Neoplasms; Estrogen Receptor beta; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Receptors, Estrogen; Receptors, Growth Factor; Retrospective Studies | 2021 |
The relationship between CEA and CA 15-3 positivity and metabolic and volumetric 18F-FDG PET/CT parameters in preoperative evaluation of breast cancer.
Topics: Breast Neoplasms; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2022 |
Uncommon Metastases From Occult Breast Cancer Revealed by 18 F-FDG and 68 Ga-FAPI PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Discrepancy between [18F]-FES and [18F]-FDG PET/CT in ER-positive breast cancer with oesophageal metastasis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen | 2022 |
FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Topics: Breast Neoplasms; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphadenopathy; Lymphatic Metastasis; mRNA Vaccines; Pilot Projects; Positron Emission Tomography Computed Tomography; Retrospective Studies; Vaccination; Vaccines, Synthetic | 2022 |
The Impact of the Amendment of the Health Insurance Coverage for F-18 Fluorodeoxyglucose Positron Emission Tomography on the Healthcare Behaviors for Breast Cancer: An Interrupted Time Series Analysis of the Korean National Data From 2013 to 2018.
Topics: Breast Neoplasms; Delivery of Health Care; Female; Fluorodeoxyglucose F18; Humans; Insurance Coverage; Interrupted Time Series Analysis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Republic of Korea; Retrospective Studies | 2022 |
Radiogenomic analysis of primary breast cancer reveals [18F]-fluorodeoxglucose dynamic flux-constants are positively associated with immune pathways and outperform static uptake measures in associating with glucose metabolism.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Endobronchial ultrasound-guided transbronchial needle aspiration facilitating diagnosis of sarcoidosis in a breast cancer patient with multiple lymphadenopathy: a case report.
Topics: Aged; Breast Neoplasms; Bronchoscopy; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphadenopathy; Mastectomy; Mediastinum; Receptors, Interleukin-2; Sarcoidosis | 2022 |
Physiological background parenchymal uptake of
Topics: Adult; Breast Density; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Menopause; Menstrual Cycle; Positron-Emission Tomography | 2022 |
Gadolinium-based contrast agent attenuation does not impact PET quantification in simultaneous dynamic contrast enhanced breast PET/MR.
Topics: Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Comparison of Magnetic Resonance Imaging With Positron Emission Tomography/Computed Tomography in the Evaluation of Response to Neoadjuvant Therapy of Breast Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome; Young Adult | 2022 |
Is it sufficient to evaluate metastatic bone involvement in breast cancer using SPECT/CT? A new approach of SPECT/CT-guided targeted bone marrow biopsy.
Topics: Biopsy; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Quality of Life; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Whole Body Imaging | 2022 |
Comparison of 68 Ga-FAPI PET and 18 F-FDG PET Findings in a Patient With Bilateral Breast Cancer of 2 Different Histopathologies.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography | 2022 |
Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence.
Topics: Axilla; Breast Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2022 |
Tc-99m-tamoxifen: A novel diagnostic imaging agent for estrogen receptor-expressing breast cancer patients.
Topics: Animals; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Rats; Receptors, Estrogen; Tamoxifen; Technetium; Tissue Distribution | 2022 |
Primary Breast Lymphoma Mimicking Metastatic Breast Cancer on 18F-FDG PET-CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Diagnostic performance of dedicated breast positron emission tomography.
Topics: Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen | 2022 |
Correlation of 18-fluorodeoxyglucose uptake values on PET-CT scan with histological prognostic markers in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Triple Negative Breast Neoplasms | 2023 |
Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoadjuvant Therapy; Neoplasm Micrometastasis; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
18F-FDG PET/CT Metabolic Response With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Treated With Cyclin-Dependent 4/6 Kinase Inhibitors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclins; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Receptor, ErbB-2; Triple Negative Breast Neoplasms | 2022 |
Role of dynamic and parametric whole-body FDG PET/CT imaging in molecular characterization of primary breast cancer: a single institution experience.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hormones; Humans; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Whole Body Imaging | 2022 |
Is there a potential biomarker in distinguishing invasive breast carcinomas with elevated Ki-67 levels among 2D-SWE, SMI, and 18F-FDG PET-CT/MRI-derived parameters?: A single-center data.
Topics: Breast Neoplasms; Elasticity Imaging Techniques; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Correlation between MAMMI-PET findings and anatomopathological outcomes in breast cancer patients.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2022 |
Influence of inputs for bone lesion segmentation in longitudinal
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor.
Topics: Breast Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Protein Kinase Inhibitors; Radiopharmaceuticals; Receptors, Estrogen; Retrospective Studies; Tumor Burden | 2022 |
Effect of radioactivity outside the field of view on image quality of dedicated breast positron emission tomography: preliminary phantom and clinical studies.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radioactivity; Radiopharmaceuticals | 2022 |
Impact of preoperative PET/CT for axillary staging in patients with early breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Critical analysis of the effect of various methodologies to compute breast cancer tumour blood flow-based texture features using first-pass
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Brown fat activation demonstrated on FDG PET/CT predicts survival outcome.
Topics: Adipose Tissue, Brown; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Microenvironment | 2023 |
An incidental male breast cancer of
Topics: Breast Neoplasms; Breast Neoplasms, Male; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Metastatic primary breast neuroendocrine neoplasms: a case series.
Topics: Adult; Breast Neoplasms; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Second Primary; Neuroendocrine Tumors; Prognosis; Retrospective Studies | 2023 |
Relationship between Baseline [
Topics: Breast Neoplasms; Carcinoma, Ductal; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2022 |
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using
Topics: Breast Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Pilot Projects; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab | 2023 |
Reproducibility assessment of uptake on dedicated breast PET for noise discrimination.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Reproducibility of Results | 2023 |
Analysis of image quality by regulating beta function of BSREM reconstruction algorithm and comparison with conventional reconstructions in carcinoma breast studies of PET CT with BGO detector.
Topics: Algorithms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Breast incidentalomas on 18-Fluorodeoxyglucose positron emission tomography-computed tomography performed for a non-mammary cause: Significance and outcomes.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Staging of breast cancer in pregnancy with ultralow dose [18F]-FDG-PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Bilateral breast multiple myeloma: a case report.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Relationship between FDG-PET and the immune microenvironment in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Microenvironment | 2023 |
Prognostic impact of
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Progressive Transformation of Germinal Centers Simulating Malignant Axillary Lymphadenopathy in a Breast Cancer Patient on FDG PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphadenopathy; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Topics: Breast Neoplasms; Feeding Behavior; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Comparison of PET-CT and MRI for evaluation of axillary lymph nodes in early breast cancer patients.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2022 |
Prediction of Clinical Molecular Typing of Breast Invasive Ductal Carcinoma Using
Topics: Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Triple Negative Breast Neoplasms | 2023 |
Prognostic significance of pretreatment
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Retrospective Studies; Triple Negative Breast Neoplasms | 2023 |
The Role of 68 Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast Cancer.
Topics: Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Prospective Studies | 2023 |
Alveolar Hemorrhage Following Positron Emission Tomography/Computed Tomography in 2 Separate Episodes 5 Months Apart.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemorrhage; Humans; Mastectomy; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Complex Fibroadenoma Mimicking Breast Cancer on 68Ga-FAPI-04 and 18F-FDG PET/CT.
Topics: Breast Neoplasms; Female; Fibroadenoma; Fibroma; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant.
Topics: Biomarkers; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron Emission Tomography Computed Tomography; Receptors, Estrogen | 2023 |
Rare Case of Phyllodes Tumor of Breast with Cardiac and Pancreatic Metastases: Findings on
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Phyllodes Tumor; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2023 |
Breast Cancer and Physiologic Avidity From Breast Feeding on FDG PET/CT.
Topics: Adult; Breast Feeding; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
18F-FDG PET-CT in Cutaneous Metastases in Breast Carcinoma: An unusual presentation.
Topics: Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2023 |
Can Molecular Imaging Find a Path to Navigate Evolving Breast Cancer Treatments?
Topics: Biomarkers; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron Emission Tomography Computed Tomography; Receptors, Estrogen | 2023 |
Bone Metastases Detection in Patients with Breast Cancer: Does Bone Scintigraphy Add Information to PET/CT?
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2023 |
The Role of Axillary SUV
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2023 |
FAPI-Negative FDG-Avid Metastatic Relapse of Breast Cancer on PET/CT.
Topics: Aged; Breast Neoplasms; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Prospective validation of 18F-Fluoroethylcholine as a tracer in PET/MRI for the evaluation of breast lesions and prediction of lymph node status.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Initial Evaluation of [
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Stomach Neoplasms | 2023 |
68 Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity : A Head-to-Head Comparative Study.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Infant; Positron Emission Tomography Computed Tomography; Prospective Studies | 2023 |
FDG Localization in Acellular Dermal Matrix, a Potential Cause of Nonpernicious Uptake Following Breast Reconstruction Surgery.
Topics: Acellular Dermis; Breast Implantation; Breast Implants; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Mammaplasty; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Value of subspecialist second opinion reads of 18 F-FDG PET-CT examinations for patients with breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Referral and Consultation; Retrospective Studies | 2023 |
Assessment of androgen receptor expression in breast cancer patients using 18 F-FDG PET/CT radiomics and clinicopathological characteristics.
Topics: Androgens; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Machine Learning; Positron Emission Tomography Computed Tomography; Receptors, Androgen; Retrospective Studies | 2023 |
Gastric and Bone Metastases Arising from Invasive Lobular Carcinoma With Ductal Carcinoma Occurring in one Breast Synchronously.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Stomach | 2023 |
68 Ga-DOTA-FAPI-04 Imaging of Bilateral Phyllodes Tumor.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Phyllodes Tumor; Positron Emission Tomography Computed Tomography | 2023 |
Predictive value of radiomic signature based on 2-[
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Bone Lipogranuloma Mimicking Metastatic Disease on 18F-FDG PET/CT.
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography | 2023 |
Uterine Metastasis Presenting as Abnormal Uterine Bleeding in a Case of Primary Breast Cancer Identified on
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Uterine Hemorrhage | 2023 |
Prediction of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer by using a deep learning model with 18F-FDG PET/CT.
Topics: Breast Neoplasms; Deep Learning; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Reply to: HER2-Low Breast Cancer Can Be Visualized by HER2 PET.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptor, ErbB-2 | 2023 |
HER2-Low Breast Cancer Can Be Visualized by HER2 PET.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptor, ErbB-2 | 2023 |
Pretreatment
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Retrospective Studies; Trastuzumab; Treatment Outcome | 2023 |
Changes in myocardial blood flow in a canine model of left sided breast cancer radiotherapy.
Topics: Animals; Breast Neoplasms; Coronary Circulation; Dogs; Female; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Perfusion Imaging; Positron-Emission Tomography; Unilateral Breast Neoplasms | 2023 |
Topics: Biomarkers; Breast Neoplasms; Cyclins; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Small Bowel Metastases From Malignant Phyllodes Breast Tumor Detected by 18 F-FDG PET/CT.
Topics: Breast Neoplasms; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Phyllodes Tumor; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Lytic Bony Lesions On 18 F-FDG PET-CT Versus 99m Tc MDP Bone Scan.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
The predictive value, sensitivity, specificity, and accuracy of PET CT in the evaluation of axillary metastases in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
18F-fluorodeoxyglucose PET/computed tomography in locoregional staging and assessment of biological and clinical aggressiveness of breast cancer subtypes.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2019 |
The ability of pre-treatment F-18 FDG PET/CT metabolic parameters for predicting axillary lymph node and distant metastasis and overall survival.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Survival Analysis | 2019 |
In-transit sentinel lymph nodes predicted by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Sentinel Lymph Node Biopsy | 2019 |
Topics: Animals; Apoptosis; Arginine; Breast Neoplasms; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Neuropeptide Y; Tissue Distribution; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Lactic Acid; MCF-7 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Signal Transduction | 2019 |
Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design.
Topics: Adult; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Randomized Controlled Trials as Topic | 2020 |
Correlation analysis of 18F-FDG PET/CT for the staging and treatment effect assessment of breast cancer.
Topics: Adult; Axilla; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymph Nodes; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Tumor Suppressor Protein p53 | 2019 |
Semi-automatic segmentation from intrinsically-registered 18F-FDG-PET/MRI for treatment response assessment in a breast cancer cohort: comparison to manual DCE-MRI.
Topics: Adult; Aged; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Normal Distribution; Pattern Recognition, Automated; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results | 2020 |
Myoepithelial hyperplasia: A rare mimic of breast cancer on
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
PET-CT for Evaluating Breast Cancer Yields Incidental Finding in the Lung.
Topics: Aged; Biopsy; Breast Neoplasms; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Lymphatic Metastasis; Mammography; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Patient Repositioning Reveals a Malignant Pleura Effusion Initially Mistaken as a Bone Metastasis on 18FDG PET/CT.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Patient Positioning; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography | 2019 |
Giant primary breast Burkitt's lymphoma demonstrated on FDG PET/CT.
Topics: Breast Neoplasms; Burkitt Lymphoma; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Physiologic intestinal
Topics: Adult; Aged; Breast Neoplasms; Cohort Studies; Cytokines; Female; Fluorodeoxyglucose F18; Gastrointestinal Microbiome; Humans; Middle Aged; Radiopharmaceuticals | 2019 |
Effect of Arrabidaea chica extract against chemically induced breast cancer in animal model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Bignoniaceae; Breast Neoplasms; Carcinogens; Carcinoma; Catalase; Female; Fluorodeoxyglucose F18; Glutathione Peroxidase; Neoplasms, Experimental; Optical Imaging; Oxidative Stress; Plant Extracts; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Wistar; Reproducibility of Results; Superoxide Dismutase; Time Factors; Treatment Outcome; Vincristine | 2019 |
FDG PET/CT of a Supraclavicular Silicone Granuloma at Follow-up of a Breast Carcinoma.
Topics: Adult; Aged; Biopsy, Fine-Needle; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Silicones | 2020 |
18F-FDG PET/CT Findings in a Patient With Primary Mucinous Cystadenocarcinoma of the Breast.
Topics: Breast Neoplasms; Cystadenocarcinoma, Mucinous; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
The association of 18F-fluorodeoxyglucose PET/computed tomography parameters with tissue gastrin-releasing peptide receptor and integrin αvβ3 receptor levels in patients with breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Receptors, Bombesin | 2020 |
Response to Letter to the Editor: "18FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or Higher".
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Correlation between
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphocytes, Tumor-Infiltrating; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Retrospective Studies | 2020 |
SUV
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Heterografts; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms | 2020 |
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Retrospective Studies; Treatment Outcome; Tumor Burden | 2020 |
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Models, Statistical; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2020 |
Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
The early prediction of pathological response to neoadjuvant chemotherapy and prognosis: comparison of PET Response Criteria in Solid Tumors and European Organization for Research and Treatment of Cancer criteria in breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors | 2020 |
Convolutional Neural Network Detection of Axillary Lymph Node Metastasis Using Standard Clinical Breast MRI.
Topics: Anatomic Landmarks; Axilla; Breast Neoplasms; Datasets as Topic; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Imaging; Neural Networks, Computer; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sentinel Lymph Node | 2020 |
A prospective comparative study of ultrasonography, contrast-enhanced MRI and 18F-FDG PET/CT for preoperative detection of axillary lymph node metastasis in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2020 |
FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer.
Topics: B7-H1 Antigen; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphocytes, Tumor-Infiltrating; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2020 |
The Predictive Value of Early Changes in
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Fulvestrant; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptors, Estrogen | 2020 |
The concomitance of lymphoma and breast carcinoma in the bone.
Topics: Biomarkers, Tumor; Biopsy; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography | 2020 |
Post Contusion Breast Hematoma Mimicking Malignancy on FDG PET/CT.
Topics: Adult; Breast Neoplasms; Contusions; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hematoma; Humans; Mammography; Positron Emission Tomography Computed Tomography; Ultrasonography, Mammary | 2020 |
Asymptomatic COVID-19 positive patient suspected on FDG-PET/CT.
Topics: Aged; Betacoronavirus; Breast Neoplasms; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Fluorodeoxyglucose F18; Humans; Lung; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; SARS-CoV-2 | 2020 |
FDG PET/CT in a Pregnant Woman With Breast Cancer.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Pregnancy; Pregnancy Complications; Time Factors | 2020 |
FDG-PET/CT unilateral breast enlargement and diffuse hypermetabolism related to unilateral lactation in a patient with primary biliary cirrhosis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lactation; Liver Cirrhosis, Biliary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Tumor-infiltrating Lymphocyte Score Based on FDG PET/CT for Predicting the Effect of Neoadjuvant Chemotherapy in Breast Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphocytes, Tumor-Infiltrating; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve; Treatment Outcome; Tumor Microenvironment; Young Adult | 2020 |
Classification of Abnormal Findings on Ring-type Dedicated Breast PET for the Detection of Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Ultrasonography | 2020 |
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Mucin-1; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Topics: Adult; Animals; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Onchocerca volvulus; Onchocerciasis; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2020 |
Combination of baseline total metabolic tumor volume measured on FDG-PET/CT and β2-microglobulin have a robust predictive value in patients with primary breast lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta 2-Microglobulin; Breast Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tumor Burden; Young Adult | 2020 |
Quantitative Comparison of Prone and Supine PERCIST Measurements in Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2020 |
Comparison of serum NEDD-9, CA 15-3, and CEA levels and PET metabolic parameters in breast cancer patients with 18 F-FDG PET / CT.
Topics: Breast Neoplasms; Carcinoembryonic Antigen; Fluorodeoxyglucose F18; Humans; Microtubule-Associated Proteins; Mucin-1; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Fluorodeoxyglucose positron emission tomography/computed tomography findings after percutaneous cryoablation of early breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cryosurgery; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Complications; Radiopharmaceuticals | 2020 |
Pulmonary Adenocarcinoma Metastasis to the Breast Unexpectedly Discovered on Re-staging
Topics: Adenocarcinoma of Lung; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mammography; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2021 |
Assessment of Bone Lesions with
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Technetium | 2021 |
Clinical Utility of 18F-FDG PET/CT in Staging Localized Breast Cancer Before Initiating Preoperative Systemic Therapy.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Medicare; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; United States | 2020 |
68Ga-FAPI Outperforms 18F-FDG PET/CT in Identifying Bone Metastasis and Peritoneal Carcinomatosis in a Patient With Metastatic Breast Cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2020 |
FDG-PET/CT in high-risk primary breast cancer-a prospective study of stage migration and clinical impact.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Metabolic changes in breast cancer on dual-time-point
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2020 |
Pituitary Metastases Discovered by 18F-FDG PET/CT During Other Cancers Monitoring: Are There Any Differences of SUVs Between Benign and Malignant Diseases?
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
The frequency and malignancy rate of incidental focal breast lesions identified by 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Alternative volumetric PET pjmirometers for evaluation of breast cancer cases with 18F-FDG PET/CT imaging: Metabolic tumour volume and total lesion glycolysis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2021 |
The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2020 |
Breast implant associated anaplastic large cell lymphoma (BIA-ALCL): a challenging cytological diagnosis with hybrid PET/MRI staging and follow-up.
Topics: Breast Implants; Breast Neoplasms; Cytodiagnosis; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Mammaplasty; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Ultrasonography, Mammary | 2021 |
Use of 18F-FDG PET/CT as an Initial Staging Procedure for Stage II-III Breast Cancer: A Multicenter Value Analysis.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Medicare; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; United States | 2020 |
A Comparison of the Diagnostic Value of Positron Emission Tomography/Computed Tomography and Ultrasound for the Detection of Metastatic Axillary Nodal Disease in Treatment-Naive Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Utility of
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate | 2020 |
Case Report of 18F-FDG PET/CT Features of Polyacrylamide Hydrogel Mammoplasty.
Topics: Acrylic Resins; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma; Mammaplasty; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence | 2021 |
Bilateral Silicone Granulomas Mimicking Breast Cancer Recurrence on 18F-FDG PET/CT.
Topics: Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Silicones | 2021 |
The role of basal 18F-FDG PET/CT maximum standard uptake value and maximum standard uptake change in predicting pathological response in breast cancer patients receiving neoadjuvant chemotherapy.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; ROC Curve | 2021 |
Paraneoplastic Multicentric Reticulohistiocytosis on 18F-FDG PET/CT Breast Carcinoma Follow-up.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Histiocytosis, Non-Langerhans-Cell; Humans; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Case 285: Primary Breast Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast; Breast Neoplasms; Cyclophosphamide; Diagnostic Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Treatment Outcome; Ultrasonography, Mammary; Vincristine | 2021 |
Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast Cancer.
Topics: Adult; Aged; Biological Transport; Biomarkers, Tumor; Breast Neoplasms; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Prospective Studies | 2021 |
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Machine Learning; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
[Disseminated Bone Marrow Carcinomatosis from Breast Cancer Improved by Capecitabine-A Clinical Case Report].
Topics: Bone Marrow; Breast Neoplasms; Capecitabine; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Retrobulbar metastasis of breast primary- Once in a blue moon lesion.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2020 |
Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Correlation between semiquantitative and volumetric 18F-FDG PET/computed tomography parameters and Ki-67 expression in breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Real-time ultrasound virtual navigation in 3D PET/CT volumes for superficial lymph-node evaluation: innovative fusion examination.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Computer Systems; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Ultrasonography | 2021 |
Paraneoplastic cerebellar degeneration: Initial presentation of occult breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Paraneoplastic Cerebellar Degeneration | 2021 |
Correlation of Breast Cancer Subgroups and Axillary Metastases with 18F-FDG PET/CT and the Contribution of 18F-FDG PET/CT in the Management of the Axilla.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Turkey | 2021 |
Evaluation of Early Response to Preoperative Accelerated Partial Breast Irradiation (PAPBI) by Histopathology, Magnetic Resonance Imaging, and 18F-fluorodexoyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT).
Topics: Adult; Aged; Antigens, Viral; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Period | 2021 |
Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer.
Topics: Biomarkers; Breast Neoplasms; Cluster Analysis; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis | 2021 |
Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging; World Health Organization | 2021 |
Breast cancer preoperative
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies | 2021 |
Follicular Thyroid Carcinoma with Unusual Radioiodine-Refractory Breast Metastasis Mimicking Primary Breast Malignancy.
Topics: Adenocarcinoma, Follicular; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Thyroglobulin; Thyroid Neoplasms | 2021 |
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Treatment Outcome | 2021 |
Optimal relaxation parameters of dynamic row-action maximum likelihood algorithm and post-smoothing filter for image reconstruction of dedicated breast PET.
Topics: Algorithms; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography | 2021 |
Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer.
Topics: Biomarkers; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Spleen; Tumor Burden; Tumor Microenvironment | 2021 |
Unusual Presentation of Herpes Zoster Infection Mimicking Soft Tissue Metastases of Breast Cancer on 18F-FDG PET/CT Imaging.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Herpes Zoster; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2021 |
The Challenge of Staging Breast Cancer With PET/CT in the Era of COVID Vaccination.
Topics: Breast Neoplasms; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; SARS-CoV-2; Vaccination | 2021 |
Breast Metastasis of Primary Peritoneal Carcinoma Demonstrated on FDG PET/CT.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Design, synthesis, and evaluation of positron emission tomography/fluorescence dual imaging probes for targeting facilitated glucose transporter 1 (GLUT1).
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Fluorescent Dyes; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Mammary Neoplasms, Experimental; Mice; Molecular Structure; Optical Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
18F-FDG PET/CT features of ureteral metastases from breast cancer: a case report.
Topics: Breast Neoplasms; China; Female; Fluorodeoxyglucose F18; Humans; Mastectomy; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
Value of accurate diagnosis for metastatic supraclavicular lymph nodes in breast cancer: assessment with neck US, CT, and 18F-FDG PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2021 |
Relationship between Lymph Node Metastasis and a Low 18F-FDG PET/CT Axillary SUVmax Value in Breast Cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Turkey | 2021 |
Evidence-Based Best Practices: 18F-FDG PET Staging of Newly Diagnosed Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase Inhibitors.
Topics: Breast Neoplasms; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclins; Female; Fluorodeoxyglucose F18; Hormones; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Protein Kinase Inhibitors; Radiopharmaceuticals | 2021 |
Relationship of the standard uptake value of
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immune System; Lymphocytes, Tumor-Infiltrating; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Regression Analysis; Tumor Microenvironment; Young Adult | 2021 |
Pulmonary sarcoidosis masquerading as metastatic breast cancer: a case report.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Middle Aged; Positron-Emission Tomography; Sarcoidosis, Pulmonary | 2021 |
Both [
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Relapsed Breast Implant-Associated Anaplastic Large-Cell Lymphoma Presenting as Refractory Fluid Collections With Low Uptake on FDG PET/CT Scan.
Topics: Breast Implants; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large-Cell, Anaplastic; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptors, Estrogen | 2021 |
The Role of FDG PET/CT to Evaluation of Axillary Lymph Nodes after Neoadjuvant Chemotherapy in Breast Cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
FDG-Avid Sclerosing Adenosis of the Breast Mimicking Malignancy.
Topics: Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
AI-enhanced simultaneous multiparametric
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Retrospective Studies; Support Vector Machine | 2022 |
Prospective comparison of early interim
Topics: Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; ROC Curve; Treatment Outcome | 2021 |
GlucoCEST MRI for the Evaluation Response to Chemotherapeutic and Metabolic Treatments in a Murine Triple-Negative Breast Cancer: A Comparison with[
Topics: Animals; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mice; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms | 2022 |
FDG uptake in axillary lymph nodes after COVID-19 vaccination - a pitfall in a case of highly suspicious lymph node metastases of malignant melanoma.
Topics: Axilla; Breast Neoplasms; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; SARS-CoV-2; Vaccination | 2021 |
Letter to the Editor: PET/CT in Locally Advanced Breast Cancer: Time for a Guideline Change?
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Topics: Adult; Aged; Aged, 80 and over; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Mastectomy; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Treatment Outcome | 2021 |
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Treatment Outcome | 2017 |
Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Period; Preoperative Period | 2017 |
18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Tumor Burden | 2017 |
Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Reference Standards; Reference Values; Reverse Transcriptase Polymerase Chain Reaction | 2017 |
The value of pre- and post-neoadjuvant chemotherapy F-18 FDG PET/CT scans in breast cancer: comparison with MRI.
Topics: Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2018 |
Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Contrast Media; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome | 2017 |
Multiparametric Evaluation of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer Using Integrated PET/MR.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; ROC Curve; Treatment Outcome | 2017 |
Strong association of epidermal growth factor receptor status with breast cancer FDG uptake.
Topics: Biological Transport; Biomarkers, Tumor; Breast Neoplasms; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2017 |
Prognostic Value of Percentage Change in Metabolic Parameters as Measured by Dual-Time Point
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Premenopause; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2017 |
Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Postoperative Care; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Unnecessary Procedures; Young Adult | 2017 |
Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
Topics: Adult; Aged; Breast Neoplasms; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Treatment Outcome | 2017 |
Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2017 |
Correlation of 18F-FDG PET/CT with pathological features and survival in primary breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2017 |
FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Higher breast cancer conspicuity on dbPET compared to WB-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
Relationship between reticuloendothelial systems' FDG uptake level and clinicopathological features in patient with invasive ductal breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mononuclear Phagocyte System; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Hybrid
Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Reliability of
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging | 2017 |
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
[
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
The value of 18F-FDG PET/CT imaging in breast cancer staging.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Young Adult | 2018 |
Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Regression Analysis; Retrospective Studies | 2017 |
Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2017 |
Clinicopathological Features of Ductal Carcinoma
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Bone Marrow Metastasis Is an Early Stage of Bone Metastasis in Breast Cancer Detected Clinically by F18-FDG-PET/CT Imaging.
Topics: Adult; Aged; Bone Marrow Cells; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radionuclide Imaging | 2017 |
Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Geminin; Gene Expression; Humans; Immunohistochemistry; Ki-67 Antigen; Mitogen-Activated Protein Kinases; Positron-Emission Tomography; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Tumor Burden; Tumor Suppressor Protein p53 | 2017 |
Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer.
Topics: Biological Transport; Breast Neoplasms; Fluorodeoxyglucose F18; Glycolysis; Humans; Image Processing, Computer-Assisted; Positron Emission Tomography Computed Tomography; Retrospective Studies; Time Factors; Tumor Burden | 2017 |
Diagnostic Challenges of Postsurgical Breast Cancer Recurrence.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2017 |
Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2018 |
Texture analysis of high-resolution dedicated breast
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Signal-To-Noise Ratio | 2018 |
Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Ultrasonography | 2018 |
Role of
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Period; Predictive Value of Tests; Preoperative Period; Prognosis; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; ROC Curve; Triple Negative Breast Neoplasms | 2018 |
Diagnosis of active pericarditis by positron emission tomography (PET)/cardiac magnetic resonance (CMR) imaging.
Topics: Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Chest Pain; Edema, Cardiac; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Inflammation Mediators; Magnetic Resonance Imaging; Mastectomy; Pericarditis; Positron-Emission Tomography; Postoperative Complications | 2018 |
A Method for Manufacturing Oncological Phantoms for the Quantification of 18F-FDG PET and DW-MRI Studies.
Topics: Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Methods; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Presence of the minor allele of microRNA205 rs3842530 polymorphism increases 18FDG uptake in patients with breast cancer via targeting VEGF.
Topics: 3' Untranslated Regions; Alleles; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Contrast Media; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; MCF-7 Cells; MicroRNAs; Middle Aged; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Vascular Endothelial Growth Factor A | 2018 |
Clinical Values of Combined Diffused Optical Tomography and PET-CT in the Diagnosis of Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Optical | 2017 |
Prognostic value of FDG-PET and DWI in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies | 2018 |
Volume-based metabolic parameter of breast cancer on preoperative 18F-FDG PET/CT could predict axillary lymph node metastasis.
Topics: Adult; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2017 |
Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Whole Body Imaging; Young Adult | 2018 |
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Mastectomy, Segmental; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
FDG PET and FES PET Predict PFS on Endocrine Therapy-Letter.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Progression-Free Survival; Receptors, Estrogen | 2018 |
FDG PET and FES PET Predict PFS on Endocrine Therapy-Response.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Progression-Free Survival; Receptors, Estrogen | 2018 |
The role of PET and MRI in evaluating the feasibility of skin-sparing mastectomy following neoadjuvant therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Minimally Invasive Surgical Procedures; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Taxoids | 2018 |
SUV calculation in breast cancer: which normalization should be applied when using 18F-FDG PET?
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography | 2019 |
Rhabdomyosarcoma Revealed by a Breast Metastasis.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Rhabdomyosarcoma | 2018 |
Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Molecular Imaging; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Whole Body Imaging | 2018 |
Metaplastic Squamous Cell Carcinoma of Breast Demonstrated on 18F-FDG PET/CT.
Topics: Adult; Breast Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.
Topics: Adult; Axilla; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2018 |
A hierarchical prognostic model for risk stratification in patients with early breast cancer according to
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Models, Statistical; Multimodal Imaging; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models | 2018 |
18F-Fluoroestradiol PET/CT Correctly Diagnosed 18F-FDG-Avid Inflammatory Lymph Nodes in a Patient With Estrogen Receptor-Positive Breast Cancer.
Topics: Aged; Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Estrogen | 2018 |
Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Axilla; Axin Protein; Breast Neoplasms; Chemotherapy, Adjuvant; Drosophila Proteins; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Young Adult | 2018 |
Role of 18 FDG PET/CT in Breast Cancer.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET/CT and diffusion-weighted MR imaging.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2019 |
Mixed Epithelial and Stromal Tumor of the Kidney Mimicking Malignancy on 18F-FDG PET/CT in a Patient With Breast Cancer.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Neoplasms, Complex and Mixed; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2018 |
Topics: Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; Esophageal Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Ultrasonography, Mammary | 2018 |
Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography | 2018 |
Solitary Breast Metastasis From Rhabdomyosarcoma Shown on FDG PET/CT.
Topics: Adolescent; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar | 2018 |
Prospective Study of Serial
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals | 2018 |
Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in Japan.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Japan; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Response Evaluation Criteria in Solid Tumors | 2018 |
Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Whole Body Imaging | 2018 |
Colonic metastasis from breast carcinoma detection by CESM and PET/CT: A case report.
Topics: Aged; Asymptomatic Diseases; Breast; Breast Neoplasms; Carcinoma, Lobular; Colectomy; Colon; Colonic Neoplasms; Colonoscopy; Female; Fluorodeoxyglucose F18; Humans; Mammography; Mucin-1; Neoplasm Invasiveness; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Receptors, Cell Surface; Treatment Outcome | 2018 |
Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer.
Topics: Adult; Aged; Area Under Curve; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tumor Burden; Young Adult | 2018 |
Galactocele, Pitfall for the Evaluation by 18F-FDG PET/CT.
Topics: Adult; Breast Cyst; Breast Feeding; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Intratumoral heterogeneity in
Topics: Antineoplastic Agents; Area Under Curve; Breast Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Multivariate Analysis; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; ROC Curve; Whole Body Imaging | 2018 |
Hematopoietically Active Adrenal Myelolipoma Mimicking Breast Cancer Metastasis.
Topics: Adrenal Gland Neoplasms; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hematopoiesis; Humans; Myelolipoma; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2018 |
Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2018 |
Simultaneous breast cancer and DLBCL lymphoma - role of PET/CT examination with 18F-FDG and 18F-FES.
Topics: Aged; Breast Neoplasms; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography | 2018 |
FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Retrospective Studies | 2018 |
Case 256: Breast Implant-associated Anaplastic Large-Cell Lymphoma.
Topics: Biopsy; Breast; Breast Implants; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Semiquantification Limitations: FMTVDM
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Phenotype; Regional Blood Flow | 2018 |
Intracellular hypoxia measured by
Topics: Adult; Aged; Breast; Breast Neoplasms; Cell Hypoxia; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Misonidazole; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptors, Estrogen | 2018 |
Topics: Breast Implants; Breast Neoplasms; Fluorodeoxyglucose F18; Granuloma; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prosthesis Failure; Silicones | 2018 |
FDG/PET-CT-Based Lymph Node Atlas in Breast Cancer Patients.
Topics: Breast; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy | 2019 |
Reply: Semiquantification Limitations: FMTVDM
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Phenotype; Regional Blood Flow | 2018 |
Clinical value of delayed 18F-FDG PET/CT for predicting nipple-areolar complex involvement in breast cancer: A comparison with clinical symptoms and breast MRI.
Topics: Adult; Aged; Area Under Curve; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multivariate Analysis; Nipples; Odds Ratio; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve | 2018 |
Dual-time 18F-FDG PET/CT for the detection of liver metastases in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Time Factors; Whole Body Imaging | 2018 |
The feasibility of using 18F-FDG-PET/CT in patients with mucinous breast carcinoma.
Topics: Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mucous Membrane; Positron Emission Tomography Computed Tomography | 2018 |
68Ga-Prostate-Specific Membrane Antigen PET/CT and 18F-FDG PET/CT of Primary Signet Ring Cell Breast Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Signet Ring Cell; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Oligopeptides; Positron Emission Tomography Computed Tomography | 2018 |
2-fluoro-2-deoxy-D-glucose positron emission tomography versus conventional imaging for the diagnosis of breast cancer and lymph node metastases.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Ultrasonography | 2018 |
What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
Topics: Adult; Aged; Axilla; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Everolimus-induced pulmonary toxicity: Findings on 18F-FDG PET/CT imaging.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Breast Neoplasms; Everolimus; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Diseases, Interstitial; Middle Aged; Positron Emission Tomography Computed Tomography; TOR Serine-Threonine Kinases; Tumor Burden | 2018 |
The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast; Breast Neoplasms; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Whole Body Imaging | 2018 |
Primary and Secondary Breast Angiosarcoma: FDG PET/CT Series.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: Combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture Parameters.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Models, Statistical; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Analysis | 2019 |
Quantitative assessment of metabolic tumor burden in molecular subtypes of primary breast cancer with FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Tumor Burden | 2018 |
Correlation of tumor uptake on breast-specific gamma imaging and fluorodeoxyglucose PET/CT with molecular subtypes of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2018 |
Synchronous Metastatic Breast Carcinoma and Parathyroid Adenoma on 18F-FDG PET/CT and 99mTc-Sestamibi Imaging.
Topics: Adenoma; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2019 |
Lactic Acid Accumulation in the Tumor Microenvironment Suppresses
Topics: Animals; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Heterografts; Humans; Lactic Acid; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Radiopharmaceuticals; Tumor Microenvironment | 2019 |
Paraneoplastic syndrome - a rare but treatable cause of non-thyroid-related extraocular muscle enlargement.
Topics: Aged; Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Diplopia; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hypertrophy; Letrozole; Magnetic Resonance Imaging; Ocular Motility Disorders; Oculomotor Muscles; Paraneoplastic Syndromes; Piperazines; Positron-Emission Tomography; Prednisone; Pyridines | 2019 |
Species-dependent extracranial manifestations of a brain seeking breast cancer cell line.
Topics: Animals; Brain; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mice; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rats; Rats, Nude | 2018 |
The Prognostic Value of 18F-FDG Uptake in the Supraclavicular Lymph Node (N3c) on PET/CT in Patients With Locally Advanced Breast Cancer With Clinical N3c.
Topics: Biological Transport; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
[
Topics: Animals; Breast Neoplasms; Cardiovascular Diseases; Dogs; Female; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiation Dosage; Radiation Injuries; Radiopharmaceuticals; Radiotherapy | 2019 |
In Reply to Byun et al.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2019 |
Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunohistochemistry; Lymphatic Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Bombesin; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2019 |
Prediction of biological characteristics of breast cancer using dual-phase FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2019 |
18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Injections, Subcutaneous; Liver Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, X-Ray Computed; Tumor Burden | 2019 |
Practical Methods for Estimating Metabolic Flux (Ki) to Assess Response to Therapy via Static PET Scans.
Topics: Breast Neoplasms; Fluorides; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2019 |
Is FDG maximum standardized uptake value of primary breast cancer a prognostic factor for locoregional axillary lymph node metastasis?
Topics: Adult; Aged; Axilla; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment | 2019 |
Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Breast Neoplasms; Cardiotoxicity; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Regression Analysis; ROC Curve; Sensitivity and Specificity; Trastuzumab; Ventricular Dysfunction, Right | 2020 |
AKT-dependent sugar addiction by benzyl isothiocyanate in breast cancer cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Synergism; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Heterocyclic Compounds, 3-Ring; Humans; Isothiocyanates; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays | 2019 |
Image Guided Evolution of Nodal Contouring Guidelines in Breast Cancer.
Topics: Breast; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography | 2019 |
In Regard to Borm et al.
Topics: Breast; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography | 2019 |
Prognostic significance of high metabolic activity in breast cancer: PET signature in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Glycolysis; Humans; Positron-Emission Tomography; Prognosis | 2019 |
Comparison of different motion correction techniques for dynamic FDG-PET/CT studies in breast cancer patients.
Topics: Adult; Aged; Algorithms; Artifacts; Blood Glucose; Body Weight; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results | 2020 |
Alveolar soft part sarcoma metastatic to the breast: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cheek; Child; Facial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mastectomy, Segmental; Positron-Emission Tomography; Sarcoma, Alveolar Soft Part; Skull Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2019 |
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paraneoplastic Syndromes; Positron Emission Tomography Computed Tomography; Sarcoidosis; Whole Body Imaging | 2019 |
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.
Topics: Aged; Breast Neoplasms; Calibration; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Odds Ratio; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Regression Analysis; Treatment Outcome | 2019 |
Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis | 2019 |
Combination of breast imaging parameters obtained from
Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms | 2019 |
Multiplexed Single-Cell Measurements of FDG Uptake and Lactate Release Using Droplet Microfluidics.
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lactic Acid; Microfluidics; Positron-Emission Tomography; Radiopharmaceuticals; Single-Cell Analysis; Tumor Cells, Cultured | 2019 |
Thyroid metastasis from breast cancer detected by 18F-FDG PET/CT.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2019 |
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2019 |
Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Combined Modality Therapy; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Netherlands; Palliative Care; Positron Emission Tomography Computed Tomography; Radionuclide Imaging | 2019 |
A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients.
Topics: Adult; Aged; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2019 |
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vulvar Neoplasms | 2019 |
Aberrant Hypermetabolism of Benign Uterine Leiomyoma on 18F-FDG PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Neoplasms; Uterus | 2019 |
Automatic segmentation and classification of breast lesions through identification of informative multiparametric PET/MRI features.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Machine Learning; Middle Aged; Multimodal Imaging; Multiparametric Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2019 |
Lymphadenopathy by tuberculosis seemed like metastasis on FDG PET/CT in patients with breast carcinoma.
Topics: Adult; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymphadenopathy; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Segmental; Middle Aged; Paget's Disease, Mammary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tuberculosis; Tuberculosis, Lymph Node | 2019 |
Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Whole Body Imaging | 2019 |
Which of the fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography parameters are better associated with prognostic factors in breast cancer?
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2019 |
18F-FDG Whole-body PET/MRI of a 30-Week Pregnant Woman With Breast Cancer Revealed Interesting Fetal Findings.
Topics: Adult; Breast Neoplasms; Female; Fetus; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Pregnancy; Whole Body Imaging | 2019 |
The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphocytes, Tumor-Infiltrating; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Microenvironment | 2019 |
A Comparison of Angiogenesis and Glycolytic Imaging in Patients With Clinical Suspected Locally Advanced Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography | 2019 |
The effect of sex hormones on normal breast tissue metabolism: Evaluation by FDG PET/CT.
Topics: Adult; Breast; Breast Neoplasms; Estradiol; Female; Fluorodeoxyglucose F18; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Middle Aged; Positron Emission Tomography Computed Tomography; Progesterone; Radiopharmaceuticals; Reference Values; Retrospective Studies; Testosterone | 2019 |
Fully automated analysis for bone scintigraphy with artificial neural network: usefulness of bone scan index (BSI) in breast cancer.
Topics: Automation; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Retrospective Studies; Whole Body Imaging | 2019 |
Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Medical Overuse; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen | 2019 |
Prognostic Significance of Metabolic Parameters and Textural Features on
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis | 2019 |
Metabolic and volume-based parameters of (18F)FDG PET/CT for primary mass and axillary lymph node metastasis in patients with invasive ductal carcinoma: a retrospective analysis in relation to molecular subtype, axillary lymph node metastasis and immunohi
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2019 |
A false positive fluorodeoxyglucose lymphadenopathy in a patient with pulmonary carcinoid tumor and previous breast reconstruction after bilateral mastectomy.
Topics: Biopsy; Breast Neoplasms; Carcinoid Tumor; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Lymphatic Diseases; Mammaplasty; Mastectomy; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Silicone Gels; Tomography, X-Ray Computed | 2014 |
Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Axilla; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; ROC Curve; Trastuzumab | 2013 |
First clinical experience with a dedicated PET for hanging breast molecular imaging.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Molecular Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Tomography, X-Ray Computed | 2013 |
The clinical value of tumor FDG uptake for predicting axillary lymph node metastasis in breast cancer with clinically negative axillary lymph nodes.
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Radionuclide Imaging; Retrospective Studies | 2013 |
Role of 18F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
The role of the breast radiologist in evaluation of breast incidentalomas detected on 18-fludeoxyglucose positron emission tomography/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Laryngeal Neoplasms; Lung Neoplasms; Mammography; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Thyroid Neoplasms; Ultrasonography, Mammary | 2013 |
A pulmonary metastasis of a cystosarcoma phyllodes of the breast detected by 18F-FDG PET/CT.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Phyllodes Tumor; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
(18)F-FDG PET/CT-positive internal mammary lymph nodes: pathologic correlation by ultrasound-guided fine-needle aspiration and assessment of associated risk factors.
Topics: Breast Neoplasms; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed; Washington | 2013 |
The relationship between 18F-FDG metabolic volumetric parameters and clinicopathological factors of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Tumor Burden | 2013 |
Genotyping analysis and ¹⁸FDG uptake in breast cancer patients: a preliminary research.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genotype; Humans; Multimodal Imaging; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2013 |
Diffuse FDG uptake due to fat necrosis following transverse rectus abdominus myocutaneous (TRAM) flap reconstruction.
Topics: Biological Transport; Breast Neoplasms; Carcinoma, Ductal, Breast; Fat Necrosis; Female; Fluorodeoxyglucose F18; Humans; Mammaplasty; Middle Aged; Postoperative Complications; Radiography; Radionuclide Imaging; Rectus Abdominis | 2013 |
Breast implant foreign body reaction mimicking breast cancer recurrence on FDG PET/CT.
Topics: Breast Implants; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Foreign-Body Reaction; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Radiography; Radionuclide Imaging | 2013 |
The vanadyl chelate bis(acetylacetonato)oxovanadium(IV) increases the fractional uptake of 2-(fluorine-18)-2-deoxy-D-glucose by cultured human breast carcinoma cells.
Topics: Animals; Breast Neoplasms; Chelating Agents; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, SCID; Organometallic Compounds; Positron-Emission Tomography; Tumor Cells, Cultured | 2013 |
Synchronous quadruple primary tumors of thyroid, breast, pancreas, and stomach: a case report.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
A new method for apparent diffusion coefficient measurement using sequential (18)F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast.
Topics: Adult; Biological Transport; Breast Neoplasms; Carcinoma, Ductal, Breast; Diffusion; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Observer Variation; Positron-Emission Tomography; Time Factors; Young Adult | 2013 |
Hypoxia stimulates 18F-fluorodeoxyglucose uptake in breast cancer cells via hypoxia inducible factor-1 and AMP-activated protein kinase.
Topics: AMP-Activated Protein Kinases; Biological Transport; Breast Neoplasms; Cell Hypoxia; Doxorubicin; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia-Inducible Factor 1; MCF-7 Cells | 2013 |
18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Sodium Fluoride; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Triple-negative and non-triple-negative invasive breast cancer: association between MR and fluorine 18 fluorodeoxyglucose PET imaging.
Topics: Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Iohexol; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Antitumor effect of 89Sr for multiple bone metastases of breast cancer: diagnosis by 18F-FDG PET/CT.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Strontium Radioisotopes; Tomography, X-Ray Computed | 2014 |
Unsuspected uterine metastasis of breast carcinoma diagnosed by 18F-FDG PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Neoplasms | 2013 |
Toward a planning scheme for emission guided radiation therapy (EGRT): FDG based tumor tracking in a metastatic breast cancer patient.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Neoplasm Metastasis; Organs at Risk; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2013 |
Sequential (18)F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triple Negative Breast Neoplasms | 2014 |
HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Breast Neoplasms; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Survival Rate; Taxoids; Trastuzumab; Treatment Outcome | 2013 |
Pre-chemotherapy 18F-FDG PET/CT upstages nodal stage in stage II-III breast cancer patients treated with neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2013 |
Reply to "¹⁸F-2-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography in predicting pathologic complete response after neoadjuvant chemotherapy: the early metabolic response is the answer".
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2013 |
Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study.
Topics: Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Risk Factors; ROC Curve; Tomography, X-Ray Computed | 2013 |
[The compared study in detecting the recurrence and metastases of breast cancer patients post treatment between (18)F-FDG PET/CT and conventional workup].
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
18F-FDG-PET/CT in predicting pathologic complete response after neoadjuvant chemotherapy: the early metabolic response is the answer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Axilla; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Risk Assessment; ROC Curve; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms; Tumor Burden | 2013 |
18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2; Tomography, X-Ray Computed | 2013 |
Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Solitary breast metastasis from recurrent gallbladder carcinoma simulating a second primary on 18F-FDG PET/CT.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Retrospective Studies; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms; Young Adult | 2014 |
18F-FDG PET-CT imaging in the neoadjuvant setting for stages II-III breast cancer: association of loco‑regional SUVmax with classical prognostic factors.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Ki-67 Antigen; Middle Aged; Models, Statistical; Neoadjuvant Therapy; Neoplasm Staging; Phenobarbital; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Discussion on the alteration of 18F-FDG uptake by the breast according to the menstrual cycle in PET imaging.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammary Glands, Human; Menstrual Cycle; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2013 |
Lymph node to primary tumor SUV ratio by 18F-FDG PET/CT and the prediction of axillary lymph node metastases in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2014 |
Port-site metastasis after laparoscopic removal of an isolated adrenal metastasis in a patient with breast cancer detected with FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Multicenter trials using ¹⁸F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs.
Topics: Antineoplastic Agents; Bias; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Multicenter Studies as Topic; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Research Design; Sample Size; Treatment Outcome | 2013 |
Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Cell Proliferation; Female; Fluorodeoxyglucose F18; Glucose; Hemoglobins; Humans; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Optical Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2013 |
¹⁸F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Detection of internal mammary lymph node metastasis with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation.
Topics: Aged; Anti-Bacterial Agents; Biopsy; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Osteomyelitis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Can positron emission tomography/computed tomography with the dual tracers fluorine-18 fluoroestradiol and fluorodeoxyglucose predict neoadjuvant chemotherapy response of breast cancer?--A pilot study.
Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Estradiol; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Value of F-18 FDG PET/CT in detection and prognostication of isolated extra-axillary lymph node recurrences in postoperative breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2014 |
Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Treatment Outcome | 2014 |
Recurrent breast cancer in the subpectoral space after implant reconstruction.
Topics: Adult; Breast Implantation; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mastectomy, Modified Radical; Neoplasm Recurrence, Local; Pectoralis Muscles; Positron-Emission Tomography; Radiopharmaceuticals; Reoperation; Surgical Flaps; Tomography, X-Ray Computed | 2014 |
The effect of aromatase inhibition on the cognitive function of older patients with breast cancer.
Topics: Aged; Aged, 80 and over; Aromatase; Aromatase Inhibitors; Brain Mapping; Breast Neoplasms; Case-Control Studies; Cognition; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Staging; Neuropsychological Tests; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2014 |
Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Metabolic Clearance Rate; Middle Aged; Molecular Imaging; Multimodal Imaging; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Obtaining quantitative global tumoral state indicators based on whole-body PET/CT scans: a breast cancer case study.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging | 2014 |
FDG avidity at PET/CT during adjuvant hormonal therapy in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Hormones; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2013 |
Early predictive value of non-response to docetaxel in neoadjuvant chemotherapy in breast cancer using 18F-FDG-PET.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Taxoids | 2014 |
[Differential diagnosis of local tumor recurrence or radionecrosis after stereotactic radiosurgery for treatment of brain metastasis].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiosurgery | 2014 |
Pathology-confirmed granuloma mimicking liver metastasis of breast cancer.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Tomography, X-Ray Computed | 2014 |
Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphoscintigraphy; Middle Aged; Neoplasm Staging; Organotechnetium Compounds; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Young Adult | 2014 |
[Early prediction of successful neoadjuvant chemotherapy response].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging | 2013 |
Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
Topics: Animals; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Hexokinase; Humans; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 | 2014 |
Early changes in [18F]FDG incorporation by breast cancer cells treated with trastuzumab in normoxic conditions: role of the Akt-pathway, glucose transport and HIF-1α.
Topics: Antibodies, Monoclonal, Humanized; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Chromones; Down-Regulation; Drug Interactions; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MAP Kinase Signaling System; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Trastuzumab | 2014 |
Erdheim-Chester disease with an 18F-fluorodeoxyglucose-avid breast mass and BRAF V600E mutation.
Topics: Biopsy; Breast Neoplasms; Diagnosis, Differential; Erdheim-Chester Disease; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Staging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?
Topics: Algorithms; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Limit of Detection; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
A pilot study of FDG PET/CT detects a link between brown adipose tissue and breast cancer.
Topics: Adipose Tissue, Brown; Aged; Aged, 80 and over; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pilot Projects; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
HER2-positive breast cancer: ¹⁸F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy.
Topics: Adult; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Bridged-Ring Compounds; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Genes, erbB-2; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Taxoids; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome | 2014 |
Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.
Topics: Adult; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Coordination Complexes; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2014 |
Diagnostic and prognostic value of pretreatment SUV in 18F-FDG/PET in breast cancer: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
Topics: Adult; Aged; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Additional value of F-18 FDG PET/CT for initial staging in breast cancer with clinically negative axillary nodes.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Radiopharmaceuticals | 2014 |
Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Autophagy; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Microtubule-Associated Proteins; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Trastuzumab | 2014 |
Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Immunohistochemistry; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms | 2014 |
Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Breast Neoplasms; Cluster Analysis; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Models, Statistical; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Regression Analysis; ROC Curve; Tomography, X-Ray Computed | 2014 |
Metabolic impact of partial volume correction of [18F]FDG PET-CT oncological studies on the assessment of tumor response to treatment.
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Phantoms, Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Reproducibility of Results; Tomography, X-Ray Computed | 2014 |
Benign schwannoma in supraclavicular region: a false-positive lymph node recurrence of breast cancer suspected by PET scan.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neurilemmoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Longitudinal, intermodality registration of quantitative breast PET and MRI data acquired before and during neoadjuvant chemotherapy: preliminary results.
Topics: Adult; Algorithms; Breast; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Treatment Outcome; Tumor Burden | 2014 |
Nuclear imaging and early breast cancer detection.
Topics: Breast Neoplasms; Drug Resistance, Neoplasm; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Molecular Imaging; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Distant subcutaneous recurrence of a parathyroid carcinoma: abnormal uptakes in the (99m)Tc-sestamibi scan and (18)F-FDG PET/CT imaging.
Topics: Biomarkers; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Parathyroid Hormone; Parathyroid Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Role of [18F]fluorodeoxyglucose positron emission tomography-computed tomography, sonography, and sonographically guided fine-needle aspiration biopsy in the diagnosis of axillary lymph nodes in patients with breast cancer: comparison of diagnostic perfor
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Endoscopic Ultrasound-Guided Fine Needle Aspiration; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2014 |
Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary; Young Adult | 2016 |
Clinical practice guideline for dedicated breast PET.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Insurance; Japan; Occupational Exposure; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Risk; Whole Body Imaging | 2014 |
Optical imaging for monitoring tumor oxygenation response after initiation of single-agent bevacizumab followed by cytotoxic chemotherapy in breast cancer patients.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Breast Neoplasms; Cytotoxins; Female; Fluorodeoxyglucose F18; Hemodynamics; Hemoglobins; Humans; Middle Aged; Multimodal Imaging; Optical Imaging; Oxygen; Treatment Outcome | 2014 |
The combination of FDG PET and dynamic contrast-enhanced MRI improves the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy.
Topics: Adult; Aged; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Can 18F-FDG PET improve the evaluation of suspicious breast lesions on MRI?
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Invasive cribriform carcinoma of the breast: mammographic, sonographic, MRI, and 18 F-FDG PET-CT features.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2015 |
Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Sternal intraosseous schwannoma mimicking breast cancer metastasis.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neurilemmoma; Positron-Emission Tomography; Radiopharmaceuticals; Sternum; Tomography, X-Ray Computed | 2014 |
FDG PET/CT reveals the primary tumor in a patient with occult breast carcinoma undetected by other modalities.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Lobular breast carcinoma: a case of rare possible 18F-FDG PET/CT and bone scan false negative.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Carcinoma, Lobular; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2015 |
Evaluation of bone metastases from breast cancer by bone scintigraphy and positron emission tomography/computed tomography imaging.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2014 |
Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
Topics: Aged; Aged, 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Breast Neoplasms; Cross-Sectional Studies; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Male; Mandible; Mandibular Diseases; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiography, Bitewing; Radiography, Panoramic; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tooth Extraction; Zoledronic Acid | 2014 |
Journal Club: Diagnostic value of (18)F-FDG PET/CT and MRI in predicting the clinicopathologic subtypes of invasive breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Value of 18F-FDG PET/CT for early prediction of pathologic response (by residual cancer burden criteria) of locally advanced breast cancer to neoadjuvant chemotherapy.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
The role of interim 18F-FDG PET/CT in predicting early response to neoadjuvant chemotherapy in breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
The Japanese Breast Cancer Society Clinical Practice Guideline for screening and imaging diagnosis of breast cancer.
Topics: Breast Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Physical Examination; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2015 |
CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curve.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |
Glycolytic activity with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
18F-FDG PET/CT in a case of parasite infection mimicking lung and breast malignancy.
Topics: Animals; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Helminthiasis; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
FDG PET/CT in evaluation of unusual cutaneous manifestations of breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study.
Topics: Adipose Tissue, Brown; Adult; Antibodies, Monoclonal, Humanized; Body Mass Index; Breast Neoplasms; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pilot Projects; Positron-Emission Tomography; Taxoids; Tomography, X-Ray Computed; Trastuzumab; Weight Gain | 2014 |
[18F]-fluorodeoxyglucose positron emission tomography can contribute to discriminate patients with poor prognosis in hormone receptor-positive breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Survival Analysis; Tomography, Emission-Computed, Single-Photon | 2014 |
Frontal hypometabolism in elderly breast cancer survivors determined by [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Cognition; Executive Function; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Neuropsychological Tests; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Survivors | 2015 |
Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2014 |
A strange case of phyllodes tumor detected using (18)F-FDG PET/CT in an adolescent patient affected by Hodgkin lymphoma: a possible pitfall.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Phyllodes Tumor; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Whole Body Imaging | 2014 |
A 16-channel MR coil for simultaneous PET/MR imaging in breast cancer.
Topics: Breast; Breast Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Signal-To-Noise Ratio | 2015 |
Stable metabolic disease on FDG-PET provides information on response to endocrine therapy for breast cancer.
Topics: Adult; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hormones; Humans; Lymphatic Metastasis; Middle Aged; Mucin-1; Pilot Projects; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2017 |
Mediastinal sarcoidosis mimicking lymph malignancy recurrence after anti-neoplastic therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gastrectomy; Granuloma; Humans; Hysterectomy; Lymphatic Irradiation; Lymphatic Metastasis; Mastectomy, Segmental; Mediastinal Diseases; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Tumour 18 F-FDG Uptake on preoperative PET/CT may predict axillary lymph node metastasis in ER-positive/HER2-negative and HER2-positive breast cancer subtypes.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2015 |
Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Positron-Emission Tomography; Prognosis; Receptors, Estrogen; ROC Curve; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Tumour and lymph node uptakes on dual-phased 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography correlate with prognostic parameters in breast cancer.
Topics: Adult; Aged; Axilla; Biological Transport; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Receptor, ErbB-2; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Sarcoidosis mimicking metastatic breast cancer on FDG PET/CT.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Multiparametric evaluation of breast lesions using PET-MRI: initial results and future perspectives.
Topics: Adult; Aged; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2014 |
Breast cancer. Predicting nonresponders--light at the end of the PET tunnel.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2 | 2015 |
Preoperative 18F-FDG PET/CT predicts disease-free survival in patients with primary invasive ductal breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer.
Topics: Breast Neoplasms; Carcinoma; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Detection of breast cancer in an FDG-PET cancer screening program: results of a nationwide Japanese survey.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Japan; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Surveys and Questionnaires; Tomography, X-Ray Computed; Young Adult | 2015 |
Predicting pathological complete response in breast cancer early.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2 | 2014 |
(68)Ga-AMBA and (18)F-FDG for preclinical PET imaging of breast cancer: effect of tamoxifen treatment on tracer uptake by tumor.
Topics: Animals; Biological Transport; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Mice; Oligopeptides; Positron-Emission Tomography; Tamoxifen; Tumor Burden | 2015 |
Volume-based metabolic tumor response to neoadjuvant chemotherapy is associated with an increased risk of recurrence in breast cancer.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mastectomy; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Registries; Retrospective Studies; Risk; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT.
Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Treatment Outcome; Whole Body Imaging | 2017 |
Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.
Topics: Animals; Antineoplastic Agents, Hormonal; Biomarkers; Breast Neoplasms; Cell Line, Tumor; Diagnostic Imaging; Disease Models, Animal; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Humans; Ligands; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Promegestone; Receptors, Progesterone; Tomography, X-Ray Computed | 2015 |
18F-FDG-PET/CT in implant-associated anaplastic large cell lymphoma of the breast.
Topics: Breast Implants; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large-Cell, Anaplastic; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Measuring tumor metabolism by 18F-FDG PET predicts outcome in a multicenter study: a step off in the right direction.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Receptor, ErbB-2 | 2015 |
The performance of contrast-enhanced FDG PET/CT for the differential diagnosis of unexpected ovarian mass lesions in patients with nongynecologic cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case-Control Studies; Colorectal Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cohort Studies; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2014 |
Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caspase 3; Caspase 7; Cell Line, Tumor; Cetuximab; Doxorubicin; Drug Interactions; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Metformin; Radionuclide Imaging; Radiopharmaceuticals; Signal Transduction; Trastuzumab | 2015 |
The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Significance of hormone receptor status in comparison of 18F -FDG-PET/CT and 99mTc-MDP bone scintigraphy for evaluating bone metastases in patients with breast cancer: single center experience.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2015 |
[Accidental discovery of 18F-fluorodeoxyglucose PET/CT-positive papilloma in sinus sphenoidalis in a patient with recurrence of breast cancer].
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Papilloma; Paranasal Sinus Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sphenoid Sinus | 2015 |
FDG and (82)Rb PET/MRI features of brain metastasis of breast cancer.
Topics: Brain Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rubidium Radioisotopes | 2015 |
(18) F-FDG PET/CT for initial staging in breast cancer patients - Is there a relevant impact on treatment planning compared to conventional staging modalities?
Topics: Algorithms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Postoperative Care; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2015 |
Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
Multiple Pathologies Seen on a Single Contrast-Enhanced 18F-FDG PET/CT: Reiteration of Lessons Previously Learned.
Topics: Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphadenitis; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Ovarian hyperstimulation and breast cancer on PET imaging with sonographic correlation.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovulation Induction; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
Topics: Animals; Breast Neoplasms; Chemistry, Pharmaceutical; Chlorocebus aethiops; COS Cells; Drug Design; Female; Fluorodeoxyglucose F18; Glycopeptides; Glycosylation; HEK293 Cells; Humans; Inhibitory Concentration 50; Inositol; Kidney; MCF-7 Cells; Mice; Mice, Nude; Microscopy, Fluorescence; Neuropeptide Y; Positron-Emission Tomography; Radiopharmaceuticals; Signal Transduction; Tissue Distribution | 2015 |
Impact of radical surgery on outcome in locally advanced breast cancer patients without metastasis at the time of diagnosis.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2015 |
Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2015 |
A comparative study of 18F-FDG PET/CT and ultrasonography in the diagnosis of breast cancer and axillary lymph node metastasis.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Ultrasonography; Young Adult | 2017 |
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Sensitivity and Specificity; Technetium Compounds | 2016 |
Added value of using a cocktail of F-18 sodium fluoride and F-18 fluorodeoxyglucose in positron emission tomography/computed tomography for detecting bony metastasis: a case report.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
Prone Versus Supine Breast FDG-PET/CT for Assessing Locoregional Disease Distribution in Locally Advanced Breast Cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Patient Positioning; Positron-Emission Tomography; Prone Position; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Supine Position; Tomography, X-Ray Computed | 2015 |
Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients.
Topics: Bone Neoplasms; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
FDG-PET/CT detection of very early breast cancer in women with breast microcalcification lesions found in mammography screening.
Topics: Aged; Breast Neoplasms; Calcinosis; Comorbidity; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Taiwan; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
The diagnostic value of 18F-FDG PET/CT in association with serum tumor marker assays in breast cancer recurrence and metastasis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; CA-125 Antigen; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography | 2015 |
The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients.
Topics: Biopsy; Breast Neoplasms; Computer Simulation; Diagnostic Imaging; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Immunohistochemistry; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Prediction of macrometastasis in axillary lymph nodes of patients with invasive breast cancer and the utility of the SUV lymph node/tumor ratio using FDG-PET/CT.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Micrometastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sentinel Lymph Node Biopsy; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors.
Topics: Adult; Aged; Breast; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; ErbB Receptors; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cross-Sectional Studies; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Sensitivity and Specificity; Taxoids; Tomography, X-Ray Computed; Trastuzumab | 2015 |
Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Large-Core Needle; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; In Situ Hybridization; Lymph Node Excision; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
The clinical significance of standardized uptake value in breast cancer measured using 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2015 |
Early prediction of pathological complete response in luminal B type neoadjuvant chemotherapy-treated breast cancer patients: comparison between interim 18F-FDG PET/CT and MRI.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
VALIDATION OF THERAPEUTIC RESPONSE ASSESSMENT BY BONE SCINTIGRAPHY IN PATIENTS WITH BONE-ONLY METASTATIC BREAST CANCERS DURING ZOLEDRONIC ACID TREATMENT: COMPARISON WITH COMPUTED TOMOGRAPHY ASSESSMENT.
Topics: Adult; Aged; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Zoledronic Acid | 2015 |
Association between ¹⁸F-FDG uptake and molecular subtype of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Herpes Zoster Mimicking Breast Cancer With Axillary Lymph Node Metastasis on PET/CT.
Topics: Adult; Axilla; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Herpes Zoster; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Diagnostic performance of (18)F-fluorodeoxyglucose PET/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radionuclide Imaging | 2016 |
Intratumoral metabolic heterogeneity predicts invasive components in breast ductal carcinoma in situ.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Young Adult | 2015 |
RECIST for Response (Clinical and Imaging) in Neoadjuvant Clinical Trials in Operable Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Neoadjuvant Therapy; Positron-Emission Tomography; Reproducibility of Results; Response Evaluation Criteria in Solid Tumors; Sensitivity and Specificity; Triple Negative Breast Neoplasms | 2015 |
(18)F-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with (18)F-FDG and bioluminescence imaging.
Topics: Animals; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Luminescent Measurements; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Incidence of Internal Mammary Lymph Nodes with Silicone Breast Implants at MR Imaging after Oncoplastic Surgery.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Implants; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Mammaplasty; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Silicones; Tomography, X-Ray Computed | 2015 |
Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and ¹⁸F-FDG PET/CT.
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2015 |
Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
Topics: Adult; Aged; Breast; Breast Neoplasms; Equipment Design; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Mammography; Middle Aged; Models, Biological; Multimodal Imaging; Patient Positioning; Phantoms, Imaging; Positron-Emission Tomography; Prone Position; Prospective Studies; Radiopharmaceuticals; Supine Position; Tomography, X-Ray Computed | 2015 |
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Imaging Potential and Biodistribution in vivo of 2-[18F]Fluoropropionic Acid in Breast Cancer-bearing Mice.
Topics: Animals; Breast Neoplasms; Fluorodeoxyglucose F18; Mice; Positron-Emission Tomography; Tissue Distribution | 2015 |
A Case of Intraductal Papilloma of the Breast With High 18F-FDG Uptake on PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Papilloma, Intraductal; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sodium Fluoride; Survival Rate; Tomography, X-Ray Computed | 2015 |
Predictive Value of Positron Emission Tomography/Computed Tomography to Assess Early Treatment Response to Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade Without Chemotherapy for HER2-Positive Metastatic Breast Cancer: Are We Ready to Embra
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging | 2015 |
Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Mice; Misonidazole; Positron-Emission Tomography; Pyrroles; Sunitinib | 2015 |
Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Tumor Burden | 2015 |
The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Care; Retrospective Studies; ROC Curve | 2016 |
Concerning pretreatment ¹⁸F-FDG PET/CT imaging in patients with large or locally advanced breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Risk stratification in patients with advanced-stage breast cancer by pretreatment [(18) F]FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Cholesterol Granuloma: An Unusual and Benign Cause of Focal FDG Uptake in the Breast Detected on PET/CT.
Topics: Aged; Breast Neoplasms; Cholesterol; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar Degeneration.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Paraneoplastic Cerebellar Degeneration; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2016 |
Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Mammography; Mastectomy; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone and Bones; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies | 2015 |
[MRI/PET for the detection of bone metastases. The new gold standard?].
Topics: Bone Neoplasms; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Association between semiquantitative PET parameters and molecular subtypes of breast invasive ductal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biomarkers, Tumor; Breast Neoplasms; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; ROC Curve; Time Factors; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome; Young Adult | 2015 |
Liver and bone metastases from breast cancer: Eovist magnetic resonance and diffusion weighted imaging, 18F-FDG positron emission/computed tomography.
Topics: Adult; Breast Neoplasms; Carcinoma; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed | 2016 |
Early prediction of response to neoadjuvant chemotherapy in breast cancer patients: comparison of single-voxel (1)H-magnetic resonance spectroscopy and (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Treatment Outcome | 2016 |
Detection of Internal Mammary Adenopathy in Patients With Breast Cancer by PET/CT and MRI.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Topics: Adult; Aged; Bone and Bones; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate; Whole Body Imaging | 2015 |
Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2016 |
Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
Topics: Aged; Algorithms; Biomarkers; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Sample Size | 2016 |
(18)F-FDG/PET May Help to Identify a Subgroup of Patients with T1-T2 Breast Cancer and 1-3 Positive Lymph Nodes Who Are at a High Risk of Recurrence after Mastectomy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Risk Assessment; Risk Factors; Tumor Burden | 2016 |
Background Intestinal 18F-FDG Uptake Is Related to Serum Lipid Profile and Obesity in Breast Cancer Patients.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intestines; Lipids; Middle Aged; Obesity; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors | 2015 |
18F-FDG PET/CT Imaging of Bilateral Renal Metastasis of Breast Adenoid Cystic Carcinoma.
Topics: Aged; Breast Neoplasms; Carcinoma, Adenoid Cystic; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
A Clinical Pitfall: Optimal Management of Single Dural-based Metastatic Carcinoma of the Breast Mimicking Meningioma.
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Middle Aged; Positron-Emission Tomography | 2015 |
Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation.
Topics: Algorithms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Radium-223 dichloride therapy in breast cancer with osseous metastases.
Topics: Aged; Alkaline Phosphatase; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Off-Label Use; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Radium; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
A preliminary report of breast cancer screening by positron emission mammography.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Mammography; Mass Screening; Middle Aged; Retrospective Studies | 2016 |
Total Lesion Glycolysis and Sequential (90)Y-Selective Internal Radiation Therapy in Breast Cancer Liver Metastases: Preliminary Results.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Survival Rate; Tomography, X-Ray Computed; Tumor Burden; Yttrium Radioisotopes | 2015 |
Positron Emission Mammography Image Interpretation for Reduced Image Count Levels.
Topics: Adult; Aged; Algorithms; Breast; Breast Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Mammography; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Time Factors | 2016 |
Variations in (18)F-FDG uptake in breast cancer depending on PET/CT acquisition position.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Positioning; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
Topics: Adult; Aged; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Mammography; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Correlation between 18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography and Clinicopathological Features in Invasive Ductal Carcinoma of the Breast.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen | 2015 |
18F-FDG PET/CT and MRI findings in a case of granulocytic sarcoma of the breast.
Topics: Adolescent; Allografts; Bone Marrow Transplantation; Breast; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Graft vs Leukemia Effect; Humans; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Sarcoma, Myeloid | 2016 |
Additional Prone 18F-FDG PET/CT Acquisition to Improve the Visualization of the Primary Tumor and Regional Lymph Node Metastases in Stage II/III Breast Cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Patient Positioning; Positron-Emission Tomography; Prone Position; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbazoles; Cardiomyopathies; Cardiotonic Agents; Cardiovascular Agents; Carvedilol; Cell Line, Tumor; Cell Survival; Dexrazoxane; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Enalapril; Female; Fluorodeoxyglucose F18; Humans; Metformin; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Trastuzumab | 2016 |
Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2016 |
Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients.
Topics: Angiogenesis Inhibitors; Breast Neoplasms; Embolization, Therapeutic; Endpoint Determination; Female; Fluorodeoxyglucose F18; Humans; Liver Function Tests; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2016 |
Metabolic activity of breast cancer metastatic lesions on positron emission tomography/computed tomography: comparison with histological and biological characteristics of primary tumor.
Topics: Bone Neoplasms; Breast Neoplasms; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ki-67 Antigen; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2016 |
False-Positive Axillary Lymph Nodes Due to Silicone Adenitis on (18)F-FDG PET/CT in an Oncological Setting.
Topics: Axilla; Breast Implants; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphadenitis; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Silicones; Transgender Persons | 2016 |
Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
Integrated PET/MR mammography for quantitative analysis and correlation to prognostic factors of invasive ductal carcinoma.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis | 2018 |
Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Osteolysis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Case 227: Endobronchial Carcinoid Tumor with Incidental Metastatic Breast Cancer Detected with Somatostatin Receptor Scintigraphy ((111)In Pentreotide).
Topics: Adult; Biopsy; Breast Neoplasms; Bronchial Neoplasms; Bronchoscopy; Carcinoid Tumor; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, X-Ray Computed | 2016 |
Tumor Heterogeneity Assessed by 18F-FDG PET/CT Is Not Significantly Associated with Nodal Metastasis in Breast Cancer Patients.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2016 |
Is PET/CT Necessary in the Management of Early Breast Cancer?
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Monitoring; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Hemoglobins; Humans; Middle Aged; Molecular Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spectroscopy, Near-Infrared; Tomography, Optical; Treatment Outcome | 2016 |
The Synthesis and Evaluations of the (6 8) Ga-Lissamine Rhodamine B (LRB) as a New Radiotracer for Imaging Tumors by Positron Emission Tomography.
Topics: Animals; Breast Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; MCF-7 Cells; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Rhodamines; Tissue Distribution; Xenograft Model Antitumor Assays | 2016 |
Prognostic Role of Early and End-of-Neoadjuvant Treatment 18F-FDG PET/CT in Patients With Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2016 |
Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT.
Topics: Breast; Breast Diseases; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cross-Sectional Studies; Disease-Free Survival; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Mastectomy; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome | 2017 |
Molecular Imaging and Its Role in the Management of Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Molecular Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2016 |
The Impact That Number of Analyzed Metastatic Breast Cancer Lesions Has on Response Assessment by 18F-FDG PET/CT Using PERCIST.
Topics: Adult; Aged; Aged, 80 and over; Body Composition; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Treatment Outcome | 2016 |
[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy.
Topics: Bone and Bones; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiographic Image Enhancement; Tomography, X-Ray Computed | 2016 |
FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Contribution of FDG PET/CT for the Optimization of the Management of Additional Lesions Detected on Local Staging Breast MRI.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Comparison of Whole-Body (18)F FDG PET/MR Imaging and Whole-Body (18)F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer.
Topics: Adult; Aged; Breast Neoplasms; Breast Neoplasms, Male; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Whole Body Imaging | 2016 |
The Prognostic Impact of Early Change in 18F-FDG PET SUV After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Monitoring; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2016 |
Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2016 |
A Comparison of Near-Infrared Diffuse Optical Imaging and 18F-FDG PET/CT for the Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Value of fourth and subsequent post-therapy follow-up 18F-FDG PET/CT scans in patients with breast cancer.
Topics: Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Maryland; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2016 |
Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Whole Body Imaging | 2016 |
Assessment of Aggressiveness of Breast Cancer Using Simultaneous 18F-FDG-PET and DCE-MRI: Preliminary Observation.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
IgG4-Related Kidney Disease in a Patient With History of Breast Cancer: Findings on 18F-FDG PET/CT.
Topics: Autoimmune Diseases; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Middle Aged; Nephritis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
PET/MRI: A New Frontier in Breast Cancer Imaging.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
18F-Fluciclovine (FACBC) and Its Potential Use for Breast Cancer Imaging.
Topics: Breast Neoplasms; Diagnostic Imaging; Fluorodeoxyglucose F18; Positron-Emission Tomography | 2016 |
Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
Topics: Adult; Biological Transport; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Recurrence; Tumor Burden | 2016 |
Staging PET-CT Scanning Provides Superior Detection of Lymph Nodes and Distant Metastases than Traditional Imaging in Locally Advanced Breast Cancer.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2016 |
Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Osteoblasts; Osteolysis; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2016 |
Is (18)FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?
Topics: Biological Transport; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Receptor, ErbB-2; Receptors, Estrogen | 2016 |
Getting the Most out of 18F-FDG PET Scans: The Predictive Value of 18F-FDG PET-Derived Blood Flow Estimates for Breast Cancer.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Clinicopathological Features of Cases with Primary Breast Cancer not Identified by 18F-FDG-PET.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies | 2016 |
Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Coordination Complexes; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Magnetic Resonance Imaging; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Taxoids | 2016 |
Ductal carcinoma in situ and ductal carcinoma in situ with microinvasion: correlation of FDG uptake with histological and biological prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Retrospective Studies | 2017 |
Circulating microparticles bearing Fibrin associated with whole-body 18FDG-PET: diagnostic tools to detect paraneoplastic polymyalgia rheumatica.
Topics: Aged; Breast Neoplasms; Cell-Derived Microparticles; Colonic Neoplasms; Female; Fibrin; Fluorodeoxyglucose F18; Humans; Middle Aged; Paraneoplastic Syndromes; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography; Whole Body Imaging | 2016 |
Unusual Breast Masses: Ewing Sarcoma Metastases.
Topics: Adolescent; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Sarcoma, Ewing; Ultrasonography, Mammary | 2016 |
Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Breast Neoplasms, Male; Disease-Free Survival; Estradiol; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Fulvestrant; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2 | 2017 |
Molecular mechanism of (18)F-FDG uptake reduction induced by genipin in T47D cancer cell and role of uncoupling protein-2 in cancer cell glucose metabolism.
Topics: Biological Transport; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glucose; Humans; Iridoids; Lactic Acid; Matrix Metalloproteinases; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Time Factors; Uncoupling Protein 2 | 2016 |
Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI.
Topics: Adult; Aged; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Metabolome; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Decoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study.
Topics: Aged; Animals; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Intense 99mTc-MDP and 18F-NaF Activity in Long-standing Subcutaneous Implants.
Topics: Breast Implants; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate | 2016 |
The role of FDG PET/CT in detection of distant metastasis in theinitial staging of breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Relation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer.
Topics: Adult; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Survival Rate | 2016 |
Dynamic 2-Deoxy-2-[
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Mice, Nude; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Xenograft Model Antitumor Assays | 2017 |
Prognostic significance of preoperative
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gonadotropin-Releasing Hormone; Humans; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tamoxifen; Tumor Burden | 2016 |
Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Calcinosis; Carcinoma, Intraductal, Noninfiltrating; Early Detection of Cancer; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
18F-FDG PET/CT Imaging of Cauda Equina Syndrome Secondary to Leptomeningeal Metastatic Breast Cancer.
Topics: Adult; Breast Neoplasms; Carcinoma; Cauda Equina; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Polyradiculopathy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunotherapy; Lacrimal Apparatus Diseases; Lung Neoplasms; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multidetector Computed Tomography; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Soft Tissue Neoplasms; Splenic Neoplasms; Stomach Neoplasms; Treatment Outcome | 2016 |
[Multimodal imaging of breast cancer recurrence : Prospective intraindividual comparison of
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Voxelwise analysis of simultaneously acquired and spatially correlated
Topics: Adult; Aged; Breast; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Movement; Positron-Emission Tomography | 2017 |
Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer.
Topics: Adult; Biomarkers, Tumor; Body Mass Index; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk; Risk Factors | 2016 |
Clinical Significance of 18F-FDG-PET in Invasive Lobular Carcinoma.
Topics: Aged; Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2016 |
Occult breast primary malignancy presenting as isolated axillary lymph node metastasis - early detection of primary site by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adult; Axilla; Breast Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging | 2016 |
PET/CT with
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Trastuzumab; Young Adult | 2017 |
Incidental 18F-FDG PET/CT bilateral breast uptake due to carcinoma.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Carcinoma, Papillary; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Reply:
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Treatment Outcome | 2017 |
MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prone Position; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2017 |
Role of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating breast mucosa-associated lymphoid tissue lymphoma: A case series.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
Skeletal Scintigraphy in Radiation-Induced Fibrosis With Lymphedema.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Lymphedema; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy; Technetium Tc 99m Medronate | 2017 |
18F-FDG PET/CT in the Staging and Management of Breast Cancer: Value in Disease Outcome and Planning Therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Axilla; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Diphosphonates; Docetaxel; Epirubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Letrozole; Lymph Node Excision; Lymph Nodes; Mastectomy; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy; Ribs; Taxoids; Triazoles; Zoledronic Acid | 2017 |
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Middle Aged; Neoplasm Grading; Neoplasm Staging; Patient Outcome Assessment; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Tumor Burden | 2017 |
Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Taxoids; Trastuzumab; Treatment Outcome; Whole Body Imaging | 2017 |
Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; BRCA1 Protein; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mastectomy; Neoadjuvant Therapy; Neoplasm Grading; Positron-Emission Tomography; Treatment Outcome | 2017 |
Delayed Tumor Seeding Along Axillary Lymph Node Biopsy Tract Visualized on FDG PET/CT.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Seeding; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2017 |
Idiopathic fibrosing mediastinitis mimicking nodal metastasis from breast cancer.
Topics: Biopsy; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunohistochemistry; Mediastinitis; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Radiopharmaceuticals; Sclerosis; Treatment Outcome | 2017 |
Cerebral Parenchymal Photopenia on FDG-PET/CT Reflecting Vasogenic Edema Due to Leptomeningeal Metastasis in Breast Cancer.
Topics: Brain; Breast Neoplasms; Edema; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
FDG PET/CT Assesses the Risk of Femoral Pathological Fractures in Patients With Metastatic Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Case-Control Studies; Female; Femoral Fractures; Fluorodeoxyglucose F18; Fractures, Spontaneous; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2017 |
A Restless Leg Syndrome Incidentally Detected by an 18F-FDG Positron Emission Tomography.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Restless Legs Syndrome | 2017 |
Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Middle Aged; Molecular Imaging; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Republic of Korea; Risk Factors; Sensitivity and Specificity; Survival Rate; Tumor Hypoxia | 2017 |
PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Middle Aged; Multimodal Imaging; Neoplasm Staging; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Young Adult | 2017 |
Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging | 2017 |
A Case of Adenomyoepithelioma of the Breast Showing Strong Uptake of
Topics: Adenomyoepithelioma; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Mastectomy, Segmental; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Ultrasonography, Mammary | 2017 |
Whole-body PET/CT-mammography for staging breast cancer: initial results.
Topics: Algorithms; Axilla; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2008 |
FDG positron emission tomography imaging of drug-induced pneumonitis.
Topics: Aged; Anxiety Disorders; Brain Neoplasms; Breast Neoplasms; Dibenzothiazepines; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pneumonia; Positron-Emission Tomography; Quetiapine Fumarate; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Axilla; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Probability; Prognosis; Prospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Statistics, Nonparametric; Survival Analysis; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2008 |
Modeling spheroid growth, PET tracer uptake, and treatment effects of the Hsp90 inhibitor NVP-AUY922.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Positron-Emission Tomography; Radiopharmaceuticals; Resorcinols; Spheroids, Cellular | 2008 |
Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cohort Studies; Combined Modality Therapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Mastectomy, Segmental; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2008 |
[Standard uptake value of 18F-fluorine-2-deoxyglucose is correlated with the expression of estrogen receptor in duct carcinoma of breast].
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Reference Values | 2008 |
F-18 FDG uptake in cutaneous metastases from breast cancer.
Topics: Aged; Biopsy; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2008 |
Breast cancer staging in a single session: whole-body PET/CT mammography.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
[18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Doxorubicin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Paclitaxel; Thymidine; Thymidine Kinase | 2008 |
Monitoring of early response to neoadjuvant chemotherapy in breast cancer with (1)H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Algorithms; Breast Neoplasms; Chemotherapy, Adjuvant; Choline; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Middle Aged; Neoadjuvant Therapy; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Regulation of the Warburg effect in early-passage breast cancer cells.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic Acid; Mice; Mice, SCID; Phenotype; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Xenograft Model Antitumor Assays | 2008 |
Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Correlation among [18F]fluorodeoxyglucose positron emission tomography/computed tomography, cancer antigen 27.29, and circulating tumor cell testing in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Improved breast cancer detection of prone breast fluorodeoxyglucose-PET in 118 patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Prone Position; Radiopharmaceuticals; Supine Position; Whole Body Imaging | 2008 |
A case of lymphocytic mastopathy requiring differential diagnosis from primary breast lymphoma.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphocytes; Lymphoma; Magnetic Resonance Imaging; Mammography; Mastitis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2009 |
[A case of low grade ductal carcinoma in situ of the breast with difficulties in making the preoperative diagnosis after detection by FDG-PET].
Topics: Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography | 2008 |
Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT.
Topics: Aged; Axilla; Breast Neoplasms; Contrast Media; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Dysfunction of the neural network associated with sustained attention in cancer patients with clinically significant depressive symptoms.
Topics: Adult; Attention; Brain Mapping; Breast Neoplasms; Depression; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prefrontal Cortex; Severity of Illness Index | 2008 |
Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Dual-time-point 18F-FDG PET/CT versus dynamic breast MRI of suspicious breast lesions.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Ductal carcinoma in situ: correlation between FDG-PET/CT and histopathology.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Positron emission tomography and breast lesions: low FDG activity in early phase imaging is not essentially benign.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests | 2009 |
Abnormal FDG uptake on 18F-fluorodeoxyglucose positron emission tomography in patients with cancer diagnosis: case reports of tuberculous lymphadenitis.
Topics: Antitubercular Agents; Breast Neoplasms; Colonic Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tuberculosis, Lymph Node | 2009 |
Chronic thyroiditis in patients with advanced breast carcinoma: metabolic and morphologic changes on PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Thyroid Gland; Thyroiditis; Tomography, X-Ray Computed | 2009 |
Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Physical Examination; Positron-Emission Tomography | 2009 |
Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Statistics, Nonparametric; Young Adult | 2009 |
Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Triiodobenzoic Acids; Whole Body Imaging | 2010 |
Lesion detection in dynamic FDG-PET using matched subspace detection.
Topics: Algorithms; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Monte Carlo Method; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2009 |
Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
F-18 flurodeoxyglucose negative, F-18 fluoride accumulating in a brain metastasis in a treated case of carcinoma of the breast.
Topics: Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Female; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Umbilical metastasis from breast cancer detected by FDG PET.
Topics: Abdominal Neoplasms; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Umbilicus; Whole Body Imaging | 2009 |
Breast carcinoma metastatic to renal oncocytoma detected on F-18-FDG PET/CT.
Topics: Adenoma, Oxyphilic; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Unexpected foci of 18F-FDG uptake in the breast detected by PET/CT: incidence and clinical significance.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
Inflammatory pseudotumours resembling multiple hepatic metastases and their complete regression, as revealed by 18F-FDG PET/CT.
Topics: Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Humans; Liver Neoplasms; Positron-Emission Tomography; Remission Induction; Tomography, X-Ray Computed | 2009 |
Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
A false-positive fluorodeoxyglucose positron emission tomography (FDG-PET) imaging result for a patient after augmentation mammaplasty.
Topics: Adult; Aged; Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Mammaplasty; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplastic Cells, Circulating; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Differentiation of FDG-avid loco-regional recurrent and compromised benign lesions after surgery for breast cancer with dual-time point F-18-fluorodeoxy-glucose PET/CT scan.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2009 |
[The role of preoperative investigation with 18-FDG-PET/CT in primary operable breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
[The role of 18F-FDG SPECT-CT in detecting recurrence and metastases in breast cancer patients with elevated tumor markers].
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging | 2009 |
Prone breast dual-time-point PET/CT compared with MRI for determining breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Breast angiosarcoma: FDG PET findings.
Topics: Adolescent; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Neoplasms, Radiation-Induced; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
A false positive for metastatic lymph nodes in the axillary region of a breast cancer patient following mastectomy.
Topics: Axilla; Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging.
Topics: Breast Neoplasms; Carcinoma, Ductal; Diagnosis, Differential; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diagnostic Imaging; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mice, Transgenic; Positron-Emission Tomography; Prognosis; Receptor, ErbB-2; Reproducibility of Results; Trastuzumab; Xenograft Model Antitumor Assays | 2009 |
Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Iohexol; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Perfusion Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, X-Ray Computed | 2010 |
Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplastic Cells, Circulating; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
A different role for FDG PET/CT in axillary lymph node staging in breast cancer.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
[Assessment of diagnostic criteria for FDG-PET cancer screening program according to the interpretation of FDG-PET and combined examination].
Topics: Breast Neoplasms; Colonic Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Mass Screening; Occult Blood; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Non-Hodgkin's lymphoma of supraclavicular lymph nodes can mimic metastasis of breast cancer during chemotherapy on FDG PET/CT.
Topics: Adult; Breast Neoplasms; Clavicle; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Mastopathic-type fibroadenoma and ductal adenoma of the breast with false-positive fluorodeoxyglucose positron emission tomography.
Topics: Adult; Biopsy; Breast Neoplasms; False Positive Reactions; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography, Mammary | 2009 |
Three synchronous tumours identified by FDG-PET/CT.
Topics: Adenoma, Villous; Aged; Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sigmoid Neoplasms; Tongue Neoplasms | 2009 |
Controlling familywise error rate for matched subspace detection in dynamic FDG PET.
Topics: Algorithms; Breast Neoplasms; Computer Simulation; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Monte Carlo Method; Normal Distribution; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2009 |
18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Immunohistochemistry; Mice; Mice, Nude; Positron-Emission Tomography; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome | 2009 |
Multiple (18)F-FDG, PET-CT for postoperative monitoring of breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2009 |
FDG hepatic superscan caused by massive breast cancer invasion.
Topics: Breast Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Liver; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Intra-operative use of PET probe for localization of FDG avid lesions.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Melanoma; Neoplasms; Positron-Emission Tomography; Stomach Neoplasms | 2009 |
The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.
Topics: Adult; Aged; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
[The role of / 18FDG PET/CT for the initial staging and therapy in primary breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancer.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Proliferation; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Mitotic Index; Pilot Projects; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies | 2010 |
Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Prognosis; Receptors, Estrogen; Treatment Outcome | 2010 |
Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2013 |
Incidental breast lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2010 |
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Topics: Amyloid Precursor Protein Secretases; Animals; Breast Neoplasms; Cyclic S-Oxides; Down-Regulation; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Intracellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Transgenic; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Receptor, ErbB-2; Receptors, Notch; Signal Transduction; Thiadiazoles; TOR Serine-Threonine Kinases | 2010 |
Increased 18F-FDG uptake and expression of Glut1 in the EMT transformed breast cancer cells induced by TGF-beta.
Topics: Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Epithelial Cells; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Mesoderm; Radiopharmaceuticals; Transforming Growth Factor beta; Vimentin | 2010 |
1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histologic prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Japan; Magnetic Resonance Spectroscopy; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Protons; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2010 |
Subcutaneous panniculitis-like T-cell lymphoma with breast involvement: functional and morphological imaging findings.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Magnetic Resonance Imaging; Panniculitis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subcutaneous Tissue; Thorax; Tomography, X-Ray Computed; Upper Extremity | 2010 |
False-positive (18)F-fluorodeoxyglucose positron emission tomography/computed tomography caused by incidental injury in a bulky intracystic carcinoma of the breast.
Topics: Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Foreign-Body Reaction; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
18F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: a multicentre study.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Italy; Middle Aged; Mucin-1; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
FDG PET/CT manifestations of hematopoietic malignancies of the breast.
Topics: Adult; Breast Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Unilateral solitary breast metastasis from medullary carcinoma of thyroid detected by FDG-PET.
Topics: Adult; Breast Neoplasms; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Thyroid Neoplasms; Whole Body Imaging | 2010 |
Heterogeneity of metabolic response to systemic therapy in metastatic breast cancer patients.
Topics: Adult; Aged; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Cell Count; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Neoplastic Cells, Circulating; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Survival; Tomography, Emission-Computed | 2010 |
The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography, Mammary | 2010 |
The XbaI G>T polymorphism of the glucose transporter 1 gene modulates 18F-FDG uptake and tumor aggressiveness in breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genotype; Glucose Transporter Type 1; Humans; Middle Aged; Neoplasm Invasiveness; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
Topics: Adult; Aged; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2011 |
FDG PET/CT for monitoring response to neoadjuvant chemotherapy in breast cancer patients.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
Topics: Adult; Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2010 |
Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements.
Topics: Algorithms; Breast Neoplasms; Dideoxynucleosides; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Reproducibility of Results; Tumor Burden | 2010 |
Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Is a SUV cut-off necessary in the evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?
Topics: Biological Transport; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genes.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, SCID; Neoplasm Metastasis; Osteolysis; Positron-Emission Tomography; Protease Inhibitors; Pyrazines; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2010 |
[Imaging methods in the current diagnosis of and screening for breast cancer].
Topics: Biopsy; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Male; Mammography; Mass Screening; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2010 |
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Recurrence; Tomography, X-Ray Computed | 2011 |
17beta-estradiol augments 18F-FDG uptake and glycolysis of T47D breast cancer cells via membrane-initiated rapid PI3K-Akt activation.
Topics: Animals; Biological Transport; Breast Neoplasms; Cattle; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Enzyme Activation; Estradiol; Estrogens; Fluorodeoxyglucose F18; Glycolysis; Hexokinase; Humans; Kinetics; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2010 |
Breast cancer and hormonal stimulation: is glycolysis the first sign of response?
Topics: Biological Transport; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogens; Fluorodeoxyglucose F18; Glycolysis; Humans; Positron-Emission Tomography; Receptors, Estrogen | 2010 |
Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed | 2011 |
Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
[Tumor diagnosis with PET-CT. Are false hopes raised in cancer patients? (interview by Ute Kempf)].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Insurance Coverage; Lung Neoplasms; Male; National Health Programs; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Unnecessary Procedures | 2010 |
Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim.
Topics: Breast Neoplasms; Clinical Trials as Topic; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Reference Standards; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Young Adult | 2011 |
The impact of FDG-PET/CT on the management of breast cancer patients with elevated tumor markers and negative or equivocal conventional imaging modalities.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Time course of tumor SUV in 18F-FDG PET of breast cancer: presentation of a simple model using a single reference point for time corrections of tumor SUVs.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis | 2011 |
F-18 FDG PET/CT findings of a case of sacral nerve root neurolymphomatosis that occurred during chemotherapy.
Topics: Breast Neoplasms; Drug-Related Side Effects and Adverse Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Middle Aged; Positron-Emission Tomography; Sacrum; Spinal Nerve Roots; Tomography, X-Ray Computed | 2011 |
Beyond FDG: Many Molecular Imaging Agents Are in Development.
Topics: Biomarkers, Tumor; Breast Neoplasms; Dihydrotestosterone; Drug Design; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Prostatic Neoplasms; Radiology; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Androgen; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography.
Topics: Adrenal Glands; Breast Neoplasms; Contrast Media; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
F-18 FDG PET/CT for detection of malignant involvement of peripheral nerves: case series and literature review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2011 |
MRI and PET/CT of patients with bone metastases from breast carcinoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Monitoring response to neo-adjuvant chemotherapy with F-18 FDG PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Multiplexed PET probes for imaging breast cancer early response to VEGF₁₂₁/rGel treatment.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Mice; Mice, Nude; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Ribosome Inactivating Proteins, Type 1; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2011 |
FDG PET/CT features of ovarian metastasis.
Topics: Adult; Breast Neoplasms; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2011 |
Novel PET biomarkers for breast cancer imaging.
Topics: Biomarkers, Tumor; Breast Neoplasms; Dideoxynucleosides; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Methionine; Positron-Emission Tomography | 2011 |
Breast cancer.
Topics: Bone and Bones; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2011 |
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Analysis | 2011 |
Bilateral breast involvement of Hodgkin lymphoma revealed by FDG PET/CT.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
A robust state-space kinetics-guided framework for dynamic PET image reconstruction.
Topics: Breast Neoplasms; Computer Simulation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kinetics; Models, Biological; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2011 |
Could the serial determination of Ca15.3 serum improve the diagnostic accuracy of PET/CT?: results from small population with previous breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Blood Chemical Analysis; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Changes in 2-fluoro-2-deoxy-D-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; Glucose; Hexokinase; Humans; Lactic Acid; Receptor, ErbB-2; Tetrazolium Salts; Thiazoles; Trastuzumab; Tumor Stem Cell Assay | 2011 |
The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Breast; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2011 |
False-positive positron emission tomography in patients with history of malignancy.
Topics: Adult; Anus Neoplasms; Biopsy; Breast Neoplasms; Carcinoma; Carcinoma, Lobular; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Glucose transporter expression of intraductal papilloma of the breast detected by fluorodeoxyglucose positron emission tomography.
Topics: Adult; Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Humans; Magnetic Resonance Imaging; Papilloma, Intraductal; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography, Mammary | 2011 |
Whole-body FDG PET/CT in diagnosis of internal mammary nodal metastasis of ovarian carcinosarcoma.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Pancreatic metastasis detected by F-18 FDG PET/CT in a patient with breast cancer.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Recent progress in carcinogenesis, progression and therapy of breast cancer: the 20th Hiroshima Cancer Seminar--the 4th Three Universities' Consortium International Symposium, October 2010: 31 October 2010, International Conference Center Hiroshima.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Cell Transformation, Neoplastic; Cost-Benefit Analysis; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p16; Disease Progression; Drug Resistance, Neoplasm; Estrogens; Female; Fluorodeoxyglucose F18; Hexosyltransferases; Humans; Insurance Coverage; International Cooperation; Membrane Proteins; MicroRNAs; Molecular Targeted Therapy; Neoplasm Proteins; Positron-Emission Tomography; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Receptor, ErbB-2; Receptors, Immunologic; Signal Transduction; Sirtuin 1; Universities | 2011 |
Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Postoperative Period; Tomography, X-Ray Computed; Young Adult | 2011 |
AJR teaching file: incidental breast cancer detected with 18F-FDG PET/CT.
Topics: Arm; Biopsy; Breast Neoplasms; Carcinoma, Merkel Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Response to low-dose oral capecitabine monotherapy in an elderly frail patient with metastatic breast carcinoma and impaired renal function: documentation by fluorodeoxyglucose positron emission tomography.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Carcinoma, Ductal; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.
Topics: Adult; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Rapidly growing complex fibroadenoma with surrounding ductal hyperplasia mimics breast malignancy on serial F-18 FDG PET/CT imaging.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Hyperplasia; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.
Topics: Adenocarcinoma; Astrocytoma; Breast Neoplasms; Cell Line, Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, myc; Glucose; Glycolysis; Humans; Male; Melanoma; Neoplasm Proteins; Positron-Emission Tomography; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Radiopharmaceuticals; RNA, Messenger; RNA, Neoplasm | 2011 |
Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
Topics: Adult; Analysis of Variance; Area Under Curve; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Clinical significance of incidental finding of focal activity in the breast at 18F-FDG PET/CT.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2011 |
Three synchronous primary malignancies detected by F-18 FDG PET/CT: breast, rectal, and urothelial bladder carcinomas.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Rectal Neoplasms; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urothelium; Whole Body Imaging | 2011 |
18F-fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response.
Topics: Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compounds; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Taxoids; Tomography, X-Ray Computed | 2012 |
Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
FDG PET/CT differentiating two malignant tumors in the same patient.
Topics: Bone Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Ribs; Sarcoma, Synovial; Spinal Neoplasms; Tomography, X-Ray Computed | 2012 |
Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Carbon Radioisotopes; Cell Proliferation; Choline; Choline Kinase; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Are we ready for an early evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoadjuvant Therapy; Positron-Emission Tomography | 2011 |
Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET.
Topics: Adult; Aged; Analysis of Variance; Breast Neoplasms; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Retrospective Studies | 2011 |
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
Topics: Adult; Aged; Breast Neoplasms; Diagnostic Imaging; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Hungary; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series.
Topics: Adult; Biological Transport; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
Topics: Animals; Biological Transport; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Inositol; Male; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasm Transplantation; Positron-Emission Tomography; Radiochemistry; Transplantation, Heterologous | 2011 |
[Indications for the use of PET or PET/CT in patients with breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Case of the season: Large B-cell lymphoma involving both breasts.
Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Cytarabine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2011 |
Positron emission tomography and neoadjuvant therapy of breast cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Trastuzumab | 2011 |
FDG-PET/CT in the diagnosis of recurrent breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Gold nanoparticle probes: design and in vitro applications in cancer cell culture.
Topics: Antibodies; Apoptosis; Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cysteamine; Disulfides; Female; Fluorodeoxyglucose F18; Gold; Halogenation; Humans; Immunoconjugates; Isotope Labeling; Mannose; Membrane Proteins; Mesylates; Metal Nanoparticles; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Molecular Targeted Therapy; RNA-Binding Proteins | 2012 |
[18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen | 2012 |
Whither the PET scan? The role of PET imaging in the staging and treatment of breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Imaging technologies in breast diagnosis and surgical treatment.
Topics: Biopsy; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Mastectomy; Positron-Emission Tomography | 2011 |
Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2012 |
Factors associated with the development of new onset diffuse thyroid F18-fluorodeoxyglucose uptake after treatment of breast cancer in patients without a history of thyroid disease or thyroid dysfunction.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Retrospective Studies; Thyroid Gland; Thyroiditis | 2012 |
Can FDG PET/CT monitor the response to hormonal therapy in breast cancer patients?
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hormones; Humans; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
[Role of positron-emission tomography with 18F-FDG in the diagnosis of breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Detection of metastatic bone lesions in breast cancer patients: fused (18)F-Fluoride-PET/MDCT has higher accuracy than MDCT. Preliminary experience.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Mammography and ultrasonography evaluation of unexpected focal 18F-FDG uptakes in breast on PET/CT.
Topics: Adult; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2012 |
Evaluation of the relationship between [18F]FDG and P-glycoprotein expression: an experimental study.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Positron-Emission Tomography; Prohibitins; Rhodamine 123; Technetium Tc 99m Sestamibi; Verapamil | 2012 |
Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sentinel Lymph Node Biopsy; Taxoids; Tomography, X-Ray Computed | 2013 |
Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET.
Topics: Adult; Aged; Blood Volume; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Liver Neoplasms; Magnetic Resonance Imaging; Microspheres; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tomography, X-Ray Computed; Young Adult; Yttrium Radioisotopes | 2012 |
Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Oestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FES.
Topics: Aged; Breast Neoplasms; Contrast Media; Endometrial Neoplasms; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Neoplasms, Hormone-Dependent; Phenotype; Positron-Emission Tomography; Sensitivity and Specificity | 2012 |
Preoperative PET/CT in early-stage breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Increased FDG uptake in breast cancer is associated with prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2012 |
99mTc-MDP- and 18F-FDG-avid metastatic liver lesion: the similarities and differences between 2 modalities.
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
[¹⁸F]fluorodeoxyglucose positron emission tomography-computed tomography in breast cancer: when... and when not?
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron-Emission Tomography; Sentinel Lymph Node Biopsy | 2012 |
Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
Topics: Adult; Aged; Analysis of Variance; Area Under Curve; Biopsy, Needle; Breast Neoplasms; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Magnetic Resonance Imaging; Microcirculation; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
FDG PET/CT of a late-term pregnant woman with breast cancer.
Topics: Adult; Breast Neoplasms; Female; Fetus; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Third; Tomography, X-Ray Computed | 2012 |
FDG uptake in sacroiliac joint due to osteitis condensans ilii shown on PET/CT in a patient with breast cancer: the value of coregistered CT in avoiding misinterpretation.
Topics: Breast Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Multimodal Imaging; Osteitis; Positron-Emission Tomography; Sacroiliac Joint; Tomography, X-Ray Computed | 2012 |
Evaluation of sequential FDG-PET/CT for monitoring bone metastasis of breast cancer during therapy: correlation between morphological and metabolic changes with tumor markers.
Topics: Adult; Aged; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed | 2012 |
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms | 2012 |
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Defining the role of PET-CT in staging early breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphopenia; Middle Aged; Neoplastic Cells, Circulating; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; Tomography, Emission-Computed; United States; Women's Health | 2012 |
Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Incidental Findings; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Statistics, Nonparametric; Tomography, X-Ray Computed; Ultrasonography, Mammary; Whole Body Imaging | 2012 |
Comparative study of the value of dual tracer PET/CT in evaluating breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Choline; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2012 |
On ROC analysis with nonbinary reference standard.
Topics: Breast Neoplasms; Diagnostic Tests, Routine; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Models, Statistical; Neoplasm Metastasis; Positron-Emission Tomography; Reference Standards; ROC Curve | 2012 |
Is [18F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer?
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Positron emission tomography with computed tomography (PET-CT) to evaluate the response of bone metastases to non-surgical treatment.
Topics: Aromatase Inhibitors; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Ibandronic Acid; Letrozole; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Nitriles; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Tomography, X-Ray Computed; Triazoles | 2010 |
Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2012 |
FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial results.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Fat necrosis may mimic local recurrence of breast cancer in FDG PET/CT.
Topics: Aged; Breast; Breast Neoplasms; Diagnosis, Differential; False Positive Reactions; Fat Necrosis; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
3T-MRI, elastography, digital mammography, and FDG-PET CT findings of subcutaneous panniculitis-like T-cell lymphoma (SPTCL) of the breast.
Topics: Aged; Breast Neoplasms; Elasticity Imaging Techniques; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Magnetic Resonance Imaging; Mammography; Multimodal Imaging; Panniculitis; Positron-Emission Tomography; Radiographic Image Enhancement; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Young Adult | 2012 |
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy.
Topics: Adult; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT appearance of metastatic brachial plexopathy involving epidural space from breast carcinoma.
Topics: Aged; Brachial Plexus Neuropathies; Breast Neoplasms; Epidural Space; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
18 F-fluorodeoxyglucose uptake predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: a retrospective cohort study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Mastectomy; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Delineation of the cardiac substructures based on PET-CT and contrast-enhanced CT in patients with left breast cancer treated with postoperative radiotherapy.
Topics: Adult; Aged; Breast Neoplasms; Cardiac Volume; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Heart Diseases; Heart Ventricles; Humans; Middle Aged; Pilot Projects; Postoperative Period; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Stroke Volume | 2013 |
Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Comparison of 18F-FDG positron emission tomography/computed tomography and computed tomography in patients with already-treated breast cancer: diagnostic and prognostic implications.
Topics: Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Effects of DNA ploidy and S-phase fraction on fluorine-18 FDG uptake of primary breast cancer lesions.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; DNA; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ploidies; Positron-Emission Tomography; Radiopharmaceuticals; S Phase; Tomography, X-Ray Computed | 2013 |
A prospective study of bone tumor response assessment in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2013 |
Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biomarkers, Tumor; Biopsy, Fine-Needle; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2013 |
Update on emerging technologies in breast imaging.
Topics: Breast; Breast Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2012 |
Incidental diffuse thyroid 18F-FDG uptake related to autoimmune thyroiditis may be a favorable prognostic factor in advanced breast cancer.
Topics: Aged; Biological Transport; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Retrospective Studies; Thyroid Gland; Thyroiditis, Autoimmune | 2012 |
[The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Remission Induction; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Cilengitide affects tumor compartment, vascularization and microenvironment in experimental bone metastases as shown by longitudinal ¹⁸F-FDG PET and gene expression analysis.
Topics: Animals; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Integrin alphaVbeta3; Longitudinal Studies; Male; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Real-Time Polymerase Chain Reaction; Receptors, Vitronectin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Snake Venoms; Tumor Cells, Cultured; Tumor Microenvironment | 2013 |
Evaluating the impact of new imaging tests: promises and pitfalls.
Topics: Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.
Topics: Adult; Aged; Analysis of Variance; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Contrast Media; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2012 |
Fluorodeoxyglucose--positive internal mammary lymph node in breast cancer patients with silicone implants: is it always metastatic cancer?
Topics: Adult; Breast Implants; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymph Nodes; Lymphatic Metastasis; Mammaplasty; Mastectomy; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Silicone Gels; Thoracic Surgery, Video-Assisted | 2013 |
Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Proteins; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2013 |
Comparison between 18F-FDG PET image-derived indices for early prediction of response to neoadjuvant chemotherapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Treatment Outcome | 2013 |
Multiple target-specific molecular agents for detection and image analysis of breast cancer characteristics in mice.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Mammary Neoplasms, Animal; Mice; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Positron-Emission Tomography; Tomography, X-Ray Computed; Transplantation, Heterologous | 2013 |
[The utility of FDG-PET/CT for pre/post operative diagnosis].
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Postoperative Period; Preoperative Period; Tomography, X-Ray Computed | 2012 |
18F-FDG imaging of the primary breast leiomyosarcoma and follow-up lung metastasis.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Rare lymphoid malignancies of the breast: report of two cases illustrating potential diagnostic techniques.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Mammography; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2012 |
The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone | 2013 |
Potential utility of early metabolic response by 18F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in a selected group of breast cancer patients receiving preoperative chemotherapy.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Multimodal Imaging; Outcome Assessment, Health Care; Positron-Emission Tomography; Preoperative Period; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Remission Induction; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2013 |
18F-fluoromisonidazole PET/CT: a potential tool for predicting primary endocrine therapy resistance in breast cancer.
Topics: Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Ki-67 Antigen; Letrozole; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasms, Hormone-Dependent; Nitriles; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triazoles | 2013 |
PET scan detects recurrent breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[The value of F-18 fluorodeoxyglucose in positron emission tomography diagnosis of breast carcinoma].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy.
Topics: Adult; Aged; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Carcinoma; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Comparison of fluorodeoxyglucose positron emission tomography and "conventional diagnostic procedures" for the detection of distant metastases in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2002 |
Fluorine-18 FDG-PET in detecting local recurrence and distant metastases in breast cancer--Taiwanese experiences.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer.
Topics: Adult; Aged; Blood Glucose; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Clinical impact of [(18)F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Tomography, Emission-Computed | 2002 |
Incidental detection of primary breast carcinoma with a modified coincident camera in a patient with non-Hodgkin's lymphoma and melanoma.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Melanoma; Neoplasm Staging; Neoplasms, Multiple Primary; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Whole-Body Counting | 2002 |
Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |
Breast cancer imaging with PET and SPECT agents: an in vivo comparison.
Topics: Animals; Breast Neoplasms; Fluorodeoxyglucose F18; Metabolic Clearance Rate; Muscle, Skeletal; Neoplasm Transplantation; Radiometry; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients.
Topics: Adult; Aged; Breast Neoplasms; Colonic Neoplasms; Diagnostic Errors; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germanium; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radioisotopes; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
FDG-positron emission tomographic imaging in carcinoma of the breast: interference by massive sarcoidosis.
Topics: Adult; Breast Neoplasms; Carcinoma, Lobular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sarcoidosis; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2003 |
[18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Topics: Biomarkers, Tumor; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Follow-up of women with breast cancer: comparison between MRI and FDG PET.
Topics: Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions.
Topics: Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Middle Aged; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.
Topics: Adult; Aged; Breast; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Metabolic Clearance Rate; Middle Aged; Quality Control; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 2003 |
Acute bronchitis imaged with F-18 FDG positron emission tomography.
Topics: Acute Disease; Breast Neoplasms; Bronchitis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastitis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed | 2003 |
F-18 FDG positron emission tomographic imaging in a case of ruptured breast implant: inflammation or recurrent tumor?
Topics: Breast Implants; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Prosthesis Failure; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Positron emitting 18F-2-deoxy-2-fluoro-D-glucose: potential hot new therapy.
Topics: Animals; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammary Neoplasms, Experimental; Mice; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer.
Topics: Animals; Apoptosis; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Transgenic; Necrosis; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.
Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Regional Blood Flow; Tomography, Emission-Computed | 2003 |
Locally advanced breast cancer: is PET useful for monitoring primary chemotherapy?
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 2003 |
Comparison of FDG-PET and dynamic contrast-enhanced MRI in the evaluation of suggestive breast lesions.
Topics: Adenocarcinoma; Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Correlation of MRI/PET rim enhancement in breast cancer: a delivery related phenomenon with therapy implications?
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoadjuvant Therapy; Tomography, Emission-Computed | 2003 |
High predictive value of F-18 FDG PET patterns of the spine for metastases or benign lesions with good agreement between readers.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Observer Variation; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Spinal Neoplasms; Tomography, Emission-Computed | 2003 |
Radiotherapeutic use of 2-deoxy-2-[18F]fluoro-D-glucose--a comment.
Topics: Animals; Apoptosis; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammary Neoplasms, Experimental; Mice; Tomography, Emission-Computed; Treatment Outcome | 2004 |
[The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Medical Oncology; Neoplasms; Outcome Assessment, Health Care; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 2003 |
FDG-PET for evaluation of recurrent lymph node metastases in patients with surgically resected breast cancer: adding spot images to whole body images.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2004 |
Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.
Topics: Adenoma, Liver Cell; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
FDG positron emission tomography for evaluating breast cancer.
Topics: Blue Cross Blue Shield Insurance Plans; Breast Neoplasms; Device Approval; Female; Fluorodeoxyglucose F18; Humans; Insurance Coverage; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Outcome Assessment, Health Care; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2003 |
18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[2003 update of recommendations for clinical practice: standards, options and recommendations for the use of FDG-PET in the management of gynaecological and breast cancers].
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Neoplasm, Residual; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms | 2004 |
Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Histiocytosis, Sinus; Humans; Incidental Findings; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
F-18 FDG positron emission tomography demonstration of pulmonary carcinoid.
Topics: Aged; Breast Neoplasms; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Iatrogenic artifacts on whole-body F-18 FDG PET imaging.
Topics: Adult; Artifacts; Breast Neoplasms; Catheterization; Catheters, Indwelling; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intubation; Lung Neoplasms; Lymphoma; Male; Middle Aged; Ostomy; Prostheses and Implants; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomography.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Surveys and Questionnaires; Tomography, Emission-Computed | 2004 |
Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC).
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammary Arteries; Mediastinum; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2004 |
Don't give up your gamma probe.
Topics: Axilla; Biopsy; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2004 |
The relationship between vascular and metabolic characteristics of primary breast tumours.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy.
Topics: Adult; Aged; Biopsy; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2004 |
FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
Topics: Adenocarcinoma; Aged; Antibodies, Neoplasm; Breast Neoplasms; Carcinoma, Small Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Paraneoplastic Syndromes, Nervous System; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Rectal metastasis from infiltrating lobular breast carcinoma: imaging with 18F-FDG PET.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Rectal Neoplasms; Tomography, Emission-Computed | 2005 |
The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Polymorphism, Genetic; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2004 |
Multiple nodular adenosis concurrent with primary breast lymphoma: pitfall in PET.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Breast Diseases; Breast Neoplasms; Calcinosis; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2005 |
Strategies in detection of the primary tumour in anti-Yo associated paraneoplastic cerebellar degeneration.
Topics: Adenocarcinoma; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Unknown Primary; Paraneoplastic Cerebellar Degeneration; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2005 |
Paravertebral infection (phlegmon) demonstrated by FDG dual-head coincidence imaging in a patient with multiple malignancies.
Topics: Aged; Back Pain; Breast Neoplasms; Cellulitis; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lumbar Vertebrae; Melanoma; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Staphylococcal Infections | 2005 |
F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Rare Diseases | 2005 |
Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle.
Topics: Adult; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Menopause; Menstrual Cycle; Middle Aged; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Uterine Cervical Neoplasms | 2005 |
Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
Incidental detection of rounded atelectasis during tc-99m MIBI scintimammography.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Neoplasm Recurrence, Local; Pulmonary Atelectasis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
Intraductal papilloma of the breast: F-18 FDG PET demonstration.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Intestinal Neoplasms; Papilloma, Intraductal; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Bone metastasis detected by FDG PET in a patient with breast cancer and fibrous dysplasia.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Carcinoma, Ductal, Breast; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Mucin-1; Radionuclide Imaging; Radiopharmaceuticals; Whole-Body Counting | 2005 |
Focal nodular hyperplasia (FNH): a potential cause of false-positive positron emission tomography.
Topics: Breast Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Osteoblastic bone metastases in breast cancer: is not seeing believing?
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Osteoblasts; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2005 |
Relative roles of bone scintigraphy and positron emission tomography in assessing the treatment response of bone metastases.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Treatment Outcome | 2005 |
Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Radiopharmaceuticals; Receptor, ErbB-2; Tomography, Emission-Computed; Trastuzumab; Treatment Outcome; Vinblastine; Vinorelbine | 2005 |
18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcome.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index | 2005 |
Incidental detection of bilateral elastofibroma dorsi with F-18 FDG PET/CT.
Topics: Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Subtraction Technique; Thoracic Wall; Tomography, X-Ray Computed | 2005 |
A rare case of paraneoplastic cerebellar degeneration discovered by whole-body F-18 FDG PET.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Tomography, X-Ray Computed; Whole Body Imaging | 2005 |
Imaging bone metastases in breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
FDG PET and SPECT of bone metastases in breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2005 |
Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. CASE 3. Hoarseness caused by cancer metastasis to the vagus nerve.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Cranial Nerve Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hoarseness; Humans; Melanoma; Tomography, X-Ray Computed; Vagus Nerve Diseases | 2005 |
Focal F-18 fluorodexyglucose positron emission tomography uptake in a hyalinized nodule as a false positive splenic metastasis in a patient with breast cancer and metastatic thyroid cancer.
Topics: Aged; Breast Neoplasms; Calcinosis; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Hyalin; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Diseases; Splenic Neoplasms; Thyroid Neoplasms | 2005 |
Metastatic cancer in thyroid detected by FDG PET.
Topics: Breast Neoplasms; Carcinoma, Ductal; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2006 |
Value of fluorodeoxyglucose positron emission tomography in women with breast cancer (Br J Surg 2005; 92: 1363-1367).
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Imaging in breast cancer - breast cancer imaging revisited.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Optics and Photonics; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2005 |
Imaging of primary breast cancer with 18F-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour.
Topics: Aged; Breast Neoplasms; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
The search for occult metastatic disease in breast cancer patients: how far should we go?
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Patient Satisfaction; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2006 |
18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Patient Satisfaction; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Clinical insights into paraneoplastic cerebellar degeneration.
Topics: Adult; Ataxia; Atrophy; Biopsy; Bone Marrow; Breast Neoplasms; Carcinoma, Ductal; Cerebellar Neoplasms; Cerebellum; Diagnosis, Differential; Disease Progression; Dysarthria; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Migraine Disorders; Ovarian Cysts; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Purkinje Cells; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Inflammatory F-18 FDG uptake secondary to ruptured breast prosthesis.
Topics: Breast Implants; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Prosthesis Failure; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2006 |
Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.
Topics: Adult; Aged; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Regression Analysis | 2006 |
A retrospective analysis of the impact of 18F-FDG PET scans on clinical management of 133 breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidence; Middle Aged; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; United States | 2006 |
Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Glucose Transporter Type 1; Hexokinase; Humans; Radiopharmaceuticals; RNA, Messenger; Tritium | 2006 |
Clear-PEM: a dedicated PET camera for improved breast cancer detection.
Topics: Breast Neoplasms; Equipment Design; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Enhancement; Phantoms, Imaging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
PET-CT demonstration of extensive muscle metastases from breast cancer.
Topics: Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2006 |
A case of orbital malt lymphoma with breast involvement detected by 18FDG-positron emission tomography.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Orbital Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
[Update of 'standards, options and recommendations' for FDG-PET in breast and gynaecological cancers].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; France; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Ovarian Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms | 2006 |
[Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms | 2006 |
Flare response in 18F-fluoride ion PET bone scanning.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Thoracic Vertebrae | 2006 |
The role of whole-body fluorine-18-FDG positron emission tomography in the detection of recurrence in symptomatic patients with stages II and III breast cancer.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies.
Topics: Animals; Breast Neoplasms; Drug Evaluation; Drug Evaluation, Preclinical; Female; Filgrastim; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Metabolic Clearance Rate; Organ Specificity; Pilot Projects; Polyethylene Glycols; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Recombinant Proteins; Reference Values; Retrospective Studies; Tissue Distribution | 2006 |
Ductal carcinoma in-situ of the breast detected by [F-18] fluorodeoxyglucose positron emission tomography.
Topics: Biopsy, Needle; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Japan; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Risk Assessment; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Treatment Outcome | 2006 |
Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.
Topics: Abdomen; Acute Disease; Adult; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hepatitis C; Humans; Lymphatic Diseases; Lymphatic Metastasis; Mastectomy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Spinal Neoplasms; Spleen; Tamoxifen; Thoracic Vertebrae; Tomography, X-Ray Computed | 2006 |
Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Mastectomy, Segmental; Mediastinal Neoplasms; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2006 |
F-18 FDG PET-CT appearance of metastatic brachial plexopathy in a case of carcinoma of the breast.
Topics: Brachial Plexus; Brachial Plexus Neuropathies; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cicatrix; Combined Modality Therapy; Diagnosis, Differential; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Mastectomy; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy, Adjuvant; Tomography, X-Ray Computed | 2006 |
Unexpected focal hypermetabolic activity in the breast: significance in patients undergoing 18F-FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Child; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
[2005 monitoring report: use of positron emission tomography with fluorodeoxyglucose in the management of patients with breast cancer, ovarian cancer, and uterine cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; France; Humans; Meta-Analysis as Topic; Neoplasm Metastasis; Ovarian Neoplasms; Practice Guidelines as Topic; Quality of Health Care; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms | 2006 |
"Cold" vertebrae on F-18 FDG PET: Causes and characteristics.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hemangioma; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Spine | 2006 |
Monitoring primary breast cancer throughout chemotherapy using FDG-PET.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; ROC Curve | 2007 |
Usefulness of (18)F-fluorodeoxyglucose PET for radiosurgery planning and response monitoring in patients with recurrent spinal metastasis.
Topics: Adult; Breast Neoplasms; Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy Planning, Computer-Assisted; Sarcoma; Spinal Neoplasms; Thoracic Vertebrae | 2006 |
Preoperative FDG-PET for axillary metastases in patients with breast cancer.
Topics: Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2006 |
Tumor 18F-FDG incorporation is enhanced by attenuation of P53 function in breast cancer cells in vitro.
Topics: Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals; Tumor Suppressor Protein p53 | 2006 |
The automatic production of 16alpha-[18F]fluoroestradiol using a conventional [18F]FDG module with a disposable cassette system.
Topics: Breast Neoplasms; Chromatography, High Pressure Liquid; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Quality Control; Radiochemistry; Radiopharmaceuticals; Receptors, Estrogen | 2007 |
Pulmonary suture abscess with false-positive 18F-fluorodeoxyglucose positron emission scan mimicking lung cancer recurrence.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Abscess; Lung Neoplasms; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sutures | 2006 |
Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cerebellum; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forecasting; Humans; Immunohistochemistry; Lymph Nodes; Middle Aged; Neoplasm Metastasis; Nerve Tissue Proteins; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Time Factors | 2006 |
Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2007 |
The role of FDG-PET/CT in suspected recurrence of breast cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2006 |
Sequential positron emission tomography using [18F]fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Survival Analysis; Treatment Outcome | 2006 |
F-18 FDG PET scan findings in a case of carcinoma of the breast with a rare site of metastases to the gingival region.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases | 2006 |
Juvenile fibroadenoma of the breast demonstrated on 111in-octreotide SPECT and 18F-FDG PET/CT.
Topics: Adolescent; Breast Neoplasms; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2007 |
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2007 |
[Evaluation of efficacy and clinical impact of FDG-PET on patients with suspicion of recurrent cutaneous melanoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case Management; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Unnecessary Procedures | 2006 |
F-18 FDG PET imaging of disseminated sarcoidosis.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Sarcoidosis | 2007 |
A surgical perspective on positron emission tomography.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Image Enhancement; Melanoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies | 2007 |
Uptake characteristics of FDG in multiple juvenile cellular fibroadenomata of the breast: FDG-PET and histopathologic correlation.
Topics: Adolescent; Breast Neoplasms; Diagnosis, Differential; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2007 |
Incidental diagnosis of endometrial carcinoma in a patient with breast cancer by FDG PET/CT.
Topics: Adenocarcinoma; Breast Neoplasms; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
False positive 18F-FDG PET/CT due to gynaecomastia.
Topics: Breast Neoplasms; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Gynecomastia; Humans; Male; Melanoma; Middle Aged; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Breast MRI and 18F FDG PET/CT in the management of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2007 |
Findings of fluorine-18-FDG PET in extranodal origin lymphoma--in three cases of diffuse large B cell type lymphoma.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Stomach Neoplasms | 2006 |
Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets.
Topics: Adult; Breast Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Filgrastim; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins | 2007 |
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2007 |
Gastric linitis plastica from metastatic breast carcinoma: FDG and FES PET appearances.
Topics: Aged; Breast Neoplasms; Carcinoma, Lobular; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Linitis Plastica; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |
Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2007 |
Elastofibroma dorsi mimicking metastatic disease on fluorodeoxyglucose F-18 positron emission tomography in a breast cancer patient.
Topics: Aged; Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Soft Tissue Neoplasms | 2007 |
Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2007 |
Pituitary metastasis of breast cancer confirmed by fluorine-18 fluorodeoxyglucose positron emission tomography: a case report.
Topics: Breast Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
[Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Choroid Neoplasms; Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Injections, Intravenous; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Radiopharmaceuticals; Retrospective Studies; Sigmoid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2007 |
Treatment of breast tumor cells in vitro with the mitochondrial membrane potential dissipater valinomycin increases 18F-FDG incorporation.
Topics: Adenosine Triphosphate; Breast Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Membrane Potentials; Mitochondria; Radiopharmaceuticals; Valinomycin | 2007 |
Imaging in endocrinology: Langherans cell histiocytosis of the thyroid gland detected by 18FDG-PET/CT.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyrotropin | 2007 |
[FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2007 |
The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2007 |
Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals | 2007 |
[Value of fused 18F-FDG PET/CT images in predicting efficacy of neoadjuvant chemotherapy on breast cancer].
Topics: Adult; Aged; Apoptosis; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; In Situ Nick-End Labeling; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Analysis of blood flow and glucose metabolism in mammary carcinomas and normal breast: a H2(15)O PET and 18F-FDG PET study.
Topics: Adult; Aged; Blood Flow Velocity; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Metabolic Clearance Rate; Middle Aged; Neovascularization, Pathologic; Oxygen Radioisotopes; Positron-Emission Tomography; Tissue Distribution; Water | 2007 |
Correlation between hybrid 18F-FDG PET/CT and apoptosis induced by neoadjuvant chemotherapy in breast cancer.
Topics: Adult; Aged; Apoptosis; Biopsy; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; In Situ Nick-End Labeling; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
18F-FDG PET in detecting primary breast cancer.
Topics: Adult; Breast Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
18F-FDG dual-headed gamma camera PET in detection of axillary nodal disease in patients with large or locally advanced breast cancer: possible alternative staging of axilla.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Decreased [18F]fluoro-2-deoxy-d-glucose incorporation and increased glucose transport are associated with resistance to 5FU in MCF7 cells in vitro.
Topics: Biological Transport, Active; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Humans; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
What is the role of FDG-PET in the initial staging of breast cancer?
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iohexol; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2007 |
Comparison of 99mtechnetium-pertechnetate and 123iodide SPECT with FDG-PET in patients suspicious for breast cancer.
Topics: Adult; Aged; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prone Position; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m; Supine Position; Thoracic Neoplasms; Tomography, Emission-Computed, Single-Photon | 2007 |
Breast metastasis by medullary thyroid carcinoma detected by FDG positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Medullary; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Clavicle; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Discordant findings of skeletal metastasis between tc 99M MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers--two case reports and literature review.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2007 |
Pulmonary echinococcosis mimicking multiple lung metastasis of breast cancer: the role of fluoro-deoxy-glucose positron emission tomography.
Topics: Albendazole; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Diagnosis, Differential; Echinococcosis, Pulmonary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Treatment Outcome | 2008 |
Two cases of occult breast cancer in which PET-CT was helpful in identifying primary tumors.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
FDG-PET on the trail of an unsuspected primary malignancy in the breast.
Topics: Adenocarcinoma; Biopsy; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2008 |
Improved detection of breast cancer on FDG-PET cancer screening using breast positioning device.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Clinical Protocols; Equipment Failure Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Mass Screening; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prone Position; Radiopharmaceuticals; Reproducibility of Results; Supine Position; Whole Body Imaging | 2008 |
Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results.
Topics: Ablation Techniques; Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron-Emission Tomography; Radiofrequency Therapy; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2008 |
Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnostic Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
[18FDG-PET in patients with in situ breast carcinomas. A cause of false negative results].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Mastectomy, Segmental; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2008 |
Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2008 |
Costosternal chondrodynia simulating recurrent breast cancer unveiled by FDG PET.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sternum; Tietze's Syndrome | 2008 |
Disseminated tuberculosis masquerading as metastatic breast carcinoma on PET-CT.
Topics: Adult; Breast Diseases; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2008 |
Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Chest wall mass caused by salmonella enteritidis - a pitfall of PET imaging interpretation.
Topics: Aged; Anti-Infective Agents; Breast Neoplasms; Ceftriaxone; Ciprofloxacin; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Salmonella enteritidis; Salmonella Infections; Thoracic Diseases; Thoracic Wall; Tomography, X-Ray Computed | 2008 |
[Detection of metastases in breast cancer patients: comparison of FDG PET with chest X-ray, bone scintigraphy and ultrasound of the abdomen].
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiography, Thoracic; Retrospective Studies; Ultrasonography | 2008 |
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
Topics: Breast; Breast Neoplasms; Deoxyglucose; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Radioligand Assay; Receptors, Estrogen; Tomography, Emission-Computed | 1995 |
Fluorine-18-fluorodeoxyglucose-guided breast cancer surgery with a positron-sensitive probe: validation in preclinical studies.
Topics: Animals; Beta Particles; Breast Neoplasms; Deoxyglucose; Equipment Design; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Mammary Neoplasms, Experimental; Phantoms, Imaging; Radioimmunodetection; Rats; Rats, Inbred Lew | 1995 |
Presurgical visualization of primary breast carcinoma with PET emission and transmission imaging.
Topics: Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Preoperative Care; Tomography, Emission-Computed | 1995 |
Keeping abreast of time.
Topics: Adult; Breast Neoplasms; Breast Self-Examination; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Magnetic Resonance Imaging; Mammography; Middle Aged; Radioimmunodetection; Receptors, Somatostatin; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Ultrasonography, Mammary | 1995 |
Positron emission tomography: 2-deoxy-2-[18F]-fluoro-D-glucose uptake in locally advanced breast cancers.
Topics: Adult; Aged; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Predictive Value of Tests; Tomography, Emission-Computed | 1995 |
Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings.
Topics: Adult; Aged; Breast Neoplasms; Breast Neoplasms, Male; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Mammography; Middle Aged; Tomography, Emission-Computed | 1994 |
Detection of breast cancer in women after augmentation mammoplasty using fluorine-18-fluorodeoxyglucose-PET.
Topics: Adult; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Mammaplasty; Prostheses and Implants; Silicone Elastomers; Tomography, Emission-Computed | 1994 |
Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Tomography, Emission-Computed | 1993 |
Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.
Topics: Blood; Body Weight; Bone Marrow; Breast; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Liver; Lung; Middle Aged; Spleen; Tissue Distribution; Tomography, Emission-Computed | 1993 |
Positron emission tomography of glucose metabolism in breast cancer. Potential for tumor detection, staging, and evaluation of chemotherapy.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Tomography, Emission-Computed; Xeromammography | 1993 |
[Whole body positron emission tomography in breast cancer].
Topics: Adenocarcinoma; Adenofibroma; Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Prospective Studies; Tomography, Emission-Computed | 1993 |
Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer.
Topics: Adenocarcinoma; Adult; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Tomography, Emission-Computed | 1993 |
Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Tomography, Emission-Computed | 1993 |
Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.
Topics: Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Staging; Time Factors; Tomography, Emission-Computed; Ultrasonography, Mammary | 1996 |
Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm, Residual; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography, Mammary | 1996 |
Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT.
Topics: Breast Neoplasms; Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1996 |
FDG-PET screening for cerebral metastases in patients with suspected malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Retrospective Studies; Sarcoma; Testicular Neoplasms; Tomography, Emission-Computed | 1996 |
Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Deoxyglucose; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Time Factors; Tomography, Emission-Computed | 1996 |
1996 SNM annual meeting: medical problem solving.
Topics: Artifacts; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Dementia; Deoxyglucose; Eye Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Therapy; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasms; Radioisotopes; Radiotherapy; Rhenium; Societies, Medical; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Stereotactic coordinates from ECT sinograms for radionuclide-guided breast biopsy.
Topics: Biopsy, Needle; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Phantoms, Imaging; Software; Stereotaxic Techniques; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry.
Topics: Axilla; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
[Detection of multi-focal breast carcinoma using 2[18F] fluoro-deoxy-D-glucose positron emission tomography (FDG-PET)].
Topics: Adult; Blood Glucose; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Deoxyglucose; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Glycolysis; Humans; Neoplasm Staging; Neoplasms, Second Primary; Tomography, Emission-Computed | 1996 |
Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Deoxyglucose; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]tyrosine PET.
Topics: Blood Glucose; Breast; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Ductal, Breast; Deoxyglucose; Female; Fibrocystic Breast Disease; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed; Tyrosine | 1997 |
'False-positive' uptake of FDG in a hepatic adenoma.
Topics: Adenoma; Adult; Breast Neoplasms; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Breast imaging with fluorine-18-FDG PET: quantitative image analysis.
Topics: Breast Diseases; Breast Neoplasms; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Tomography, Emission-Computed | 1997 |
[PET scan in general practice for diagnosis of breast carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Breast; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
Topics: Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
[Positron-emission tomography in oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Middle Aged; Neutrophils; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed | 1998 |
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
Topics: Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Differentiation of cardiac tumor from thrombus by combined MRI and F-18 FDG PET imaging.
Topics: Adult; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Diseases; Heart Neoplasms; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Thrombosis; Tomography, Emission-Computed | 1998 |
Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Chromatography, Thin Layer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Phosphorylation; Radiopharmaceuticals; Tomography, Emission-Computed; Tumor Cells, Cultured | 1998 |
Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multivariate Analysis; Prognosis; Tomography, Emission-Computed | 1998 |
[Muscle uptake of 18FDG in positron emission tomography].
Topics: Antineoplastic Agents; Anxiety; Breast Neoplasms; Diazepam; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Muscle Contraction; Muscle Relaxants, Central; Muscle, Skeletal; Peripheral Nervous System Diseases; Radiopharmaceuticals; Skin Neoplasms; Tissue Distribution; Tomography, Emission-Computed | 1998 |
Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images.
Topics: Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
FDG PET evaluation of granular cell tumor of the breast.
Topics: Breast Neoplasms; Diagnostic Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
F-18 FDG whole-body positron emission tomography scan in primary breast sarcoma.
Topics: Adolescent; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Phyllodes Tumor; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Incidental second primary in the breast detected by F-18 FDG positron emission tomography scan.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Second Primary; Radiopharmaceuticals; Teratoma; Tomography, Emission-Computed | 1998 |
Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 1998 |
F-18-FDG uptake in tuberculosis.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paget's Disease, Mammary; Radionuclide Imaging; Radiopharmaceuticals; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 1998 |
Lactating breast exhibiting high F-18 FDG uptake.
Topics: Adult; Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lactation; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
Topics: Adult; Aged; Breast Neoplasms; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Receptors, Estrogen; Survival Rate; Tomography, Emission-Computed | 1996 |
Evaluation of the detectability of breast cancer lesions using a modified anthropomorphic phantom.
Topics: Axilla; Breast Neoplasms; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Models, Anatomic; Phantoms, Imaging; Radiopharmaceuticals; Thorax; Tomography, Emission-Computed | 1998 |
Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Estrogen; Tamoxifen; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer.
Topics: Adult; Breast Neoplasms; Case-Control Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Prospective Studies; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1999 |
Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
Topics: Aged; Axilla; Brachial Plexus; Breast Neoplasms; Chemotherapy, Adjuvant; Clavicle; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Modified Radical; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Peripheral Nervous System Diseases; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Thoracic Neoplasms; Tomography, Emission-Computed | 1999 |
Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Middle Aged; Phantoms, Imaging; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
A new look at breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
False-positive positron emission tomographic scan for recurrent breast cancer resulting from a bee sting.
Topics: Adult; Animals; Axilla; Breast Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Hymenoptera; Insect Bites and Stings; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Spleen; Tomography, Emission-Computed | 1999 |
Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Topics: Biological Transport; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cell Membrane; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Enzymologic; Glucose Transporter Type 1; Hexokinase; Humans; Isoenzymes; Kinetics; Liver Neoplasms; Monosaccharide Transport Proteins; Radiopharmaceuticals; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1999 |
A small breast cancer detected by PET.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Detection of cancer in augmented breasts by positron emission tomography.
Topics: Axilla; Breast; Breast Implantation; Breast Implants; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Effect of patients' being prone during FDG PET for the diagnosis of breast cancer.
Topics: Adult; Aged; Blood Glucose; Breast; Breast Neoplasms; Calcinosis; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Predictive Value of Tests; Prone Position; Supine Position; Tomography, Emission-Computed | 1999 |
Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Prospective Studies; ROC Curve; Tomography, Emission-Computed | 1999 |
Effect of attenuation correction on lesion detectability in FDG PET of breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
To AC or not to AC: that is the question.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
F-18 FDG uptake in breast infection and inflammation.
Topics: Adult; Breast; Breast Diseases; Breast Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematoma; Humans; Mastitis; Middle Aged; Postoperative Hemorrhage; Radiopharmaceuticals; Staphylococcal Infections; Tomography, Emission-Computed; Tuberculosis | 2000 |
F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Respiratory Tract Infections; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Positron emission mammographic instrument: initial results.
Topics: Adult; Aged; Algorithms; Breast; Breast Neoplasms; Efficiency; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Mammography; Middle Aged; Phantoms, Imaging; Radiographic Image Enhancement; Radiopharmaceuticals; Software; Time Factors; Tomography, Emission-Computed | 2000 |
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Prednisolone; Radiopharmaceuticals; Sensitivity and Specificity; Taxoids; Tomography, Emission-Computed; Vincristine | 2000 |
[Diagnostic evaluation of the breast using PET: optimization of data acquisition and postprocessing].
Topics: Algorithms; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Radionuclide Imaging; Radiopharmaceuticals | 2000 |
Positron emission tomography with fluorine-18 fluorodeoxyglucose to evaluate response of early breast carcinoma treated with stereotaxic interstitial laser therapy.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Laser Coagulation; Middle Aged; Radiopharmaceuticals; Stereotaxic Techniques; Tomography, Emission-Computed | 2000 |
Comparative efficacy of positron emission tomography and ultrasonography in preoperative evaluation of axillary lymph node metastases in breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography | 2000 |
Lymph node metastasis from breast cancer diagnosed by F-18 FDG whole-body PET (case report).
Topics: Adenocarcinoma; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Tomography, Emission-Computed | 2000 |
Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Mammography; Middle Aged; Pilot Projects; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Limited angle, limited approach?
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Squamous Cell; Coordination Complexes; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; Free Radical Scavengers; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Radiopharmaceuticals; Reference Values; Regional Blood Flow; Thiosemicarbazones; Tissue Distribution; Tomography, Emission-Computed | 2000 |
[1959-1999: from serum markers to 18-FDG in oncology. The experience of the René-Huguenin Center].
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; CA-125 Antigen; CA-19-9 Antigen; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Neoplasm Proteins; Ovarian Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Hypoxia-Induced increase in FDG uptake in MCF7 cells.
Topics: 4-Chloromercuribenzenesulfonate; Breast Neoplasms; Cell Hypoxia; Cell Line; Dithiothreitol; Female; Fluorodeoxyglucose F18; Hexokinase; Humans; Monosaccharide Transport Proteins; Tritium; Tumor Cells, Cultured | 2001 |
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
Topics: Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunohistochemistry; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
F-18 FDG positron emission tomography in primary breast non-Hodgkin's lymphoma.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Similar pelvic abnormalities on FDG positron emission tomography of different origins.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Pelvic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
SIMS ion microscopy in cancer research: single cell isotopic imaging for chemical composition, cytotoxicity and cell cycle recognition.
Topics: Animals; Breast; Breast Neoplasms; Calcium; Cations; Cell Cycle; Cell Death; Cell Line; Epithelial Cells; Female; Fluorine; Fluorodeoxyglucose F18; Freeze Drying; HeLa Cells; Humans; Kidney; Microscopy, Confocal; Pyrimidines; S Phase; Spectrometry, Mass, Secondary Ion; Swine; Thapsigargin; Thiones; Tumor Cells, Cultured | 2001 |
Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 2001 |
A case of cerebral metastases of unknown origin: utility of F-18 FDG positron emission tomography to localize the primary tumor.
Topics: Aged; Brain Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Noise reduction in oncology FDG PET images by iterative reconstruction: a quantitative assessment.
Topics: Algorithms; Breast Neoplasms; Colonic Neoplasms; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Phantoms, Imaging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Medicine; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Referral and Consultation; Specialization; Surveys and Questionnaires; Tomography, Emission-Computed | 2001 |
Re: Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Tomography, Emission-Computed | 2001 |
Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
FDG PET for evaluating breast cancer.
Topics: Blue Cross Blue Shield Insurance Plans; Breast Neoplasms; Device Approval; Drug Approval; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2001 |
Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; DNA-Binding Proteins; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lymphocytes; Microcirculation; Middle Aged; Monosaccharide Transport Proteins; Necrosis; Nuclear Proteins; Radiopharmaceuticals; Regional Blood Flow; Tomography, Emission-Computed; Transcription Factors | 2002 |
11C-methionine PET imaging of leptomeningeal metastases from primary breast cancer--a case report.
Topics: Breast Neoplasms; Carbon Isotopes; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Methionine; Middle Aged; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2002 |
[A case report. FDG-PET in occult breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet!
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2002 |
Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomography.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Drug Monitoring; Epirubicin; Female; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Paclitaxel; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.
Topics: Adult; Aged; Blood Flow Velocity; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Oxygen Radioisotopes; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Water | 2002 |
Symposium of breast imaging.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromatography, High Pressure Liquid; Deoxyglucose; Drug Screening Assays, Antitumor; Fluorodeoxyglucose F18; Humans; Phosphorylcholine; Tomography, Emission-Computed; Tumor Cells, Cultured | 1992 |
The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease.
Topics: Adolescent; Adult; Aged; Axilla; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Tomography, Emission-Computed | 1992 |
Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose.
Topics: Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Tomography, Emission-Computed | 1991 |
Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Breast Neoplasms; Deoxyglucose; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Tomography, Emission-Computed | 1991 |
[18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Deoxy Sugars; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Radionuclide Imaging | 1989 |